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Abstract
Background: Traditional psychosocial treatments have been adapted for use with
individuals with bipolar affective disorders due to the limited prophylactic nature of
pharmacotherapy and the recognition of the role of psychosocial factors in the course of
this disorder. Psychosocial interventions that include a prodromal monitoring and
management component have been empirically shown to be an effective adjunct to
medication for the treatment of bipolar disorder.
Aims: There is a deficit of quantitative research that examines the impact of individual-
related (e.g. age, self-efficacy), disorder-related (e.g. time since diagnosis, experience of
prodromal symptoms) and treatment-related (e.g. level of psychosocial input) factors on
individuals’ ability to manage this disorder via the use of prodromal monitoring. The
current research aimed to investigate factors that are associated with the identification
and management of prodromal symptoms.
Method:  Participants completed five self-report measures in order to provide
information on their experience of prodromal symptoms, current mood state, general
self-efficacy, view of social support from significant others, and demographic and
clinical-related variables. The data were collected from 101 participants, 58 of whom
were female. The sample consisted of individuals with a diagnosis of bipolar disorder
type I and II.
Results: Univariate and bivariate analyses were used to explore the relationship between
individual, disorder, and treatment-related variables associated with participants’
experience of bipolar disorder. Variables that were significantly associated with
participants’ perception of their ability to identify and manage prodromes were further
investigated using ordinal logistic regression analyses.
The results indicated that general self-efficacy and prodromal-specific help from
significant others were associated with an increase in participants’ perception of their
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ability to identify manic and depressive prodromal symptoms. General self-efficacy was
also associated with participants’ view of their ability to manage cognitive and
behavioural prodromes. Experience of prodromal symptoms (e.g. consistency of
symptoms experienced, type of prodrome experienced) was associated the participants’
perception of their ability to identify and manage prodromes. In general, disorder-related
variables (e.g. time since diagnosis, mood state, diagnosis type, and number of episodes
experienced) were not significantly associated with the participants’ view of their ability
to identify and manage prodromal symptoms. Individual-related variables such as gender
and age, however, were associated with prodromal identification.
Conclusion: The results indicated the need to consider constructs such as general self-
efficacy and experience of prodromal symptoms (e.g. consistency of symptoms, types of
prodromes experienced, and ability to recognise prodromes when they first present)
when helping patients to learn how to identify and manage prodromal symptoms. In
addition gender differences and the role of help from significant others were highlighted
as variables that should be considered when using prodromal monitoring approaches
with patients with bipolar disorder. Limitations of the research are reviewed in relation





This chapter presents information on the course of bipolar affective disorders, diagnostic
criteria, and potential social and emotional disorder-related consequences. Aetiological
and maintenance factors are also discussed with reference to psychosocial factors.
Information on treatment approaches for bipolar disorders (e.g. Cognitive Behavioural
Therapy and Family Focused Therapy) is then provided. Lastly, the role of prodromal
monitoring, as a self-management approach, is discussed.
1.2 Bipolar disorder and diagnostic criteria
The clinical course of bipolar disorder can range from mild depression and brief
hypomania to severe psychotic mania or depression (Emilien et al., 2007). The manic
phase lasts for a minimum of one week and is characterised by abnormally and
persistently elevated mood (APA, 2000). During a manic episode cognitive, behavioural,
and affective symptoms can be experienced. Common manic symptoms experienced by
individuals include extreme optimism, increased self-worth, racing thoughts, reduced
need for sleep, increased activity, agitation, restlessness, inability to concentrate,
irritability, and poor judgement. During the depressive phase, which lasts for a minimum
of two weeks, cognitive, behavioural, and affective symptoms can also be experienced
(APA, 2000). Common depressive symptoms include low self-esteem, suicidal thoughts,
difficulty concentrating, sense of hopelessness, changes in eating and sleeping patterns,
and a loss of interest in enjoyable activities. Individuals can also experience mixed
episodes which are characterised by the presence of both mania and major depression for
at least a one-week period (APA, 2000).
The diagnostic criteria for bipolar disorder were first provided in the American
Diagnostic and Statistical Manual in 1980 (DSM-III: American Psychiatric Association,
1980). Diagnostic criteria were later included in the World Health Organization
Classification of Diseases (ICD-10, WHO, 1992). The DSM-IV (1999) diagnostic
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criteria tend to be used in this research area. For the DSM-IV diagnostic criteria for
manic, depressive, mixed and hypomanic episodes refer to Appendix 1.
While the potential for there to be up to seven subtypes of bipolar disorder has been
recognised (Akiskal & Pinto, 1999), this disorder is generally discussed with reference
to two types – bipolar I disorder and bipolar II disorder. In order for a diagnosis of
bipolar I disorder to be given, an individual has to have had at least one manic episode
during their psychiatric history in addition to recurrent depressive episodes. Individuals
diagnosed as having bipolar II disorder will have experienced recurrent depressive
episodes with hypomanic episodes (i.e. episodes that do not reach the criteria for manic
episodes, APA, 2000). When individuals experience four or more episodes in a 12-
month period they are given a rapid cycling specifier (APA, 2000).
1.2.1 Issues associated with the diagnosis of bipolar disorder
Bipolar disorder is commonly misdiagnosed and accurate diagnoses can be subsequently
delayed over 10 years (Hirschfeld, 2001). Ruggero et al., (2010) carried out a
prospective study in which the diagnostic consistency, in a first admission sample (N =
195), was reviewed on four admission occasions over a 10-year period. They concluded
that 49.3 percent of the participants were inconsistently diagnosed at least once in the
course of 10 years.
Delays to a bipolar disorder diagnosis or inaccurate diagnoses may result from disorder
and or clinical-related issues. For example, patients may fail to seek help when they are
manic or hypomanic because these mood states are not recognised as abnormal
(Hirschfeld, 2004). When individuals first present with depression, clinicians may not
enquire about past manic symptoms (Brickman et al., 2002) or patients may not recall or
report manic episodes. Other factors that can result in diagnostic inconsistency include
greater number of psychiatric symptoms, a high presence of psychotic symptoms, a low
level of general functioning, and a change in presentation over the course of the disorder
(Ruggero et al., 2010). While there are clear diagnostic criterion for the mood states
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associated with bipolar disorders (i.e. DSM-IV, APA, 2000) the disorder’s
characteristics and course are complex and vary among individuals (Emilien et al.,
2007): the idiosyncratic nature of this disorder can further complicate a diagnosis.
The high rate of co-morbidity observed in individuals with bipolar disorder can also
complicate accurate diagnosis. McElroy et al., (2001) examined rates of co-morbidity in
a sample of 288 outpatients with bipolar I and II disorder. They concluded that 65
percent of the sample met criteria for Axis l disorder, 42 percent for anxiety disorders,
42 percent for substance misuse, and 5 percent for eating disorders. Other common co-
morbidities include personality disorder (Akiskal et al., 1985) and attention-deficit
hyperactivity disorder (ADHD, Oswald et al., 2007).
1.3 The course of bipolar disorder
The prevalence of bipolar disorder is estimated at 0.8 percent to 1.6 percent of the
population (e.g. Kessler et al., 1997). Research places the average age of onset between
19 years (Burke, 1990) and 28 years of age (Goodwin & Jamison, 2007). The frequency
of which bipolar disorder first presents declines with age: 6 percent to 8 percent of first
time presentations develop in persons aged 60 years and older (Emilien et al., 2007).
There is no discrepancy between prevalence rates for males and females for bipolar I
disorder. More females than males, however, are thought to suffer from bipolar II
disorder (Oswald et al., 2007). In addition, more females are given a rapid cycling
specifier (Emilien et al., 2007).
Manic and depressive episodes are generally recurrent: for example, more than 90
percent of individuals who have a single manic episode will go on to have future
episodes (Gitlin et al., 1995).  It is estimated that individuals will experience a mean of
eight episodes (five manic and three depressive) during the course of their illness (ten
Have et al., 2002). However, between 10 percent to 15 percent of patients will have
more than 10 episodes in their lifetime (Goodwin & Jamison, 2007). There is a positive
linear relationship between the number of episodes experienced and relapse rates (Maj,
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1999). Estimates place relapse rates at 40 percent in a 1-year period, 60 percent in a 2-
year period, and almost 75 percent within 5-year period (e.g. Tohen et al., 1990). It is
worth noting that when the number of episodes experienced is assessed for research or
audit purposes hospital admissions tend to be used as of measure of relapse. Therefore
relapse rates may be higher as episodes managed within the community (e.g. by home
treatment teams) may not be included in such figures. Information regarding the
potential social and emotional impact of bipolar disorder is presented in section 1.4.
1.4 The social and emotional impact of bipolar disorder
Bipolar disorder is a severe condition that is associated with high levels of functional
impairment, morbidity, and suicide (Oswald et al., 2007). This disorder can have a
detrimental effect on social functioning due to substantial impairments in work, family,
and social relationships even after acute symptoms have resolved (Keck et al., 1998).
Between 30 percent and 60 percent of individuals with bipolar disorder fail to regain full
functioning in occupational and social domains when in remission (MacQueen et al.,
2001); this may be due to the high rate of inter-episode symptoms (e.g. poor sleep)
experienced by individuals with bipolar disorder (e.g. Gitlin et al., 1995).
Repeated hospitalisations and recurrent episodes are highly disruptive to the patients'
functioning in everyday life (Lam et al., 2000). High rates of divorce (Kessler et al.,
1998) and unemployment (Goldberg et al., 1995) are also observed in this group.
Furthermore, individuals with bipolar disorder experience a high rate of stigmatisation
(Hayward et al., 2002).
Individuals with bipolar disorder are at increased risk of suicide and self-harm (Novick
et al., 2010). Approximately 25 percent to 50 percent of individuals with this disorder
attempt suicide on one occasion (Jamison, 2000). A recent meta-analysis concluded that
there is no difference in the risk of suicide for individuals with bipolar I and II disorder
(Novick et al., 2010).
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Bipolar disorder is viewed as a debilitating chronic mental illness (e.g. Oswald, et al.,
2007). Consequently, pharmacotherapy and psychosocial therapeutic approaches have
been developed as treatment options. Information regarding these interventions is
presented in section 1.5 and 1.6.
1.5.Pharmacotherapy treatment for bipolar disorder
Pharmacotherapy has historically been the first line treatment for bipolar disorder. This
may be partially due to pharmacotherapy trials that demonstrate the prophylactic nature
of Lithium and other anticonvulsant drugs in controlling cycling of mood states (Alloy et
al., 2005; Lam & Wong, 2005). A further explanation may involve the perceived
aetiological factors (i.e. genetic and biological predisposition) associated with the onset
of bipolar disorder and the subsequent influence this has had on the early development
of treatment options. For example, bipolar disorder has a well documented genetic
determinant as evidenced by adoption, family, and twin studies (Finn, 2007); heritability
estimates are as high as 85 percent (McGuffin et al., 2003).
While clinical drug trials demonstrate that Lithium, anticonvulsants, and antipsychotic
agents are effective in stabilising acute symptoms of bipolar disorder maintenance, drug
treatment is associated with relapse even when drug regimes are optimised (Miklowitz et
al., 2003). Approximately one third of bipolar disorder patients relapse while being
prescribed Lithium treatment (e.g. Goodwin & Geddes, 2003). Figures for other
pharmacological alternatives (e.g. Sodium Valproate and Carbamazepine) show a
similar rate of relapse (Jones, 2004).
One explanation for the observed relapse rate may involve an inconsistent medication
adherence that is common among people with bipolar disorder (Lam & Wong, 2005;
Strober et al., 1990).  Non-adherence may be due to problems engaging in long-term
medication use (e.g. issues with accepting the diagnosis, side effects of medication) or
due to individuals choosing to stop medication in order to experience the mood state
associated with manic episodes (Lam & Wong, 2005).
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While it is generally agreed that there is a genetic and biological predisposition to
bipolar disorder, these processes are unable to fully account for different expression,
timing, and polarity of symptoms (O’Connell, 1986). Therefore, psychosocial theories
have been postulated to explain aetiological-related aspects. For example, the stress-
diathesis model (e.g. Frank et al., 1994) recognises the interaction between stressful life
events and predisposed biological, biochemical, and neurological instabilities in the
onset of bipolar disorder in vulnerable individuals (e.g. those genetically predisposed to
developing the disorder). This model therefore recognises the contribution of both
genetic and psychosocial factors in the development and subsequent maintenance of
bipolar disorder.
In recent years, there has been a shift from the sole management of bipolar disorder via
pharmacotherapy to a combined hierarchical treatment model in which pharmacotherapy
and psychosocial interventions both feature. Prior to discussing psychosocial
interventions, information pertaining to psychosocial explanations for the onset of
bipolar disorder episodes is presented in section 1.6.
1.6 Overview of psychosocial models for bipolar disorder
The following five psychological models are associated with the onset and maintenance
of manic and depressive episodes in bipolar disorder: Behavioural Activation/Inhibition
Systems model (Gray, 1990); Cognitive Therapy model (Lam et al., 1999); the
Interpersonal and Social Rhythm Therapy approach (Frank, et al., 1999); the Interacting
Cognitive Subsystems approach (Barnard, 1985); and the Schematic, Propositional,
Analogical, Associative Representation Systems (SPAARS) approach (Power &
Dagleish, 1997, cited in Power, 2005). Information relating to the Cognitive Therapy
model and Interpersonal and Social Rhythm Therapy approach will be discussed as they
are relevant to the current research. For a detailed discussion of the main psychological
models refer to Power’s (2005) theoretical critique.
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1.6.1 Cognitive Therapy Model
The cognitive model for bipolar disorder is based on the cognitive model for affective
disorder (Beck, 1967). The bipolar model also takes biological, psychological, and social
elements into account (Wright & Lam, 2004). The model purports that the onset of
manic and depressive episodes are associated with dysfunctional schemas, life events,
goal attainment-striving, and the paradoxical nature of an individual’s need for support
versus a desire to be autonomous.
1.6.1.1 Depressive episodes
Within the model it is proposed that individuals with dysfunctional schemas are prone to
develop depression (Wright & Lam, 2004). Dysfunctional schemas increase the
likelihood of a negative appraisal of situations and contexts and can be activated during
negative life events (Alloy et al., 2005). Once an individual is in a depressed state and
their dysfunctional schemas are activated, they can become biased towards making
thinking errors and subsequently experience an increase in negative automatic thoughts.
An increase in negative thoughts can serve to maintain a depressive state. When the
individual is remitted, dysfunctional assumptions are assumed to be latent (Wright &
Lam, 2004).
Anti-dependency beliefs have also been implicated in the onset and maintenance of
depressive episodes. Lam et al., (2004) found that remitted bipolar patients endorsed
more anti-dependency beliefs than euthymic unipolar patients. It appears that individuals
with bipolar disorder hold paradoxical beliefs concerning support of others as they may
validate their personal worth via others while also maintaining a desire to be
independent (Wright & Lam, 2004). This conflict may generate further perceptions of
failure and frustration for individuals during depressive episodes. Therefore,
autonomous beliefs are thought to act as a maintenance factor in bipolar depression
(Wright & Lam, 2004).
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1.6.1.2 Manic episodes
To account for the onset of manic episodes within the framework of the cognitive model,
Lam et al., (1999) highlighted the role of goal striving and attainment achievement
oriented attitudes for individuals with bipolar disorder. It is purported that such attitudes
lead to extreme striving behaviour and consequently a disruption in an individual’s
routine, sleep pattern, exercise, and diet. Goal striving behaviour that disrupts sleep-
wake routines can lead to onset of bipolar disorder episodes as social and circadian
rhythms are disrupted (Malkoff-Schwartz et al., 2000). The role of goal attainment in the
onset of manic episodes has received support from research conducted by Lozano and
Johnson (2001). They found that achievement-striving scores were predictive of
increased manic symptoms. Furthermore, Johnson et al., (2000) concluded that goal
attainment life events are related to increases in manic symptoms rather than positive
events.
Research findings associated with the impact of goal attainment behaviour may be
understood in terms of a positive feedback loop. A positive feedback loop in individuals
with bipolar disorder can lead to attempts to enhance positive mood states with
increasing goal attainment behaviour, disregard of feedback from others (exacerbated by
activation of anti-dependency beliefs), and the disruption of normal routines (Power,
2005).
Life events are also viewed as a precipitating factor for the onset of manic episodes.
Research shows that bipolar disorder patients experience significantly more excess life
events compared with control participants (e.g. Bebbington et al., 1993). Hammen and
Gitlen (1997) found that patients who relapsed experienced more severe life events and
greater accumulated stress six months prior to an onset of an episode. Neale (1988)
suggested that life events that are perceived as a threat towards self-esteem can trigger
grandiose thoughts that serve to prevent underlying depressive cognitions from being
activated. The activation of such thoughts can, however, result in the onset of a manic
episode. The type of mood-state that follows a life event is determined in part by the
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individual’s emotional response (e.g. feelings of helplessness may result in a depressive
episode or perceived threat to self-esteem may result in a manic episode).  Therefore
manic and hypomanic episodes are assumed to result from a reaction to threat towards
self-esteem and helplessness as a result of the individual trying to gain control.
While there is support for the negative life event hypothesis (e.g. Winters & Neal, 1985),
other research has failed to find support for this explanation. For example, Hall et al.,
(1977) carried out a prospective study using the Schedule of Life events questionnaire.
They did not find a significant difference in the number of life events experienced
among a group of relapsing and non-relapsing bipolar I disorder patients. Similar results
have been found by Hunt et al., (1992) as they concluded that 19 percent of relapses
were preceded by a life event in the month prior to the relapse. Pardoen et al., (1996)
also concluded that life events were not associated with relapse rates. They did,
however, find that hypomanic/manic episodes were associated with an increase in
marital stressors prior to relapse.
1.6.2 Interpersonal and Social Rhythm Therapy (IPSRT) approach
While significantly stressful life events have been implicated as precipitants for the
onset of affective episodes it is recognised that not all episodes are predated by such
occurrences (Malkoff-Schwartz, et al., 2000).  Life events that disrupt daily routines or
trigger goal striving behaviour, are therefore postulated to be potential episodic triggers
(e.g. Miklowitz et al., 2003). Such events are implicated with the onset of both manic
and depressive episodes due to the potential for disruptions in circadian rhythms.
Goodwin and Jamison (2007) proposed that the circadian system, that maintains the
rhythms of physiological functioning within a 24-hour period (Jones, 2004), is a primary
vulnerability factor for bipolar disorder.
A key theoretical construct that is associated with the IPSRT approach is the instability
model of bipolar disorder (Goodwin & Jamison, 1990). The model purports that
individuals with bipolar disorder are vulnerable to disruptions in circadian rhythms.
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Within the instability model taxing life events, medication noncompliance, and social
rhythm disruption are viewed as potential triggers for the onset of a manic or depressive
episode. It is therefore proposed that psychosocial stressors interact with the pre-existing
biological vulnerability to cause symptoms (Swartz et al., 2004).
1.6.3 Critique of the Cognitive Model and the Interpersonal and Social Rhythm
Therapy approach
While there is supporting evidence for the explanatory value of the Cognitive Therapy
model and the Interpersonal and Social Rhythm Therapy approach there are limitations
associated with these approaches. For example, with reference to the Cognitive Therapy
model, Power (2005) has highlighted issues involved in a single schema being able to
change its content and processing features in order to have a negative or positive
influence on the individual.  Power (2005) also asserted that because the model is
cognitively focused it inadequately attends to emotion theories. A further issue
highlighted by Power (2005) includes the complexity of manic episodes and whether
they can be explained by the process of goal attainment leading to the activation of
positive goal attainment schemas.
While research demonstrates that a relationship exists between life events and onset of
bipolar episodes, there is inadequate information regarding the specific life events that
are viewed as risk factors for the onset of an episode: this may be due to idiosyncratic
responses to life events and therefore the difficulty involved in weighting life events in
terms of individuals’ subjectively negative or positive experience of events. Further
limitations in this research area include small sample sizes, lack of clarity concerning the
polarity of episode experienced following a life event, and questions concerning the
extrapolation of findings across the spectrum of bipolar disorder. Alloy et al., (2005)
also highlighted issues around the standardisation of life event measures and how this
term is operationalised in the research area. Issues associated with the impact of the
patients’ mood on the perception of life events (e.g. as negative or positive life events)
were also highlighted by the Alloy et al., (2005): they assert that the majority of the
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research does not control for reporting biases associated with current mood state (e.g.
low mood may result in a negative view of life events which may have previously be
construed as positive events).
1.7 Psychosocial risk factors
Recent life events (e.g. Hammen & Gitlen, 1997), lack of social support (Miklowitz et
al., 1988), high expressed emotion in families (Simoneau et al., 1998), and childhood
affective trauma (Etain et al., 2008) are factors that are recognised as contributing to the
development or maintenance of manic and depressive episodes. For the purposes of the
current research, risk factors concerning social support and high expressed emotion will
be discussed as they are relevant to the current study. The role of recent life events was
discussed in relation to the cognitive model (refer to section 1.5). For a comprehensive
overview of key risk factors, refer to Alloy et al.’s (2005) literature review.
1.7.1 Social support
Research indicates that negative social support results in a worse outcome for bipolar
disorder patients (e.g. Miklowitz et al., 1988). Furthermore, poor social support and low
self-esteem are predictive of longer recovery time (Johnson et al., 1999, 2000). Research
demonstrates that social support from significant others results in a more positive course
(e.g. fewer relapses) of bipolar disorder (Alloy et al., 2005). Lam et al., (1999)
postulated that social support results in independent positive effects on psychological
well-being. They also highlight the protective aspect of social support: social support is
thought to act as a buffer during stressful times. Therefore, social support itself may not
be directly linked to improved psychological health but it may serve to moderate or
mitigate the impact of stressful events thereby reducing the impact of stress on
psychological health.
1.7.2 High expressed emotion in family interactions
Studies that focus on characteristics of family interactions conclude that high expressed
emotion (EE) in parents or spouses is associated with high rates of relapse, poor
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symptomatic outcomes, or both in bipolar patients (Miklowitz et al., 1988). Bipolar
disorder patients from high EE families have been found to have more manic symptoms
compared to those with from low EE families (Simoneau et al., 1998). Rosenfarb et al.,
(2001) examined family interactions involving the individual with bipolar disorder and
significant others. They concluded that family interactions that involved more critical
statements towards the individual with bipolar disorder were associated with higher rates
of relapse.
Due to the recognition of psychosocial factors in the maintenance of bipolar disorder
several psychosocial therapies have been developed or adapted from traditional
therapeutic approaches. Information relating to the main therapeutic approaches for
people with bipolar disorder is presented in section 1.8.
1.8 Psychosocial treatment approaches
Several forms of psychosocial therapy have been shown to be effective adjuncts to
pharmacotherapy for the treatment of bipolar disorder for example: Interpersonal and
Social Rhythm Therapy (IPSRT, e.g. Frank et al., 2002), Family-Focused Treatment
(FFT, e.g. Simoneau et al., 1999), Cognitive Behavioural Therapy (CBT, e.g. Lam et al.,
2000), and Psychoeducation (e.g. Colom et al., 2003a). The aforementioned
psychosocial interventions are discussed in the following sections.
1.8.1 Interpersonal Social Rhythms Therapy (IPSRT)
IPSRT (e.g. Frank et al., 2002) is derived from Interpersonal Therapy (IPT, Klerman et
al., 1984). It is based on the theoretical assumption that life events can serve to disrupt
social rhythms and circadian rhythms thereby making a patient with bipolar disorder
vulnerable to a relapse. IPSRT grew from a chronobiological model of bipolar disorder
that asserts that individuals with this disorder have a genetic predisposition to circadian
rhythm and sleep–wake cycle abnormalities (Frank et al., 2000). In line with this
approach it is proposed that it is a disruption to sleep-wake cycle that may be partly
responsible for the symptoms associated with bipolar disorder (Frank et al., 2000).
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Within this therapeutic approach the patient is taught how to monitor and stabilise their
sleep-wake cycle thereby stabilising irregular social rhythm (i.e. daily and nightly
routines). Additional aims include helping the patient to identify triggers that are likely
to disrupt normal social rhythms, to monitor their mood state, and to monitor social
interactions. Psychoeducation about bipolar disorder also features in this approach
(information on psychoeducation is provided in section 1.8.4). Another therapeutic focus
involves helping patients to resolve interpersonal problems, that co-existed with the
most recent episode (Miklowitz & Scott, 2009), by focusing on one of four areas (i.e.
grief, interpersonal role transition, role dispute, and interpersonal deficits). Issues in
these areas are addressed through a range of approaches (e.g. eliciting and defining the
salient problem area, supported grieving/emotional processing, and problem solving).
While research in this area has been limited to date, findings demonstrate that IPSRT is
an effective therapy for helping patients to maintain a euthymic mood state (e.g. Frank et
al., 1999, Frank et al., 2007).
1.8.2 Family-Focused Therapy
In Family-Focused Therapy (FFT, Simoneau et al., 1999) a therapist works with the
patient and their family members to provide psychoeducation, communication training,
and problem solving skills. Family members’ attitudes towards bipolar disorder are also
reviewed. Family members and the patient jointly work with the therapist to develop
relapse prevention plans.
Collectively, research demonstrates that FFT is an effective therapy for reducing relapse
rates with and without pharmacotherapy (Miklowitz & Goldstein, 1990). Long-term
beneficial effects have also been observed at a two-year follow-up (Miklowitz et al.,
2003).
1.8.3 Cognitive Behavioural Therapy
Cognitive Behavioural Therapy (CBT) focuses on helping individuals develop skills to
moderate their subjective experiences of real and perceived stressors (Beck et al., 1979).
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CBT for people with bipolar disorder can be delivered in a group format (e.g. Castle et
al., 2007) or on a one-to-one basis (e.g. Lam et al., 2000). Miklowitz et al., (2007) have
summarised the key components of CBT for individuals with bipolar disorder as
consisting of:
• psychoeducation on the course of the disorder and medication adherence,
• stress management,
• life events scheduling for reducing over-stimulation,
• cognitive restructuring,
• problem solving,
• strategies for the early detection and management of prodromal symptoms, and
• learning how to challenge negative automatic thoughts and dysfunctional beliefs.
In general, research is supportive of the benefits of CBT for individuals with bipolar
disorder in relation to relapse prevention (i.e. reducing time to relapse) (e.g. Lam et al.,
2001, 2003; Zaretsky et al., 1999). Scott et al., (2006), however, did not find a beneficial
effect for reducing relapse rates with this approach. They concluded that illness history
may interact with the individual’s response to CBT and that fewer episodes are
associated with a stronger relapse prevention effect. However, a recent systematic
review conducted by Lam et al., (2009) found no conclusive evidence to indicate that
illness history is implicated in relation to the observed benefits of CBT.
The non-significant effect observed in the Scott et al., (2006) study may be associated
with their research sample as participants who were acutely unwell were included in
their sample. The majority of research that examines the effectiveness of CBT, for
individuals with bipolar disorder, recruit euthymic participants for both the experimental
and control groups. For example, a research inclusion criterion often specifies that
participants need to be euthymic for a minimum period of six months (e.g. Colom et al.,
2009). While a non-significant effect was observed in the Scott et al., (2006) study this
research does provides important information into when CBT is appropriate for
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individuals with bipolar disorder: the results indicate that individuals who are currently
experiencing a manic or depressive episode may not be appropriate for this type of
therapy and that it is more appropriate for individuals who are in remission.
1.8.4 Psychoeducation
The aim of psychoeducation is to provide theoretical and practical information to
individuals (and significant others when appropriate) to help them understand and cope
with the consequences of their illness, to improve medication adherence, to reduce
suicide risk, and to improve social and occupational function and quality of life (Colom
& Vieta, 2004); this approach therefore goes beyond increasing medication compliance.
Psychoeducation is generally provided on an outpatient basis when the individual is no
longer acutely unwell. It can be delivered on a one-to-one basis or in a group format.
While this approach is viewed as a foundation for more comprehensive treatment
programmes (e.g. FFT and CBT), it can be offered as a stand-alone intervention.
Research demonstrates that psychoeducation can improve medication adherence (e.g.
Peet & Harvery, 1991), increase the individual’s knowledge about their illness, and
increase the length of time between episodes (e.g. Colom et al., 2003).
1.8.5 Similarities between Psychoeducation, CBT, IPSRT and FFT treatment
models
Although there is an emerging evidence base regarding the effectiveness of
psychological interventions for individuals with bipolar disorder, there is limited
evidence regarding the superiority of any particular therapy. This may be due to the
considerable overlap in the treatment modalities and treatment aims. For example, these
approaches all include a psychoeducation component and aim to promote routine and
structure in the individual’s life.
An additional shared aim of the approaches is to empower the individual by helping
them learn how to take an active role in their treatment.  Prodromal monitoring, which
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also features in the aforementioned therapies, is a therapeutic approach that enables
individuals to become actively involved in their illness management. The fundamental
principles of prodromal monitoring and research evidence that examines individual’s
experience of prodromal symptoms is discussed in section 1.9.
1.9 Self-management and psychosocial interventions
Key aims of self-management for chronic mental health conditions include involving the
individual as an active partner in their illness management, improving self-efficacy and
self-esteem. Patient surveys in the United States and the United Kingdom show that
individuals with chronic conditions desire both self-help and psychological treatments in
addition to pharmacotherapy (Hill & Shepard, 1996; Lish et al., 1994).
Prodromal monitoring (which is also known as early symptom monitoring) is an
effective way to involve an individual with bipolar disorder in his or her treatment
management. The goal of prodromal monitoring is to reduce the likelihood of
progression to a full-blown episode. This approach was originally developed for the
prevention of psychotic disorders, in particular schizophrenia (Schwannauer, 2004). It
has now been adapted for use with individuals with bipolar disorder (e.g. Lam & Wong,
1997). Information relating to prodromal monitoring is discussed in the following
section.
1.9.1 Prodromal  monitoring for individuals with bipolar disorder
Prodromes are defined as cognitive, behavioural, or affective signs of symptoms that
precede a manic or depressive episode (Lam & Wong, 2005). Prodromal symptoms are
thought to result from a combination of biology, psychological make-up, and past
experiences (Lam & Wong, 2005). They present during the interval between the time
that symptoms are first recognised to the time when symptoms reach a maximum
severity (Molnar et al., 1988). Prodromes are differentiated from residual symptoms that
can follow an episode (Morriss, et al., 2002) and subsyndromal symptoms (e.g.
symptoms that do not reach the severity of episodic symptoms). Detection and
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subsequent management of prodromal symptoms can assist in preventing an episode or
reducing the severity of an episode (e.g. Joyce, 1985; Perry et al., 1999).
The clinical psychologist’s role in prodromal monitoring work is to help the patient
identify the pattern of their prodromal symptoms and to develop coping strategies to
manage these symptoms. Patients are encouraged to consider their prodromal symptoms
in relation to mood, cognition, and behavioural symptoms and with reference to the
context in which they occur (e.g. social situations) (Lam et al., 1999). The next stage
involves categorising the symptoms into early, middle, and late stage with reference to
their temporal presentation. The clinician then works with the patient to help them to
develop ways to cope with manic and depressive prodromes. Strategies can involve
cognitive and behavioural techniques, lifestyle regulation (e.g. avoiding over stimulating
environment, sleep management), or seeking help and support from a significant other or
mental health professional.  Mood monitoring charts and self-report measures such as
the Internal State Scale (ISS, Bauer et al., 1991) can also help patients to identify
changes in their mood state that may be indicative of prodromal symptoms.  While this
approach is effective it is dependent upon a patient’s ability to identify prodromal
symptoms. Research which has examined the extent to which individuals can identify
these types of symptoms is discussed in section 1.9.2.
1.9.2 Can individuals with bipolar disorder identify manic and depressive
prodromes?
In order to be able to engage in prodromal monitoring individuals need to be able to
identify prodromal symptoms. Research has therefore sought to examine if individuals
with this disorder can reliably identify prodromal symptoms. Jackson et al., (2003)
conducted a systematic review of 17 studies that examined whether individuals with
bipolar can identify prodromal symptoms. A combination of retrospective studies (e.g.
Joyce, 1985) and prospective studies (e.g. Altman et al., 1992) were reviewed. The
methodology employed in relevant research included open-ended interview approaches
(e.g. Joyce, 1985; Molnar et al., 1988; Lam & Wong, 1997) and checklists containing
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commonly reported prodromal symptoms (e.g. Altman et al., 1992; Smith & Tarrier,
1992). Jackson et al., (2003) concluded, on the basis of the aggregated data, that at least
80 percent of the participants could identify one or more prodromal symptoms. A study
conducted by Keitner et al., (1996) interviewed relatives of 45 patients and concluded
that there was strong agreement between patients and relatives regarding the types of
prodromal symptoms experienced by the patient. Collectively, the research findings
provide support for the view that individuals with bipolar disorder can identify
prodromes.
Recent research by Mantere et al., (2008) provides further support for Jackson et al.’s
(2003) findings. Their research involved 191 in-patients and out-patients who were in
the acute phase of bipolar disorder at baseline. The prevalence, type, and duration of
preceding prodromes were investigated using open-ended questions. They concluded
that prodromes were reported by 45 percent of individuals with bipolar I disorder and 50
percent of individuals with bipolar II disorder. They did not find a difference in the type
of prodromes reported by individuals with bipolar I or II disorder. It is worth noting,
however, that the rate of reporting for prodromal symptoms in their sample was less than
that concluded by Jackson et al., (2003). Mantere et al., (2008) acknowledged that
participants' insight into prodromal symptoms might have been affected by the sub-acute
phase experienced at the time of their interviews, which may have compromised the
accurate reporting of prodromal symptoms.
1.9.3 Commomly reported manic and depressive prodromes
Research indicates that individuals report experiencing more prodromes of mania than
depression (e.g. Keitner et al., 1996; Lam & Wong, 1997; and Lam et al., 2001). Lam et
al., (2001) suggested that the observed difference in rate of recall may result from
difficulties experienced in discriminating depressive prodromal symptoms from residual
depressive symptoms. They also postulated that depressive prodromal symptoms that are
somatic and cognitive in nature might be more difficult to monitor. Manic symptoms,
however, were purported by Lam et al., (2001) as being more recognisable due to the
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associated changes in behaviour. Table 1.1 provides a summary of common prodromal
symptoms that were identified by participants in the Lam et al., (2001) study. For
example, Lam et al., (2001). used an interview approach to ask 40 patients about their
experience of prodromal symptoms at baseline and at 18-month follow-up. They found
good test re-test reliability for both manic and depressive prodromes that were reported
by the participants.
Table 1.1 Common mania and depressive prodromal symptoms reported by 40 bipolar
patients (Lam et al., 2001).
Common prodromal symptoms
             Manic prodromal symptoms             Depressive prodromal symptoms
 Not interested in sleep  Loss of interest in activity of people
 More goal-directed behaviour  Can’t put worries or anxieties aside
 Increased sociability  Interrupted sleep
 Thoughts starting to race  Feeling sad or wanting to cry
 Irritable  Low motivation
 Increased optimism  Cannot get out of bed
 Over excitable and restless  Negative thinking
 Spending too much  Feeling tired
 Increased self-esteem  Disinterest in food
 Loss of interest in food
A review of the above common prodromes indicates that individuals are able to
recognise cognitive, affective, and behavioural prodromal symptoms. Research shows
that individuals with bipolar disorder are able to report prodromal symptoms
consistently.
1.9.4 Length of prodromal stage
A study conducted by Molnar et al., (1988) reported that the mean number of days for
mania prodromes was 20.5 (range 1 to 83). The length of depression prodromes was
reported to be a mean of 11 days (range 2 to 31). Smith and Tarrier (1992) concluded
that mania prodromes lasted a mean of 20.5 days with a range of 1 to 84 days. They
found a mean time period of 19 days for depressive prodromes with a range of 2 to 365
days. These studies indicate a wide variation in the duration of depressive  prodromal
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symptoms. This may be due to the manner in which length of phase is defined in the
research or due to individual-related factors.
1.9.5 Methodological issues associated with prodromal identification research
While the research indicates that individuals with bipolar disorder have the ability to
report prodromal symptoms, Mantere et al., (2008) and Lam and Wong (2005) have
identified issues associated with this research area. Mantere et al., (2008) stated that the
research tends to involve small sample sizes and has generally focused on bipolar I
disorder patients. Lam and Wong (2005) emphasised issues involved in individuals
distinguishing between residual and prodromal symptoms. They stated that some
individuals might experience difficulties distinguishing between the onset of prodromal
symptoms and the end of residual symptoms.
Further to the above issues, research in this area has not examined whether there is an
interaction between the individual’s perception of their ability to identify manic and
depressive prodromal symptoms and individual-related factors (e.g. age, gender),
disorder-related factors (e.g. time since diagnosis, number of manic and depressive
episodes experienced), and treatment-related factors (e.g. role of significant others, the
impact of previous and current involvement with mental health services). The potential
relationship between individual, disorder and treatment-related variables on an
individual’s ability to identify and manage prodromal symptoms will be considered in
more detail in Chapter 2.
1.9.6 Summary of prodromal monitoring information
Research evidence indicates that individuals with bipolar disorder can identify both
manic and depressive prodromal symptoms (e.g. Jackson et al., 2003). To investigate
whether prodromal monitoring is an effective approach for reducing relapse rates, a
systematic review was conducted. The methodology, the results and conclusions from
the review are reported in Chapter 2. The current study’s research rationale, aims,
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research hypotheses, and research questions were developed from the systematic review
findings. This information is presented at the end of Chapter 2 in section 2.9.
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2.0 A SYSTEMATIC REVIEW OF RESEARCH THAT EXAMINES THE
EFFECTIVENESS OF PRODROMAL MONITORING FOR INDIVIDUALS
WITH BIPOLAR DISORDER
2.1 Systematic review objectives
Traditional psychosocial treatments have been adapted for use with individuals with
bipolar disorder due to the limited prophylactic nature of pharmacotherapy (Parikh et al.,
2007) and the role of psychosocial factors in the course of the disorder (Johnson et al.,
2000). Prodromal monitoring (sometimes referred to as early symptom monitoring)
plays a key role in a number of the adapted psychosocial approaches (e.g. Family-
Focused Treatment (FFT, e.g. Simoneau et al., 1999); Cognitive Behavioural Therapy
(CBT, Lam et al., 2000), Interpersonal and Social Rhythm Therapy (IPSRT, Frank et al.,
1999), and Psychoeducation (e.g. Colom et al., 2003a). Psychological interventions that
include a prodromal monitoring and management component have been shown to be
beneficial for relapse prevention (e.g. Gitlin et al., 1995; Lam et al., 2003; Morriss et al.,
2007; Scott et al., 2001).
The key objectives of the systematic review were to:
• identify research that examined the impact of prodromal monitoring on relapse rates
and psychosocial outcomes for individuals with bipolar disorder;
• review the results collectively and by intervention type (e.g. one-to-one and group-
based interventions) to determine the effectiveness of prodromal monitoring; and
• examine whether potential confounding variables (e.g. therapist factors, patients’
expectations of therapy, time since diagnosis, and role of social support) are considered
in relation to the outcome data.
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2.2 Methodology
2.2.1 Criteria for considering studies
The following inclusion and exclusion criteria were used to assess study eligibility:
Distinguishing features
• Research must explicitly include prodromal monitoring as a key part of the
intervention package (i.e. minimum of two sessions).
Research design
• The research design must include a control group.
• The participants must be randomly allocated to either the experimental or control
group.
Participants
• Male and female participants must be at least 18 years of age.
• Research that includes participants with a diagnosis of bipolar I or II disorder and a
co-morbid diagnosis is viewed as relevant if other inclusion criteria is met.
Types of clinical interventions
• Research must examine the impact of prodromal monitoring for manic and
depressive episodes.
• The intervention can be a one-to-one therapy or a group-based intervention.
• Treatment provided for the control group must not contain aspects that are offered to
the treatment group (e.g. psychoeducation or an abridged version of psychoeducation or
mood monitoring).
Key outcome measures
• Research that reports time to relapse, number of hospital admissions, number of days
spent in hospital, and quality of life measures was of interest.
Type of research output
• Research published in peer reviewed journals and grey literature will be considered.
Linguistic and date range
• The studies must be reported in English.
• The research will have been published between 1970 and 2009.
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2.3 The search strategy
2.3.1 The database literature search string
To increase the likelihood of obtaining a comprehensive sample of research a broad
research strategy was used. The search term list was constructed by noting key
identifiers and descriptors from articles that were retrieved from a search on the
PsycINFO database using the key words ‘bipolar disorder’ and ‘prodromal
management’.
The following search terms were entered as a search string into the relevant databases:
affective disorder OR affective psychosis OR Bipolar OR Manic depression OR Bipolar
affective disorder AND (early intervention OR Cognitive behavioural therapy OR
cognitive therapy OR prodromal monitoring OR relapse prevention OR family therapy
OR early warning signs OR monitoring OR skills training OR self management OR
education OR illness management)
2.3.2 The computerised bibliographic database searches
The structure of the key search terms was modified to suit individual data sources. The
PsycINFO, EMBASE, and Ovid Medicine databases were searched.
2.4 Methods of the review
2.4 Methods of the review
2.4.1 Selection of relevant research
The literature search was carried out in October 2009. One reviewer made initial
judgements regarding the suitability of the studies. Once potentially relevant information
was identified via the database searches it was copied to the Refworks Web Based
Bibliographic Management Software. The following six folders were created to manage
the retrieved literature: ‘not relevant 1’, ‘not relevant 2’, ‘not relevant 3’ ‘relevant 1’,
‘relevant 2’, and ‘relevant 3’. The three stages involved in the study eligibility screening
process are described in section 2.4.2.
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2.4.2 The study eligibility review process
In stage 1: Initial relevance decisions were based on the reading of titles generated by
the search strategy. Some of the research titles were clearly not relevant (e.g.
Carbamazepine intoxication: The result of a concomitant treatment with olanzapine?)
and were therefore moved to the ‘not relevant’ folder. Potentially relevant papers were
moved to the ‘relevant 1’ folder.
In stage 2 the abstracts of the potentially relevant research were reviewed with reference
to the inclusion and exclusion criteria. Research deemed not relevant at this stage was
moved to the ‘not relevant 2’ folder. Likewise, potentially relevant information was
moved to the ‘relevant 2 folder’.
In stage 3 the full-text article of the potentially relevant research was read in relation to
the inclusion and exclusion criteria. Relevant studies were then moved to the ‘relevant 3’
folder and non-relevant references were moved to the ‘non-relevant 3’ folder.
2.4.3 The inclusion of research from additional resources
The reference sections of all the relevant studies (from stage 3) were reviewed in order
to identify additional potentially relevant references. The abstracts of all of the
potentially relevant research were read. If the article looked to be relevant the full-text
article was read to determine if it satisfied the inclusion criteria. Three additional articles
were identified using this search strategy. The Bipolar Disorder Journal was hand-
searched from 1999 to 2009 for potentially relevant articles. No additional references
were obtained using this search strategy.
Figure 2.1 provides the results from the three stages involved in identifying relevant
research. Information from the additional resources search strategy is also provided.
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Figure 2.1 Summary of the process used to identify relevant research
2.4.4 Excluded research
Refer to Appendix 2 for explanations as to why research was excluded at stage 3 of the
study eligibility review process.
2.5 Methodological stringency
Studies designed to judge treatment should employ rigorous methodology (Chambles &
Ollendick, 2001). To assess the methodological quality of the individual studies a rating
form was used. Ost’s (2008)1 Psychotherapy Outcome Study Methodology Rating form
was adapted for the purposes of the current systematic review by including key
methodological issues associated with research in this area.
                                                                                                                                   
1 Ost’s rating scale was based on a scale devised by Tolin (1999) that was used in a meta-analysis that reviewed PTSD
research. Tolin based his scale on Foa and Meadow’s (1997, cited in Ost, 2008) guidance concerning gold standard
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The adapted version consisted of the following 21-items: (1) clarity of sample
description, (2) generalisability of the research findings for the population being studied,
(3) reliability of diagnosis, (4) specificity of the outcome measures used, (5) the
reliability and validity of the measures used, (6) use of blind evaluators, (7) level of
assessor training, (8) how participants were assigned to treatment condition, (9) use of
active and control treatments, (10) number of assessment points, (11) level of
information provided on intervention, (12) number of therapists who delivered the
intervention, (13) training and experience level of therapists, (14) whether checks were
in place to assess treatment adherence, (15) whether therapist competence was assessed,
(16) whether medication adherence was measured, (17) whether previous psychological
input was measured and controlled for in the analysis, (18) equality of therapy contact
hours between conditions, (19) handling of attrition from sample, (20) appropriateness
of statistical analysis, and (21) whether an  a priori power analysis was carried out.
(Refer to Appendix 3 for a copy of the Methodological Rating Scale).
In order to assess the methodological quality of the research studies each item was rated
as 0 for ‘poor’, 1 for ‘fair’, or 2 for ‘good’. The global methodological quality of the
research is discussed with reference to the following categories: low: score of 1 to 15,
moderate: score of 16 to 28, or high quality: score of 29 to 42.  Research-related aspects
that contribute to the global methodological quality of the individual studies were also
considered (see section 2.6.6 for more information).
2.6 Results
Eleven published research studies fulfilled the inclusion criteria. A data extraction form
was used to obtain key information from the reviewed research (see Appendix 4 for a
copy of the form).  Information relating to the studies is summarised below.
2.6.1 Description of studies
The research was conducted in four countries: Spain (Colom et al., 2003a, 2003b,
2009a, 2009b), Australia (Castle et al., 2007), the United Kingdom (Lam et al., 2000,
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2003, 2005; Perry et al., 1999, Scott et al., 2001), and the United States (Simon et al.,
2005). Perry et al.’s study examined the role of prodromal monitoring and the patient’s
ability to seek support from health professionals in relation to prodromal symptoms. One
study included prodromal monitoring and management as part of a more complex
intervention package that used a Cognitive Behaviour Therapy (CBT) approach in a
group format (Castle et al., 1997). Five studies incorporated prodromal monitoring and
coping strategies into a group psychoeducation approach (Colom et al., 2003a, Colom et
al., 2003b, Colom et al., 2009a, Colom et al., 2009b, Simon et al., 2005). The remaining
four studies examined the effectiveness of prodromal monitoring as part of one-to-one
CBT therapy (Lam et al., 2000; 2003; 2005; Scott et al., 2005).
In the Simon et al., (2005) study, individuals on the waiting list were used as the control
group. In the other studies, participants in the control group received treatment as usual
(TAU). The studies included a follow-up period; the shortest follow-up period was three
months (Castle et al., 2007) and the longest follow-up period was five years (Colom et
al., 2009a, 2009b).
2.6.2 Methods
All of the studies used a randomised controlled trial (RCT) design.  Blind assessors were
used in the studies with regards to the measures that were administered to participants.
2.6.3 Participants
In total 1,110 participants took part in the 11 studies. In four of the studies (Colom et al.,
2003b; Lam et al., 2000, 2003, 2005), the sample consisted of patients with a diagnosis
of bipolar I disorder. In the Colom et al., (2009b) study, the sample consisted of bipolar
II disorder patients. In six of the studies (Castles et al., 2007; Colom et al., 2003a;
2009a; Perry et al., 1999; Scott et al., 2001; Simon et al., 2005), patients with a
diagnosis of bipolar I and II disorder were included. The participants' mean age ranged
between 18 to 46 years across the studies. In all of the studies, the criteria for diagnosis
included a psychiatric assessment; in general the SCID-II was used. In seven of the
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studies participants with a co-morbid diagnosis were excluded (Colom et al., 2003a,
2003b, 2009a, 2009b; Lam et al., 2000, 2003, 2005).
2.6.4 Outcome measures
The majority of the studies defined a relapse as an episode that met the DSM-IV (1994)
criteria for a manic or depressive episode.  Valid and reliable measures such as the
Young Mania Rating Scale (Young et al., 1978) were used to measure the participants’
psychiatric status and relapse status. In addition, three studies included psychosocial
measures (e.g. WHO Quality of Life-BREF (WHOQOL Group, 1998) (Castle et al.,
2007; Lam et al., 2005; Scott et al., 2004).
2.6.5 Information relating to the individual studies
A summary of the main outcome findings from the relevant research studies is provided
below. In addition, strengths and limitations of the individual studies are discussed. The
studies are grouped in relation to the type of intervention being reviewed (e.g. one-to-
one CBT and group psychoeducation). For additional information regarding the studies
(i.e. methodology, statistical analyses, and the results) refer to the summary provided in
Appendix 5 and the in-depth summary in Appendix 6).
2.6.5.1 Prodromal monitoring and care plans involving health professionals
Perry et al.’s (1999) study assessed whether teaching participants to identify prodromal
symptoms significantly reduced relapse rates. The treatment group took part in a two-
stage intervention that lasted for a 12-week period. A significant between-group
difference was found for time to relapse for manic episodes: time to first manic relapse
was 65 weeks in the treatment group and 17 weeks in the control group. However, there
was no significant difference in length of manic episode between the two groups. With
regard to depressive episodes, time to first depressive relapse was 21 weeks in the
experimental group and 26 weeks in the control group (this difference did not reach
significance level).
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Key strengths of this study include the monthly assessments of the participants’ illness
status and the measurement of medication adherence. The sample size, however was
moderate. A further limitation involves the fact that while participants were taught to
identify prodromal symptoms the study does not assess if the individuals were able to
manage some of the prodromal symptoms without the help of mental health
professionals.
2.6.5.2 Prodromal monitoring as a feature of group delivered CBT
Castle et al. (1997) assessed whether a collaborative therapy package for individuals
with bipolar disorder reduced rates of relapse, improved global functioning, and
participants’ quality of life. The results showed that more participants in the control
group relapsed. While a beneficial effect of the intervention was observed the study has
a number of limitations. Firstly, the sample size is small; consequently, the data did not
meet statistical assumptions for some of the statistical tests used to analyse the data (i.e.
logistic regression analysis).  While the groups were matched on demographic and
illness-related factors medication adherence was not controlled for in the analysis:
therefore, the observed improvements could be due to an increase in medication
adherence. While some limitations are noted, a key strength of the study is the inclusion
of participants with dual-diagnosis and a diagnosis of bipolar II disorder. In addition, a 0
percent attrition rate was found: this could indicate that participants were satisfied with
the intervention.
2.6.5.3 Prodromal monitoring as a feature of group psychoeducation
In Colom et al.’s (2003a) study participants in the experimental group received TAU
and group psychoeducation that consisted of 21 sessions (90-minutes in length). The
control group received TAU.  During the study and at the 2-year follow-up, significantly
more participants in the control group relapsed. At the 2-year follow-up significantly
more participants in control group had experienced a depressive episode (significant
difference) and a manic and or hypomanic relapse (non-significant difference). At the
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12-month follow-up the control group had significantly more hospital admissions and
had spent significantly more days in hospital.
While significant effects were observed, there was a high attrition rate in the
experimental group (i.e. 26.6 percent). Key strengths of the study involve the inclusion
of individuals with bipolar I and II disorder and a large sample size. Participants who
were currently engaged in psychotherapy were also excluded from the study: this helps
to ensure that the observed benefits are not due to other therapeutic interventions.
A further study conducted by Colom et al., (2003b) used the same methodology as
described for the Colom et al., (2003a) study with the exception of the inclusion of only
highly compliant (with regards to medication) bipolar disorder patients. This type of
patient was included in order to assess whether the efficacy of psychoeducation goes
beyond an improvement in medication adherence. The results showed that significantly
more participants in the control group fulfilled criteria for recurrence during the
treatment and follow-up phase compared to the treatment group. When the patients who
relapsed were reviewed a significant difference in time to relapse was found: the
treatment group had a longer period between episodes. The number of total recurrent
episodes was also significantly lower in the treatment group and significantly fewer
participants in the treatment group experienced a manic or mixed episode in the
treatment phase. Significantly fewer participants in the treatment group experienced a
manic, mixed, or depressive episode at follow-up. Furthermore, significantly more
patients in the control group were hospitalised compared to patients in the treatment
group; this result was also observed at follow-up.
While a number of significant between-group differences were observed, the exclusion
of participants with bipolar II disorder and individuals with a dual diagnosis has an
impact upon the extent to which the results can be generalised to clinical settings. The
strengths and limitations discussed with reference to design features of the Colom et al.,
(2003a) study are also relevant for this research as the same design (with the exception
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of the inclusion of individuals who complied with their medication) was used for this
study.
A further study by Colom et al., (2009a) was carried out to assess the long-term
efficacy, at 5-year follow-up, of a group psychoeducation programme. This study was an
extension of an earlier study (Colom et al., 2003a). The authors found a significant
between-group difference for time to recurrence for both depressive and manic episodes
with the control group experiencing a shorter time between episodes. When type of
episode was reviewed a slightly lower effect size was observed for depressive episodes.
Participants in the psychoeducation group spent significantly fewer days ill: this was
significant for all types of episodes.
While the above study demonstrates the long-term efficacy of psychoeducation for
individuals with bipolar disorder, the aforementioned limitations highlighted for the
Colom et al., (2003a) study are also relevant for this study. In addition, at the 5-year
follow-up the attrition rate was high (i.e. total attrition for the study period and at follow-
up).
A further study conducted by Colom et al., (2009b) examined the efficacy of group
psychoeducation for bipolar II disorder participants (this involved a sub-analysis of data
from the Colom et al., (2009a) study. No significant between-group differences in
relapse rates during the intervention phase were found. At the 5-year follow-up there
was a significant between group difference in relapse rates Furthermore, the control
group spent significantly more days with symptoms of hypomania or depression.
The results indicated that bipolar I and II disorder patients may benefit from the same
intervention.  As this study used the sub-sample of data from the Colom et al., (2009a)
study the same limitations and strengths discussed above also apply for this study. In
addition, this study involved a small sample size. Furthermore, medication adherence
does not appear to have been reported or included as a covariate in the statistical
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analyses; consequently, it is not possible to rule out the contribution of medication
adherence to the significant findings.
In the Simon et al., (2005) study participants in the treatment condition took part in a
psychoeducation group. The group consisted of five weekly sessions followed by twice-
monthly sessions for the duration of intervention. The treatment group had significantly
lower scores over a 12-month period for mania symptoms; however, no significant
between-group differences were found for time with manic symptoms. The control
group spent significantly more time in hospital for manic episodes. No significant
between group differences were found for depressive scores throughout the follow-up
period. For individuals in the experimental group a reduction in depressive symptoms
over time was observed.
This study benefits from a large sample size and the inclusion of both bipolar I and II
disorder participants. Medication adherence, however, does not appear to have been
included as a covariate in the relevant analyses, therefore it is difficult to determine if
the observed effect on relapse rates is only due to the intervention that was delivered or
if medication adherence is also relevant.
2.6.5.4 Prodromal monitoring as a feature of one-to-one CBT
In the Lam et al.’s (2000) study participants in the control group received TAU and
multi-disciplinary team (MDT) input when required. Participants in the experimental
group received TAU, MDT, and CBT (for an average of 15 sessions) that included
prodromal monitoring approaches. Significantly more participants in the control group
experienced manic, hypomanic, and depressed episodes in comparison to the
intervention group. In addition, significantly more participants in the control group were
hospitalised during the study. The experimental group also coped significantly better
with manic prodromes at the 6- and 12-month assessment periods and with depressive
prodromes at the 12-month period.
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While significant between-group differences were observed a number of limitations are
associated with this study namely the small sample size. Furthermore, the researchers
did not have any control over MDT input; it is, therefore, possible that participants in the
control group may have received some form of psychosocial intervention. Lastly,
medication adherence was not controlled for in the statistical analyses therefore it is not
possible to state that the observed effects were down to treatment alone. The two groups
however, did not differ in terms of prescribed medication at baseline. While a number of
limitations have been identified, this study benefited from the exclusion of participants
who were receiving additional therapeutic input as this helps to clarify the effectiveness
of the intervention being assessed. The study had a good follow-up period and a low
attrition rate.
A further study conducted by Lam et al., (2003) assessed the effectiveness of Cognitive
Behavioural Therapy (CBT) compared to TAU as a means of preventing relapses and
promoting social functioning. The experimental group received between 12 to 18
individual sessions over a 6-month period and two booster sessions in the second 6-
month period.
Participants who received CBT had significantly fewer relapses compared with the
control group; this was also found at the 12-month follow-up. The experimental group
spent significantly fewer days in hospital for the total episodes experienced and for
depressive episodes. The experimental group reported better coping with manic
prodromal symptoms at both 6 and 12-month intervals and depressive prodromal
symptoms at the 6-month interval. The authors recognised that a majority of the sample
had residual depressive symptoms at baseline and stated that it may have been difficult
for participants to identify when the depressive symptoms have moved to the prodromal
stage. However, this explanation does not explain the significant difference observed at
the 6-month interval.
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Lam et al.’s (2003) research has a good sample size. Participants who fulfilled the
criteria for substance use disorder, were, however, excluded from the sample; therefore,
the extent to which the results can be extrapolated to clinical settings (due to the high
rate of substance disorder found among bipolar patients) is questionable.
As a follow-up to the Lam et al., (2003) study, Lam et al., (2005) investigated the long-
term effects of CBT. The results from the Lam et al., (2005) research showed that the
experimental group did significantly better in terms of cumulative relapse rates
compared to the control group. This difference, however, was not observed for manic
relapses. The effect of the intervention was found to be strongest during the first 12
months of the study period. This result indicates that booster sessions or maintenance
therapy may be beneficial to prolong the beneficial effects of this CBT. In general, the
experimental group showed better coping strategies over the last 18 months of the study
and better coping with manic and depressive prodromes at the 2-year period.
While beneficial effects for CBT were found in this study, Lam et al., highlighted that
they did not control for the pharmacological or psychological treatment over the follow-
up period. Furthermore, four participants in the control group received therapy during
the follow-up period; therefore it is difficult to determine the impact of this additional
support as this was not accounted for in the research design.
A study conducted by Scott et al., (2001) was carried out to explore the effectiveness of
Cognitive Therapy (CT) for individuals with bipolar disorder. Participants in the
experimental group received a maximum of 25 sessions of one-to-one CT. The CT
included relapse prevention techniques that involved prodromal monitoring and coping
strategies for identified prodromal symptoms. A greater reduction in symptoms was
observed in the experimental group (non-significant effect). A significant improvement
in functioning was, however, found immediately following CT. A significant change in
mental state was also observed as fewer people met criteria for relapse or persistent
illness following CT.
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The research findings can be viewed as having clinical ecological validity due to the
inclusion of participants with substance disorders and personality disorders.
Furthermore, the participants’ views of the intervention (acceptability and potential
benefits) were assessed; this enabled the participants’ treatment expectations to be
explored.
2.6.6 The methodological quality of the reviewed research
Information pertaining to the methodological quality of the reviewed studies is
summarised below. For additional information refer to Appendix 7.
2.6.6.1 The global methodological quality of the reviewed research
Table 2.1 provides a summary of the global methodological ratings for the 11 studies.
Table 2.1 The global methodological quality ratings for the reviewed research
Study Quality Rating
Castle et al. (2007) moderate
Colom et al. (2003a) moderate
Colom et al. (2003b) moderate
Colom et al. (2009a) moderate
Colom et al. (2009b) moderate
Lam et al. (2000) moderate
Lam et al. (2003) high
Lam et al. (2005) moderate
Perry et al. (1999) moderate
Scott et al. (2001) moderate
Simon et al. (2005) high
As summarised above, the majority of the studies received a moderate global rating and
two of the studies were categorised as being of a high methodological standard.
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2.6.6.2 Information regarding the methodological quality of the studies
In addition to a global methodological rating, the quality of the research was reviewed in
relation to key methodological information. This information is summarised below.
2.6.6.2.1 Sample information
The extent to which the research sample was representative of clinical samples is
questionable. This is largely due to the exclusion of participants with an axis l disorder,
and a substance use disorder. There is a high rate of co-morbidity among individuals
with a diagnosis of bipolar disorder (e.g. McElroy et al., 2001). It is therefore
questionable if research findings from studies that exclude research individuals with co-
morbid diagnoses can be extrapolated to clinical settings.
2.6.6.2.2 Design-related issues
Ten of the 11 studies included a follow-up period of at least one year. All of the studies
used random allocation to assign participants to the control or experimental groups. An
active treatment in comparison to either a waiting list group or a TAU group was also
used; however, none of the research compared the intervention with another previously
empirically documented active treatment. In only two of the 11 studies (Lam et al.,
2003; Simon et al., 2005) assessor training and checks were used during the intervention
to ensure treatment fidelity. Therefore, it is not possible to conclude that in the
remaining studies the packages were being delivered in a standardised manner.
2.6.6.2.3 Therapist factors
In the Lam et al., (2000, 2003, and 2005) and Simon et al., (2005) studies, the
intervention was delivered by three or more therapists: the inclusion of three or more
therapists helps to reduce the likelihood that the observed effect of the intervention is
due to therapist-related factors (e.g. experience, gender, therapeutic alliance). The
majority of the studies used therapists with considerable clinical experience. However,
with the exception of the Lam et al., (2003, 2005) studies, therapist competence was not
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monitored throughout the research study. Furthermore, none of the studies assessed for
potential impact of therapist-factors in relation to the research outcomes.
2.6.6.2.4 Confounding variables
Previous psychosocial input was not measured in the studies; therefore, it is not possible
to assess if previous psychosocial interventions had an impact upon current functioning.
Five of the studies (Castle et al., 2007; Colom et al., 2003a, 2003b, 2009a, 2009b; Scott
et al., 2001) addressed issues associated with equal contact hours between the control
and experimental groups. The provision of equal contact hours between conditions
reduces the likelihood that the observed treatment effect was due to increased contact
with mental health professionals. In six of the studies, however, equal contact time for
the two groups was not provided; therefore it is not possible to state that the observed
effect was due to the intervention alone.
2.6.6.2.5 Statistical issues
With the exception of the Castle et al., (2007) study appropriate statistical tests were
used to analyse the data. The majority of the studies (with the exception of Castle et al.,
2007 and Simon et al., 2005) used intent-to-treat analysis to manage attrition issues.
To summarise, while methodological limitations have been identified the studies were
viewed as being of at least moderate methodological quality. The research findings are
considered collectively in section 2.7.
2.7 Discussion
The research findings are considered collectively in order to determine the extent to
which prodromal monitoring is effective for reducing relapse rates for individuals with
bipolar disorder. Strengths and limitations of the research area also considered.
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2.7.1 Summary of the research results
While methodological limitations were identified, in general the research demonstrates
the efficacy of psychosocial approaches that utilise a prodromal monitoring and
management component for a reduction in relapse rates and hospital admissions for
manic and depressive episodes. Significant effects were found for both one-to-one and
group-based interventions. Two of the studies, however, did not find a significant effect
of intervention type with depressive episodes (Castle, et al., 2007; Perry et al., 1999).
This may be due to the difficulties individuals experience in separating subsyndromal
depressive symptoms from prodromal symptoms. A difference, in terms of the polarity
of symptoms, is also observed in research that examines individuals’ ability to identify
manic and prodromal symptoms: research indicates that participants identify more manic
than depressive symptoms (e.g. Keitner et al., 1996; Lam & Wong, 1997; and Lam et
al., 2001).
An alternative explanation for the observed non-significant effect in the Castle et al.,
(2007) and Perry et al., (1999) studies could involve the type of intervention used. For
example, research that utilised a one-to-one therapeutic CBT approach (e.g. Lam et al.,
2003) found a significant decrease in the number of depressive episodes experienced by
participants in the intervention group. It may be that a group-based CBT is not in-depth
or individualised enough to enable participants to learn how to distinguish between
subsyndromal and prodromal depressive symptoms. In the Perry et al., (1999) study,
participants were taught how to identify prodromal symptoms but not how to manage
them without the assistance of mental health professionals. It is possible that depressive
prodromes become more recognisable once participants have experience in managing
them, as individuals are then able to separate prodromal symptoms from subsyndromal
symptoms.
Long-term follow up not only provides insight into the enduring effects of this
therapeutic approach but also enables the participants to practise CBT strategies and
techniques. The Scott et al., (2005) study indicated that while the experimental group
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had fewer relapses than the control group there was a slight decline in effectiveness of
CBT at the 12-month follow-up.  Lam et al., (2005) found a similar result. These
findings may indicate the need for booster sessions following the intervention period.
However, Colom et al.’s (2009b) research (that involved bipolar II disorder participants)
found no effect on relapse rates following the intervention but did find a significant
effect at the five-year follow-up. This study indicates that participants may become more
skilled with CBT strategies and techniques over time. It is difficult to determine why the
results from the Colom et al., (2009b) study are in conflict with Lam et al., (2005) and
Scott et al.’s (2005) findings; the results may be due to individual differences associated
with the research samples.
2.7.2 The methodological quality of the reviewed research
While some methodological limitations have been identified, overall the research was of
a moderate methodological standard. A three-way median split approach was used to
categorise the global methodological quality of the reviewed research. While Ost’s
methodological rating form was not designed to be used in this manner, categorising the
research provides a way of identifying high, moderate, and low quality research.
Therefore, this approach can be viewed as beneficial as it provides a way of determining
the global methodological quality of the individual studies. Categorising the research in
this manner should, however, be viewed with caution as it does not enable individual
methodological items to be weighted. The categorisation of the research should therefore
be considered in relation to the individual items on the rating form.
2.7.3 Methodological limitations associated with the research area
With the exception of the Perry et al., (1999) study, the reviewed research included
prodromal monitoring and coping strategies as part of a larger intervention package:
none of the studies looked at components of therapy separately or asked the participant
which skills and strategies they found most effective. While it is not possible to conclude
that prodromal monitoring approaches are solely responsible for the observed positive
change in relapse rates, it is realistic to assume that therapeutic processes described in
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the research papers would mirror clinical practice and thus prodromal monitoring is
unlikely to be introduced and taught to a client in isolation from associated CBT
techniques and strategies.
2.7.4 Issues associated with potentially confounding variables
The participants’ prior experience of psychological therapies was also not considered in
the research. A previous positive therapeutic experience may serve to motivate the
individual, whereas a negative experience may effect outcome expectations and
subsequent motivation to engage in therapy. Whether or not participants were receiving
additional support (e.g. CPN, attending classes, help from significant others) was also
not considered. The potential impact of additional support and participant’s previous
experience of therapy should be assessed and used as a covariate in the statistical
analyses to assess the impact of prior psychosocial interventions on current functioning
and control for the impact of such factors on research outcomes.
2.7.5 What helps individuals with bipolar disorder to identify and manage
prodromes?
When prodromal monitoring is considered within the context of both disorder
management and recovery, aspects that help individuals to believe that they can take an
active role in their treatment become important factors; a sense of mastery over
symptoms helps individuals believe that they can be an active agent in their treatment
(Muesser et al., 2004). While the research has collectively demonstrated the
effectiveness of prodromal monitoring for reducing time to relapse it has not explored
which factors help individuals to identify and manage prodromal symptoms. For
example, the potential impact of disorder-related variables (e.g. consistency of
symptoms, time since diagnosis, and number of episodes experienced in relation to the
outcome measures or participant’s engagement with the interventions) on participants’
ability to identify and manage prodromal symptoms were not considered in the reviewed
research. Therefore, it is not possible to conclude whether or not such factors have an
impact on the effectiveness of the psychosocial interventions under investigation.
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Information relating to the benefits of considering the role of social support and general
self-efficacy with reference to prodromal monitoring is presented below.
While some of the studies provided information on aspects such as marital status (e.g.
Castle et al., 2007, Colom et al., 2003) the role of social support was not considered in
the reviewed research. As discussed in chapter 1 section 1.7.1 research indicates that
social support leads to a more positive course of bipolar disorder (e.g. Johnson et al.,
2000), whereas low level and less adequate support are associated with poorer
symptomatic outcomes (e.g. Kulhara et al., 1999).
To date, research in this area has not examined the relationship between either social
support from significant others and or psychosocial input from mental health
professionals with specific attention to the impact this has on an individual’s perception
of his or her ability to monitor and manage prodromal symptoms.  As social support is
associated with a more positive course of bipolar disorder it is helpful to explore the role
this type of support provides in helping individuals to identify and manage prodromal
symptoms.
Self-efficacy is a construct that has an impact upon health practices as well as adaptation
to illness and treatment as it reflects an optimistic self-belief (Bandura, 1986) and refers
to personal action control and agency (Schwarzer et al., 1999). Self-efficacy is defined
as ‘people’s beliefs about their capabilities to produce designated levels of performance
that exercise influence over events that affect their lives.’ (Bandura, 1994, p.71) While
self-efficacy can be viewed as domain-specific, it can also be viewed as relating to a
broad and stable sense of belief in the ability to cope with a variety of difficult situations
such as life events and management of prodromal symptoms (Schwarzer, 1994).
Schwarzer and Jerusalem (1995) assert that general self-efficacy is positively related to
optimism, proactive coping, and self-regulation. It would therefore appear that general
self-efficacy is an important measure to consider in relation to prodromal monitoring as
this approach involves individuals taking an active role in the management of their
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disorder. Furthermore, general self-efficacy is open to introspection via the use of
questionnaires (e.g. the General Self-Efficacy Questionnaire, Jerusalem & Schwarzer,
1995). To date, general self-efficacy has not been considered in relation to self-
management of bipolar disorder.
2.7.6 Conclusion
In conclusion, although research limitations have been identified, the research
collectively demonstrates the effectiveness of psychosocial interventions that utilise
prodromal monitoring and management approaches for reducing relapse rates. In
addition to reviewing research that examines the impact of prodromal monitoring
approaches, this systematic review has served to highlight research gaps with reference
to aspects that have not been considered in relation to prodromal monitoring. This issue
is further explored in section 2.8.
2.8 The thesis research hypotheses and research questions
Research to date has examined the relationship between prodromal monitoring in
relation to outcome measures such as time-to-relapse, hospitalisation, severity, length of
episode, and quality of life measures. The research has not investigated whether certain
factors serve to increase or decrease individuals’ perceptions that they are able to
identify and manage manic and depressive prodromal symptoms thereby increasing their
confidence as active agents in the management of their disorder.
The current research aimed to identify relevant factors that have an impact upon
individuals’ perception that they can identify and manage manic and depressive
prodromal symptoms. By investigating this issue, prodromal monitoring can become a
more specified approach that considers other relevant therapeutic factors. A quantitative
exploratory research approach was used to investigate the impact of individual (i.e. self-
efficacy, gender, age), treatment (psychosocial input, role of significant others in helping
to mange bipolar disorder), and disorder-related factors (i.e. time since diagnosis,
number of episodes experienced, consistency of prodromal symptoms, and current mood
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state) on individuals’ perceptions of their ability to identify and manage prodromal
symptoms.
The following research question was used to develop the research hypotheses:
How are individual-related, disorder-related, and treatment-related factors associated
with participants’ perception of their ability to identify and manage manic and
depressive prodromal symptoms?
Hypothesis 1:
Research hypothesis: General self-efficacy will be positively associated with
participants’ perception of their ability to identify and manage manic and depressive
prodromal symptoms. (one-tailed)
Hypothesis 2:
Research hypothesis: Social support, in relation to help from significant others in
managing bipolar disorder, will be positively associated with the participants’ view of
their ability to identify and manage prodromal symptoms.  (one-tailed)
Hypothesis 3:
Research hypothesis: Previous and current psychosocial input will be positively
associated with the participants’ perception of their ability to identify and manage
prodromal symptoms. (one-tailed)
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The following exploratory questions were also considered in relation to the research
findings:
i) Are the following factors associated with participants’ perception of their ability to
identify and manage prodromal symptoms: time since diagnosis, gender, age, number of
episodes experienced, and current mood state?
ii) Does the consistency of prodromal symptoms (across episodes) have an impact on
participants’ perception of their ability to identify and manage prodromal symptoms?
iii) Does the ability to identify prodromal symptoms when they first present have an
impact on participants’ perception of their ability to identify and manage prodromal
symptoms?
iv) Is the polarity of the prodromal symptom associated with the participants’ perception
of their ability to identify and manage manic and depressive prodromal symptoms?
v) Are types of prodromal symptoms (i.e. cognitive, affective, and behavioural)
associated with the participants’ perception of their ability to identify and manage manic
and depressive prodromal symptoms?
Information regarding the methodology that was used to examine the above hypotheses




This exploratory study utilised a cross-sectional quantitative research design to
investigate the research hypotheses and research questions. The data were obtained via
the administration of four self-report measures. An additional questionnaire (the
Prodromal Experience Questionnaire) was administered to a sub-sample of the
participants. Information regarding the inclusion of this questionnaire is discussed in
section 3.4.2.
Hypothesis 1: General self-efficacy will be positively associated with participants’
perception of their ability to identify and manage manic and depressive prodromal
symptoms. (one-tailed)
An independent design was used to allow the general self-efficacy scores to be examined
in relation to the participants’ perception of their ability to identify and manage manic
and depressive prodromal symptoms (i.e. able to, sometimes able to, not able to). The
independent variable was the participants’ perception of their ability to identify and
manage prodromal symptoms and the dependent variable was the participants’ general
self-efficacy score.
Hypothesis 2: Social support, in relation to help from significant others in managing
bipolar disorder, will be positively associated with the participants’ view of their ability
to identify and manage prodromal symptoms.  (one-tailed)
This hypothesis was tested using a between-participants design to determine whether
help from significant others is associated with the participants’ perception of their ability
to identify and manage prodromal symptoms. The independent variable was whether or
not a significant other provided support and the dependent variable was the participants’
perception of their ability to identify and manage prodromal symptoms.
Hypothesis 3: Previous and current psychosocial input will be positively associated with
the participants’ perception of their ability to identify and manage prodromal symptoms.
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(one-tailed) was tested using a correlational design in order to reveal whether there is an
association between participants’ perception of their ability to identify and manage
prodromes in relation to the level of psychosocial input they have received.
The research questions (refer to chapter 2, section 2.8) were explored through a
combination of correlational and between-participant designs. The design was dependent
on the type of data (e.g. continuous, categorical) that was being analysed
3.2 Power analysis
To date, research has not examined the relationship between individual, disorder, and
treatment-related variables and perceptions of ability to identify and manage prodromal
symptoms for people with bipolar disorder. Therefore it was not possible to determine a
suitable effect size for the current research, on the basis of empirical findings from
previous studies. A decision was therefore made to establish the number of participants
required to achieve a medium effect size of .80 (Cohen, 1992). The data were analysed
through a series of preliminary and primary analyses. Information relating to the
preliminary analysis is firstly presented, with reference required sample size, based on
power calculations. Information regarding the primary analysis is then discussed.
3.2.1 Preliminary Analysis
Hypothesis 1 investigated the impact of general self-efficacy scores on participants’
ability to identify and manage prodromal symptoms. This data was explored through the
use of a one-way ANOVA. With reference to this statistical test, Cohen (1992) states
that in order to achieve a medium effect size, (at a significance level of 0.05) a minimum
sample of 52 participants is required.
Hypothesis 2 examined whether help from significant others in managing bipolar
disorder was positively associated with the participants’ view of their ability to identify
and manage prodromal symptoms.  To test this hypothesis a 2 x 3 Pearson chi-square
statistical test was used. Cohen (1992) stated that in order to achieve a medium effect
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size, (at a significance level of 0.05) using this test of association, a minimum of 107
participants is required.
Hypothesis 3 tested whether there is a relationship between level of psychosocial input
and the participants’ perception of their ability to identify and manage prodromal
symptoms. The Spearman’s rho test was used to test whether a relationship existed
between these variables. Information provided by Cohen (1992) indicates that in order to
achieve a medium effect size (at a significance level of 0.05) using this test, a minimum
of 85 participants is required.
3.2.2 Primary Analysis
The primary analysis was conducted in order to assess the overall contribution of
relevant variables (as determined by the preliminary analyses) to the participants’ ability
to identify and manage prodromal symptoms. The ordinal logistic regression analysis
test was chosen as the most appropriate statistical technique to use in the primary
analyses. Four ordinal logistic regression tests were carried out to explore factors
associated with the participants’ ability to:
• identify manic prodromes,
• identify depressive prodromes,
• manage manic prodromes,
• manage depressive prodromes.
Predictor variables identified as being significantly related to the dependent variables
(due to results from the preliminary analysis) were entered into each regression model.
The number of predictor variables entered ranged from two to five. Therefore, an a
priori sample size was considered in relation to five predictor variables for a regression
analysis.
51
Several methods exist for establishing the number of participants required in a
regression analysis. Cohen (1992) states that in order to achieve a medium effect size,
(at a significance level of 0.05), with five predictor variables, a sample of 91 participants
is required. Harris (1985, cited in Dancey & Reidy, 2004) proposes the following
equation to calculate the recommended sample size for a regression analysis:
N > 50 + m (m = the number of predictor variables). There are five predictor variables
in the present study; therefore, based on Harris’ equation, a total of 55 participants
would be required. When considering assumptions associated with regression analysis,
Long and Freese (2006) recommend a minimum sample of 100 participants regardless of
the number of estimated parameters. For the ordinal regression analysis it was decided
that it would be best to have a minimum of 100 participants in the study, as this is in
accordance with the aforementioned figures provided by Cohen (1992) and Long and
Freese (2006).  When the required sample size was reviewed in relation to all of the tests
being carried out it was determined that it would be best to have a minimum of 107
participants.
3.3 Participants
Potential participants were recruited through adult Community Mental Health Teams
(CMHTs), Mood Stabiliser Clinics, and voluntary agency mental health services within
the geographical area of Forth Valley. Participants were also recruited from across the
country via the Bipolar Fellowship of Scotland.
With reference to the participants recruited via the CMHTs and the Mood Stabiliser
Clinics, key workers and psychiatrists referred potential participants if exclusion and
inclusion criteria (summarised in Table 3.1) were met.
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Table 3.1.  Inclusion and exclusion criteria for participation in the research
                 Exclusion Criteria                   Inclusion Criteria
Individuals who are inpatients
Individuals who have a learning
disability
Individuals who are unable to provide
informed consent
Fluent in English
A diagnosis of bipolar I or II disorder
Minimum age of 18 years old
Individuals involved with NHS services,
mental  health services within the
geographical area of Forth Valley, or the
Bipolar Fellowship self-help  groups
The research sample consisted of 101 participants with a diagnosis of bipolar disorder.
Demographic and bipolar disorder-related information pertaining to the research sample
are presented in the Chapter 4 section 4.2.1.
3.4 Measures
All of the participants were asked to complete four questionnaires. As previously noted,
a sub-sample completed a further questionnaire. The five questionnaires are described
below.
3.4.1 The Demographic Questionnaire
The Demographic Questionnaire (Appendix 8) was designed for the purposes of this
study. It was administered to participants in order to obtain demographic, clinical,
disorder, and prodromal-related information.  Participants were also asked to provide
information on whether a significant other helped them to manage prodromal symptoms.
The questions concerning the participants’ experience of prodromal symptoms were
prefaced with a description of prodromal symptoms and a list of common manic and
depressive prodromes.  The questionnaire took an average of 10 minutes to complete.
53
3.4.2 The Prodromal Experience Questionnaire
The retrospective Prodromal Experience Questionnaire was developed for the current
study in order to obtain information about participants’ experiences of prodromal
symptoms (Appendix 9). As stated above, the questions concerned with the participants’
experience of prodromal symptoms were prefaced with a list of common manic and
depressive prodromal symptoms. The researcher noted that some of the participants
were using the list to identify, through the use of a check mark, the prodromes that they
have experienced in the course of their disorder. Therefore the decision was made to
adapt the list of common prodromes into a questionnaire to collect systematic
information regarding future participants’ experience of prodromal symptoms (i.e.
prodromes experienced, easily identified, consistently experienced, and viewed as
manageable). The addition of this questionnaire enabled information on different types
of prodromes (i.e. cognitive, affective, and behavioural) to be collected and examined in
relation to individual, disorder, and treatment-related variables.
A sub-sample of 48 participants (from the original sample) completed this questionnaire.
The questionnaire contained a list of 18 commonly experienced manic and depressive
prodromes in the form of a checklist. Information provided by three studies, in which
participants were asked to either spontaneously recall prodromes (Lam & Wong, 1997;
Molnar et al., 1988) or identify prodromes they have experienced via a checklist
approach (Smith & Tarrier, 1992), was used to inform which prodromes should be
included in the checklist. The prodromes can be categorised into cognitive, affective,
and behavioural symptoms (refer to Appendix 10 for categorisation of the prodromes by
type).
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For each of the listed prodromal symptoms the participants were asked to indicate (by
using a check mark) if they:
• experienced the prodromal symptom
• were able to identify the prodromal symptom when it first presented
• always experienced the prodromal symptom
• believed they were able to manage the prodromal symptom
The questionnaire took an average of five minutes to complete.
3.4.3. The General Self-Efficacy Scale
The General Self-Efficacy Scale (GSES, Jerusalem & Schwarzer, 1995) (Appendix 11)
was administered to participants in order to gain a numerical measure of their general
self-efficacy. The construct of perceived self-efficacy reflects an optimistic self-belief
(Schwarzer, 1992).  This measure was therefore administered to the participants to
assess if self-belief has an impact upon their perception of their ability to identify and
manage prodromal symptoms.
The GSES is a 10-item questionnaire that takes approximately five minutes to complete.
It is designed for use with adults and adolescents. It was originally developed in German
but has been translated into 28 languages, including English (Schwarzer & Jerusalemm
1995).  The ten items are designed to measure how individuals cope with a range of
demands in life. Each item refers to successful coping and implies an internal-stable
attribution of success.
Participants were asked to read one statement at a time and consider the extent to which
each statement applied to them. They were instructed to respond using the following
numerical response format: 1 for not at all true, 2 for hardly true, 3 for moderately true,
and 4 for exactly true. Participants’ responses to the 10 questions were totalled to get an
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aggregate score within a range of 10 to 40. Higher scores on the measure indicate higher
levels of general self-efficacy.
Research indicates that the GSES typically yields internal consistencies between
α = .75 and .91 (e.g. Schwarzer et al., 1999). While, to date the measure has not been
used with individuals with bipolar disorder it has been used in a number of studies
involving long-term psychiatric patients (e.g. Ritsner, 2006; Vauth et al., 2007).
3.4.4 Internal State Scale
The Internal State Scale (ISS, Bauer et al., 1991) was used to obtain a measure of the
participants’ current mood state. The ISS is a 16-item self-assessment tool for
individuals with bipolar disorder (Appendix 12). The ISS was designed to provide a
simple mood self-report for both manic and depressive symptoms. The items include a
range of symptoms that describe mania and depression and represent four subscales:
activation level, sense of wellbeing, depression, and characteristics that may occur in
either affective state. The subscales discriminate among mania, depression, mixed, and
euthymic mood states.
Participants are instructed to respond to the 16 statements by using an X to indicate at
which point on a 100mm line best describes how they have felt over the past 24 hours.
The 0 anchor point is “not at all, rarely”. The 100 anchor point is ‘very much so, much
of the time. For example:
          Not at all                       Very much so
                                                       Rarely                                         Much of the time
1. Today my mood is changeable
                                                        ______________________________________
Responses are then summed to provide the subscale score. An ISS scoring algorithm
(provided by the authors) was used to classify the respondent’s mood state. The scoring
X
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algorithm uses the activation subscale and the well-being subscale scores to classify the
respondents’ mood state as: (hypo)manic, mixed state, euthymic, or depressed.
The activation subscale correlates highly (r =.60) with the Young Mania Rating Scale
(Young et al., 1978) and the Depression Index correlates with the Hamilton Depression
Rating Scale (Hamilton, 1967) (Bauer et al., 1991). The ISS also discriminates among
patients with manic symptoms and controls (Bauer et al., 1991). Further research has
also demonstrated that the ISS can discriminate mood states for both in-patients and out-
patients (Bauer et al., 1999) and community samples (Bauer et al., 2000).
3.4.5 The Significant Others Scale
To assess the participant’s perception of the role of significant others in their social
network the Role of Significant Others Scale (SOS, Power et al., 1988) (Appendix 13)
was administered to the participants. The SOS measures different sources of social
support that may be provided by a number of significant relationships within an
individual's social network. The scale distinguishes between structural and functional
aspects of support and enables a measure of ideal and actual support to be determined.
Participants are asked to list up to seven people whom they view as important people in
their life. For each person they are instructed to answer eight questions designed to
assess both structural and functional support provided by the significant other.
Participants respond by circling a number on a seven-point Likert scale that represents
the following responses: never, sometimes, or always receive this type of support. In
addition, participants are asked to indicate their ideal level of support for each
nominated person, and for the structural and functional aspects of support they are
considering.
The SOS has demonstrated good test re-test reliability over a 6-month period (Power et
al., 1988). The SOS was not developed using a clinical population as a sample of female
members of the Open University Psychology Society were recruited to provide
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information that was used to develop the SOS. The SOS has however been used in a
number of subsequent research studies that have involved long-term psychiatric patients
(e.g. Cresswell et al., 1992).
3.5 Procedure
As previously stated the participants were recruited through (i) CMHTs and Mood
Stabiliser Clinic referrals, (ii) voluntary agencies mental health services, and (iii) the
Bipolar Fellowship of Scotland. Information pertaining to the procedure used in each
recruitment source is described below.
3.5.1 CMHTs and Mood Stabiliser Clinics
The researcher met with key workers, psychiatrists, and managers in the CMHTs and
Mood Stabiliser Clinics in order to discuss the research project with specific reference to
the research rationale, aims, ethical issues, and participant inclusion and exclusion
criteria. An information sheet was given to the referrers (Appendix 14) that summarised
the information discussed at the meeting.
The referrers were asked to discuss the research with suitable patients if they believed
they met the inclusion criteria. In addition to discussing the research with the patient
they also received an information sheet (Appendix 15) that included information on
what participation in the research would involve planned use of the research findings,
and contact details for the researcher and an independent researcher if they wished to
discuss the study in more detail. If the patient expressed interest in taking part in the
study the referrer then passed their contact details on to the researcher.
All potential participants were given a minimum of 48 hours to consider taking part in
the study, during which time they were able to contact the researcher to discuss the study
in more detail if they had any questions. After this time, the researcher called the
potential participants to discuss taking part in the study. If an individual was interested
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in taking part in the study a suitable time and place was arranged (e.g. NHS setting or a
community drop-in centre) for the participant to complete the questionnaires.
Several participants stated that they wanted to complete the questionnaires at home.
When this occurred the researcher posted a questionnaire pack with a self-addressed
return envelope to the participant. The researcher then contacted the participant once
they had received the questionnaire to discuss the questionnaires in more detail and to
check if participants had any questions. The participants were advised to contact the
researcher if they found any aspect of the questionnaires distressing or anxiety-
provoking; they were also advised that if this were to occur they should stop filling out
the questionnaires.
3.5.2 Voluntary agencies
In order to recruit participants from voluntary agencies the researcher attended meetings
that involved staff and individuals who used the drop-in facilities to discuss the research.
As described above – information was provided about the inclusion and exclusion
criteria and an information sheet was given to potential participants. Following the
meeting staff took a note of individuals who were interested in taking part in the
research. These individuals were contacted following a period of 48 hours and a time
and date was arranged for them to complete the questionnaires at the respective drop-in
facilities.
3.5.3 The Bipolar Fellowship of Scotland
Individuals recruited via the Bipolar Fellowship self-help groups were informed of the
research and given the information sheet in advance of the researcher attending the
group meetings by the central office. During the meeting they were asked if they would
like to take part in the study. Individuals who agreed to take part in the study completed
the questionnaire either during the meeting or at home. As stated above, participants
who chose to take the questionnaire home were informed that they could contact the
researcher to discuss the questionnaires and the research study.
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The order of the questionnaires was counterbalanced with 50 percent of the participants
completing the questionnaires in order 1, and 50 percent completing the questionnaires
in the reverse order. Table 3.2 provides a summary of the order of the questionnaires.
Table 3.2 Order (1) that the questionnaires were given to participants
Order of the Distribution of the Questionnaires
Demographic Questionnaire
Prodromal Experience Questionnaire (sub-sample)
General Self-Efficacy Scale (Schwarzer & Jerusalem,1995)
The Internal State Scale (Bauer et al., 1991)
Significant Others Scale (Power et al., 1988)
3.6 Participant confidentiality
All of the questionnaires were anonymously completed to ensure participant
confidentiality. The completed questionnaires and the consent forms were kept in a
locked filing cabinet in NHS Forth Valley Adult Clinical Psychology Department. No
identifying information was included in any database or stored electronically.
3.7 Ethical issues
Individuals with bipolar disorder are a potentially vulnerable group due to the relapsing
nature of their condition and the fact that individuals may experience subsyndromal
symptoms and cognitive and emotional impairment when remitted. Ethical issues, in line
with British Psychological Society Code of Conduct, Ethical Principles and Guidelines
(British Psychological Society, 1995), were adhered to throughout the study in order to
reduce potential burden to the participants. Furthermore, the inclusion and exclusion
criteria were designed to highlight that acutely unwell individuals were not suitable to
take part in the study due to vulnerabilities (e.g. issues around ability to consent to
research participation) associated with being unwell.
Ethical issues were considered when selecting the research measures. A key factor in
determining which tests would be used involved ensuring that the measures would not
cause the participants undue stress. An additional consideration involved choosing
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measures that would be informative yet quick to administer and complete. Some of the
questions required participants to reflect on their experiences of having this disorder.
Participants were informed that they did not have to answer any questions that they
found too anxiety-provoking or distressing.
If a participant became upset during the study the researcher would refer them to the
appropriate service. As General Practioners (GPs) are often the first point of contact for
distressed patients they were informed by way of a standard letter (see Appendix 16)
that their patient was taking part in a study. Participants were given the researcher’s
contact details in case they wished to discuss any aspect of the study prior to or
following the questionnaires being completed. Each participant completed a consent
form prior to taking part in the study (see Appendix 17).
3.8 Ethical approval
The Fife, Forth Valley and Tayside Research Ethics Committee reviewed the proposal
for this study. After reviewing the proposal, the committee granted approval for this
research to be carried out (Appendix 18). Approval was also granted from the University
of Edinburgh Clinical Psychology Ethics Committee (Appendix 19) and the Research
and Development (R&D) office in NHS Forth Valley (Appendix 20).
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4.0 RESULTS
4.1 Overview of the preliminary analyses
The data were analysed using the Predictive Analytical Software version 17 for
Windows. The sample characterised were explored to provide additional information
about the research sample. The data was then examined in relation to the research
hypotheses (refer to section 2.7). In addition, exploratory analyses were conducted in
order to investigate the relationship between the individual, disorder, and treatment
related variables (refer to the research questions section 2.7).
The strategy of analyses and the results for each stage is provided below.
4.2 Strategy of analysis: The sample characteristics
Descriptive and inferential statistical tests were used to investigate if there were
significant differences between the three recruitment sources (i.e. Bipolar Fellowship,
psychiatric and community referrals) with reference to demographic (e.g. age, gender)
and clinical variables (e.g. diagnosis, number of episodes experienced). Statistical tests
were selected based on the type of data being analysed. Tests of normality of distribution
and homogeneity of variance were used to evaluate the data against assumptions for
parametric tests (Dancey & Reidy, 2004). The Kolmogorov-Smirnov test was used to
determine if the distribution of scores differed significantly from normality and the
Levene’s test was used to test for equality of variance. When the data did not adhere to
the assumptions of parametric tests, the non-parametric equivalent test was used. When
non-parametric tests were conducted the parametric equivalent test was also carried out
to establish if the results were in line with the non-parametric finding. Unless otherwise
specified the results from the parametric tests were in line with the non-parametric
results.
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4.2.1 Results: The sample characteristics
The data were collected from 101 participants: 58 participants (57.4 percent) were
female. Seven participants who initially agreed to take part in the research, withdrew
from the study (these individuals are not included in the total sample figure).  The main
reason for withdrawing from the research was not having time to participate.
Ninety-five percent of the sample reported that they were prescribed and taking
medication for bipolar disorder.  The researcher did not carry out medication adherence
checks. Eighty-nine percent of the sample stated they had contact with a psychiatrist
regarding management of their disorder. Demographic and clinical variables for the
three referral sources are summarised in Table 4.1.
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1-30 yrs    6.43
   (5.19)
1-40 yrs
N  % N  % N %
Male 28 34 1 14 13 50
Female 42 66 6 86 11 46
BPI 44 63 2 28.5  9 37
BPII  6 9 1 14  5 21
RC  5 7 2 29  5 21
Unknown 14 20 2 29  5 21
(BPI = bipolar I disorder, BPII = bipolar II disorder, RC = rapid cycling specifier)
There were no significant between-group differences with reference to clinical and
demographic-related variables. (Refer to Appendix 21 section 2 for the statistical test
results).
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4.3 Strategy of analysis: The preliminary analyses
4.3.1 Preliminary analyses and the research hypotheses
The procedure described in section 4.2 was used to determine whether a parametric or
non-parametric test was used to explore the data. Cohen’s (1998) guidance regarding the
size of correlations (i.e. small = < 0.3, moderate = 0.3 to 0.5, and large = > 0.5) was used
to determine the size of significant associations. The preliminary analysis was conducted
in order to test the following hypotheses:
Hypothesis 1:
General self-efficacy will be positively associated with participants’ perception of their
ability to identify and manage manic and depressive prodromal symptoms. (one-tailed)
This hypothesis was investigated through the use of a one-way ANOVA.
Hypothesis 2:
Social support, in relation to help from significant others in managing bipolar disorder,
will be positively associated with the participants’ view of their ability to identify and
manage prodromal symptoms. (one-tailed) This hypothesis was explored through the use
of the 2 x 3 Pearson chi-square test.
Hypothesis 3:
Previous and current psychosocial input will be positively associated with the
participants’ perception of their ability to identify and manage prodromal symptoms.
(one-tailed) This hypothesis was explored through the Spearman rho correlational test as
the data did not meet assumptions for parametric tests.
4.3.2 Exploratory analyses
To investigate the relationship between individual, disorder, and treatment-related
variables, univariate and bivariate statistical tests were carried out. These tests were
carried out to explore the following research questions:
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The data were also used to explore the following research questions:
i) Are the following factors associated with participants’ perception of their ability to
identify and manage prodromal symptoms: time since diagnosis, gender, age, number of
episodes experienced, and current mood state?
ii) Does the consistency of prodromal symptoms (across episodes) have an impact on
participants’ perception of their ability to identify and manage prodromal symptoms?
iii) Does the ability to identify prodromal symptoms when they first present have an
impact on participants’ perception of their ability to identify and manage prodromal
symptoms?
iv)Is the polarity of the prodromal symptom associated with the participants’ perception
of their ability to manage manic and depressive prodromal symptoms?
Table 4.2 provides a summary of how the variables of interest were measured.
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Table 4.2 Summary of how the individual, disorder, and treatment-related variables were
measured




General self-efficacy The aggregate score from the participant’s
responses to the 10 items on the GSES.
Participant’s perception of their ability to
identify manic and depressive prodromal
symptoms
Participants’ responses to questions 6 & 8
in the Demographic Questionnaire in which
they are asked to state if they believe they
can identify manic/depressive prodromes.
Response format: yes, no, or sometimes.
Participants’ perception of their ability to
manage manic and depressive prodromal
symptom
Participants’ responses to questions 7 & 9
in the Demographic Questionnaire in which
they are asked to state if they believe they
can manage manic/depressive prodromes.
Response format: yes, no, or sometimes.
Disorder-related variables
Current mood state Assessed from self-report information
provided in the ISS. Algorithm specified by
the authors (Bauer et al., 2001) used to
classify current mood state.
Number of manic and depressive episodes
experienced
Demographic Questionnaire: a definition of
what constitutes an episode (e.g.
hospitalisation) was not provided.
Time since diagnosis Demographic Questionnaire: year in which
the questionnaire was completed was
subtracted from the year the diagnosis was
received.
Consistency of manic and depressive
symptoms across episodes
Demographic Questionnaire response to
question 10 & 11.
Response format: yes or no
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Consistency of manic and depressive
prodromal symptoms across episodes
Demographic Questionnaire: response to
questions 12 & 13.
Response format: yes or no
Treatment-related variables
Role of significant others in management
of bipolar disorder
Demographic Questionnaire response to
question 5(a) (response format: yes, no)
and qualitative response to 5(b). Social
network explored through data from the
SOS questionnaire.
Level of psychosocial input received
(present and current combined)
Response to question 4 in Demographic
Questionnaire. Psychosocial input equals
the number of services (i.e. day unit, self-
help groups, CPN, clinical psychology)
individual has had contact (range 0 to 5).
4.3.3 Preliminary analyses: Results
Information regarding all significant statistical relationships is provided below.
4.3.3.1 Variable: Time since diagnosis
As the variable time since diagnosis was not normally distributed (Z = 1.637, p = .009)
non-parametric tests were used to explore if there was a significant relationship between
time since diagnosis and the following variables:
• Individual-related: general self-efficacy, age, and gender;
• Disorder-related: number of manic and depressive episodes experienced; and
• Treatment-related: psychosocial input, and role of significant others in helping to
manage bipolar disorder.
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No significant relationships were found between the variable time since diagnosis and
the disorder-related variables. Information relating to the non-significant results is
provided in Appendix 21 section 3.
4.3.3.1.1 Time since diagnosis and individual-related variables
A significant positive moderate association was found for time since diagnosis and age,
rho = .445, p < .001.
4.3.3.1.2 Time since diagnosis and treatment-related variables
A moderate positive significant association was found for psychosocial input received
and time since diagnosis, rho = .208, p = .037.
4.3.3.2 Variable: Age
The variable age was statistically examined in relation to:
• Individual-related variables: general self-efficacy;
• Treatment-related variables: psychosocial input, role of significant others; and
• Disorder-related variables: number of episodes experienced.
As the variable age was normally distributed (Z = 6.88, p = .731) when the variable of
interest satisfied parametric assumptions, parametric tests were used. When assumptions
for parametric tests were not satisfied, the non-parametric equivalent test was used. No
significant relationships were found for age and the individual and the treatment-related
variables. Refer to Appendix 21 section 4 for information regarding the non-significant
findings.
4.3.3.2.1 Age and disorder-related variables
Age and the number of manic episodes experienced by participants were significantly
correlated; a small positive effect was found, rho = .250, p = .037. However, no
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significant relationship was found for age and number of depressive episodes
experienced as rho = .012, p = .923.
4.3.3.3 Variable: Help from significant others in managing bipolar disorder
Help from a significant other (help received/help not received) was considered in
relation to the following variables:
• Individual-related: general self-efficacy, age, gender;
• Disorder-related: number of manic and depressive episodes experienced,
diagnosis type; and
• Treatment-related: psychosocial input.
No statistically significant relationships were found between help from significant others
and the variables of interest. Refer to Appendix 21 section 5.1 to 5.3 for information
regarding the non-significant findings.
Participants were asked to briefly describe the help they received from a significant
other. This information was used to categorise help received as either: i) emotional
and/or practical (e.g. provide caring support and/or help with household chores) or ii)
prodromal monitoring-related. A total of 16 (32.65 percent) participants received
emotional/practical support and 33 (67.35 percent) received prodromal monitoring-
related support. When type of help was entered as an IV, no significant effects were
found for the variables time since diagnosis, age, self-efficacy, or level of psychosocial
input.  Refer to Appendix 21 section 5 for information regarding the non-significant
findings concerning type of help and the aforementioned variables.
The type of help received was examined in relation to participants’ view of their ability
to identify and manage prodromal symptoms. Table 4.3 provides a summary of the
participants’ perception of their ability to identify and manage prodromes in relation to
the type of support they received from a significant other.
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Table 4.3 Summary of perception of ability to identify and manage prodromes in
relation to type of help received from significant other





Able to identify manic prodromes
No   4 (25)   6 (18.18)
Sometimes   8 (50) 13 (39.40)
Yes   4 (25) 14 (42.42)
Able to identify depressive prodromes
No  3 (18.75)  7 (21.21)
sometimes  6 (37.50)  5 (15.15)
yes  7 (43.75) 21 (63.64)
Able to manage manic prodromes
No   3 (18.75)  8 (24.24)
Sometimes 10 (62.50) 18 (54.55)
yes   3 (18.75)  7  (21.21)
Able to manage depressive prodromes
No  3 (18.75)  9 (27.27)
Sometimes  8 (50) 15 (45.46)
Yes  5 (31.25)   9 (27.27)
A 2 x 3 Pearson chi-square test was used to explore whether perception of ability to
identify and manage prodromes was associated with the type of help received. A
significant difference was found between participants’ perception of ability to manage
manic prodromes and the type of support they received, χ2 = 12.53, d.f.  = 2, p = .002.
Based on descriptive statistics in Table 4.3, participants who received
emotional/practical support were more likely to be able to identify their symptoms
sometimes, whereas participants who received disorder-related support were more able
to identify their symptoms all of the time. Participants’ ability to identify depressive
prodromes was also associated with type of help, χ2 = 12.54, d.f.  = 2, p = .002. The
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descriptive statistics indicated that participants who received disorder-related support
were more able to identify depressive prodromes. No significant effect was observed for
participants’ perception of their ability to manage prodromal symptoms and the type of
help provided by significant others. (Refer to Appendix 21 section 5).
4.3.3.4 Variables: Actual and ideal emotional and practical support
Support from significant others was also considered in relation to the data from the SOS
questionnaire. The SOS provides information on the actual and ideal level of support
received from significant others, therefore, data for the following variables were
summarised from the participants’ responses to the SOS:
• actual emotional support
• ideal emotional support
• actual practical support
• ideal practical support
• discrepancy between ideal and actual emotional support
• discrepancy between the ideal and actual practical support
Ninety-two participants completed the SOS questionnaire. Some participants stated that
they did not wish to complete the questionnaire because they believed they did not have
a significant other person in their life to base their answers on. On average participants
provided information for 4.42 relationships (SD = 2.23, range = 1-7). Participants
discussed their view of support for a range of significant others (e.g. mother, father,
spouse, friend, sibling, community psychiatric nurse, and in-laws). Table 4.4 provides a
summary of descriptive information based on the data provided for all type of
relationships.
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Actual emotional 2.94 (1.64)
Ideal emotional 3.12 (1.78)
Actual practical 3.20 (1.97)
Ideal practical 2.93 (1.70)
Discrepancy: emotional   .72 (.65)
Discrepancy: practical   .62 (.63)
Paired t-tests were used to examine if there were significant differences for the actual
and ideal level of emotional and practical support received from significant others. A
significant difference was observed for emotional support t = 2.65, d.f. = 91, p = .01 and
practical support t = 4.07, d.f. = 91, p <.001. A review of the descriptive information in
Table 4.4 indicates that the participants would like to receive more emotional support
and less practical support.
When comparisons were made between the type of support received, a significant
difference was observed between actual emotional and actual practical support received
t = 3.18, d.f. = 91, p = .002. A significant difference was also found for ideal emotional
and practical support t = 4.03, d.f. = 91, p <.001. A review of the descriptive statistics in
Table 4.4 indicates that participants believed they received more practical than
emotional support. When ideal support w as reviewed the results indicated  that
participants would like to have more emotional support from significant others.
The relationship between actual and ideal emotional and practical support was reviewed
in relation the following variables:
• Individual-related: age, and gender;
• Disorder-related: number of episodes experienced, mood state, and time since
diagnosis.
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There were no significant relationships between actual and ideal emotional and practical
support and the individual-related and disorder variables. Refer to Appendix 21 section 6
for additional information.
Table 4.5 provides descriptive information for the following relationships: mother,
father, and spouse.   
Table 4. 5 Mean (SD) scores for actual and ideal support received (mother, father,
spouse relationships)
support Mother (N = 25)
M (SD)
Father  (N = 9)
M (SD)
Spouse (N = 33)
M (SD)
Actual support 5.20   (.86) 5.19 (1.71) 5.88 (1.12)
Ideal support 5.37 (1.69) 5.66 (1.11) 6.00 (1.42)
Discrepancy   .83   (.85) 1.11 (1.55)   .49   (.74)
The descriptive statistics indicated that the least discrepancy between actual and ideal
support was for the relationships with spouses.
4.3.3.5 Variable: General self-efficacy
Participants’ general self-efficacy scores were explored in relation to the following
variables:
• Individual-related: gender;
• Disorder-related: number of episodes experienced, diagnosis, and current mood
state; and
• Treatment-related: role of significant others and psychosocial input.
As the variable self-efficacy was normally distributed (Z = .836, p = .486) when
homogeneity of variance was met parametric tests were used. When this assumption was
not met, non-parametric tests were used. No significant relationships were found for
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self-efficacy and individual and disorder-related variables. Refer to Appendix 21 section
7 for information regarding the non-significant findings.
4.3.3.5.1 General self-efficacy and treatment-related variables
Self-efficacy scores and level of psychosocial input received were negatively correlated,
r = -.195, p = .05. This small correlation indicates that higher levels of psychosocial
input are associated with lower general self-efficacy scores.
4.3.3.6 Variable: Identification of manic and depressive prodromes
Table 4.6 provides a summary of participants’ perception of their ability to identify
manic and depressive prodromal symptoms when they first present.







Manic prodromes 14 (13.9) 46 (45.5) 41 (40.6)
Depressive prodromes 18 (17.8) 25 (24.8) 58 (57.4)
The Pearson chi-square test was used to investigate if there was an effect of polarity with
reference to participants’ ability to identify prodromes. No significant difference was
found when participants’ ability to identify or not identify prodromal symptoms was
examined. Refer to Appendix 21 section 8 for additional information.
Participants’ perception of their ability to identify manic and depressive prodromal
symptoms was statistically explored in relation to:
• Individual-related variables: general self-efficacy, age, and, gender;
• Disorder-related variables: number of episodes experienced, time since
diagnosis, current mood state, and consistency of prodromal symptoms; and
• Treatment-related variables: role of significant others, and psychosocial input.
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4.3.3.6.1 Manic prodromal symptoms
No significant statistical relationships were found for treatment-related variables in
relation to participants’ ability to identify manic prodromal symptoms. For information
on the non-significant findings refer to Appendix 21 section 8.1.3.
4.3.3.6.2 Identification of manic prodromes and individual-related variables
Five males (11.91 percent) stated they could not identify symptoms, 15 (35.71 percent)
believed they could sometimes identify symptoms, and 22 (52.38 percent) believed they
could identify manic prodromal symptoms. Nine females (15.26 percent) believed they
were unable to identify symptoms, 19 (32.20 percent) stated they could sometimes
identify symptoms, and 31 (52.54 percent) stated they could identify symptoms. A 2 x 3
Pearson chi-square test for categorical data were used to explore whether there was an
association between gender and ability to identify manic prodromal symptoms. A
significant difference was found, χ2 = 3.72, d.f.  = 2, p = .054. This result is further
explored in the primary analyses. No significant associations were found for the
participants’ perception of their ability to identify manic prodromal symptoms and
general self-efficacy scores and age. Refer to Appendix 21 section 8.1.1.
4.3.3.6.3 Identification of manic prodromes and disorder-related variables
Table 4.7 provides a summary of the number of participants who experienced consistent
and inconsistent manic prodromal symptoms with reference to the participants’
perception of their ability to identify manic prodromal symptoms.
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Table 4.7 Summary of participants’ experience of manic prodromes in relation to














5 (10.00) 17 (34.00) 28 (56.00)
As the data were categorical, a 2 x 3 Pearson chi-square test was used to examine the
relationship between the participants’ perceptions of their ability to identify manic
prodromes and consistency of manic prodromes across episodes (consistent or
inconsistent). A significant relationship was found, χ2 = 9.752, d.f.  = 2, p = .008. No
significant associations were found between participants’ perception of their ability to
identify manic prodromal symptoms and the variables time since diagnosis and mood
state (refer to Appendix 21 section 8.1.2 for more information).
4.3.3.6.4 Identification of depressive prodromes
No significant relationships between ability to identify depressive prodromes and
individual and treatment-related variables were found. For information on the non-
significant findings refer to Appendix 21 section 8.2.1 and 8.2.3.
4.3.3.6.5 Identification of depressive prodromes and disorder-related variables
Table 4.8 provides a summary of participants’ perception of their ability to identify
depressive prodromal symptoms in relation to whether prodromal symptoms are
consistent across episodes.
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Table 4.8 Summary of participants’ experience of depressive prodromal symptoms in









11 (28.21%) 12 (30.77%) 16 (41.02%)
Consistent
prodromes
7 (11.29%) 13 (20.97%) 42 (67.74%)
A 2 x 3 Pearson chi square test was carried out to explore if there was a significant
relationship between identification of depressive prodromes and consistency of
depressive prodromes across episodes; a significant relationship was found,
χ2 =7.748, d.f.  = 2, p = .021. No other significant relationships were found with the
disorder-related variables.
4.3.3.7 Variable: Management of prodromes
Table 4.9 provides a summary of participants’ views of their ability to manage manic
and depressive prodromal symptoms.








Manic prodromes 18 (17.82) 57 (56.43) 26 (25.75)
Depressive prodromes 24 (23.76) 50 (49.51) 27 (26.73)
When statistical comparisons were made between participants’ ability to manage manic
and depressive prodromes no significant differences were found for participants’ ability
to manage prodromal symptoms. Refer to Appendix 21 section 9 for additional
information.
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The sample’s ability to manage manic and depressive prodromes was explored in
relation to:
• Individual-related variables: general self-efficacy, age, and gender;
• Disorder-related variables: time since diagnosis, number of episodes
experienced, current mood state, participants’ perception of their ability to
identify prodromes, consistency of prodromes; and
• Treatment-related variables: role of significant others and psychosocial input.
4.3.3.7.1 Management and manic prodromes
No significant relationships were found between treatment-related variables and
participants’ perceptions of their ability to manage prodromal symptoms. For
information on the non-significant findings refer to Appendix 21 section 9.1.2.
4.3.3.7.1.1 Management of manic prodromes and individual-related variables
Participants who were able to manage prodromal symptoms had a mean general self-
efficacy score of 29.77 (SD = 5.37, range = 18-38). Participants who reported that they
could sometimes manage these prodromes a mean score of 25.60 (SD = 6.11, range =
10-39). Participants who said they could not manage manic prodromes had a mean self-
efficacy score of 24.28 (SD = 6.43, range = 15-39). As assumptions of normal
distribution (Z = .836, p = .486) and homogeneity of variance were met (Levene’s test =
0.101, d.f.  = 2, 98, p = .904) a one-way ANOVA was carried out to investigate if there
were between group differences regarding self-efficacy scores. A significant effect was
found as F = 12.75, d.f. = 2, 98, p = .004.
The Tukey post hoc test was used to explore the significant difference. A significant
difference was found between self-efficacy scores for participants who stated they could
manage manic prodromes and those who stated they were unable to manage symptoms.
A significant difference was also found for participants who could manage and those
who perceived that they could sometimes manage symptoms. There was no significant
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difference between the ‘sometimes could’ and the ‘could not’ manage groups. A non-
significant association was found between participants’ perception of their ability to
manage manic prodromal symptoms and the variables age and gender (refer to Appendix
21 section 9.1.1 for additional information).
4.3.3.7.1.2 Management of manic prodromes and disorder-related variables
Participants who stated they could manage manic prodromal symptoms had experienced
a median number of four manic episodes (range = 1-100). Those who stated they could
sometimes manage symptoms reported experiencing a median of five episodes (range =
1-216). A median number of seven episodes (range = 1-300) were experienced by
participants who stated they could not manage prodromal symptoms.
As the number of manic episodes experienced was not normally distributed the Kruskal-
Wallis test was used to determine if there were between-group differences. A significant
difference was observed as χ2 = 6.85, d.f. = 2, p = .033. The Mann-Whitney U test was
used to explore the significant effect. A significant difference was found for participants
who could not and could sometimes manage manic symptoms as U = 235.5, p = .032. A
significant difference was also found between participants who could sometimes manage
symptoms and those who stated they can manage symptoms as U = 298.5, p = .028.
No significant difference was observed between participants who stated they cannot
manage symptoms and those who said they can manage symptoms as U = 174.5, p =
.908.
Table 4.10 provides a summary of the participants’ ability to manage manic prodromal
symptoms in relation to their perception of their ability to identify prodromal symptoms.
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Table 4.10 Summary of participants’ perception of their ability to manage manic













3 (5.26) 42 (73.69) 12 (21.05)
Able to
identify
0 (0%) 2 (7.69%) 24 (92.31%)
When the relationship between participants’ ability to manage prodromal symptoms and
their perceptions of their ability to identify symptoms was explored via a 3 x 3 Pearson
chi-square test a significant relationship was found, χ2  = 17.60, d.f. = 2, p <.001.  Based
on the descriptive data it would appear that participants who are able to identify manic
prodromes are more likely to be able to manage these symptoms. This finding will be
explored in more detail in the primary analysis. No significant associations were found
for time since diagnosis and current mood state with reference to the participants’
perception of their ability to manage prodromal symptoms (refer to Appendix 21 section
9.1.3 for additional information).
4.3.3.7.2 Management of depressive prodromes
No significant relationships were found for the individual and treatment-related
variables and perception of the participants’ ability to manage depressive prodromal
symptoms. For information on the non-significant findings refer to Appendix 21 section
9.2.1 and 9.2.3.
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4.3.3.7.2.1 Management of depressive prodromes and disorder-related variables
Table 4.11 provides a summary of participants’ view of their ability to manage
depressive prodromal symptoms in relation to their perception of the consistency of their
depressive prodromal symptoms.
Table 4.11 Summary of participants’ experience of depressive prodromes in relation to










11 (28.21) 21 (53.84)  7 (17.95)
Consistent
prodromes
13 (20.97) 29 (46.77) 20 (32.26)
A 2 x 3 Pearson chi-square test was used to explore whether a relationship exists
between consistency of prodromal symptoms across episodes and participants’ view of
their ability to manage prodromal symptoms. A significant association was found as χ2 =
5.328, d.f. = 1, p = .022. Based on the descriptive data it appears that participants who
experienced consistent depressive prodromes were more likely to be able to mange these
prodromes. This significant association will be explored in more detail in the primary
analysis.
Table 4.12 provides a summary of participants’ ability to manage prodromal symptoms
in relation to their perception of their ability to identify manic prodromal symptoms.
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Table 4.12 Summary of participants’ perception of their ability to manage depressive













 2 (8.00) 21 (84.00)   2 (8.00)
Able to
identify
 9 (15.52) 26 (44.83) 24 (39.65)
When the relationship between participants’ ability to manage prodromal symptoms and
their perception of their ability to identify symptoms was explored via a 3 x 3 Pearson
chi square test a significant relationship was found as χ2  = 27.109, d.f. = 2, p <.001. The
descriptive data indicates that participants who believe they are unable to identify
prodromes also believe that they are unable to manage these symptoms. This
relationship will be explored in more detail in the primary analysis. A non-significant
relationship was found for the variables time since diagnosis, number of episodes
experienced, and current mood state (refer to Appendix 21 section 9.2.2 for additional
information).
4.4 Strategy of analysis: Participants’ experience of prodromes
A sub-sample of 48 participants completed the Prodromal Experience Questionnaire.
The questionnaire contained a list of 36 common manic and depressive prodromal
symptoms. The prodromal symptoms can be categorised by polarity and type (i.e.
affective, cognitive, and behavioural).
To investigate if there is a significant difference in the number of manic and depressive
prodromes that participants endorsed as experienced, identified when the symptom first
presents, consistently experienced, and manageable statistical tests were carried out.
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Statistical tests were also conducted to explore if prodromal type has an impact upon
participants’ perception of their ability to identify and manage prodromes.
In addition, participants’ perception of their ability to identify and manage cognitive,
affective, and behavioural manic and depressive prodromes was statistically analysed in
relation to:
• Individual-related variables: age, gender, general self-efficacy;
• Treatment-related: psychosocial input, role of significant others; and
• Disorder-related: time since diagnosis, number of manic and depressive episodes
experienced, mood state, and consistency of symptoms experienced.
As the data did not violate the assumption of normal distribution parametric tests were
used to explore the association between variables of interest. The statistical analyses
associated with participants’ experience of prodromal symptoms will be used to explore
the research question:
Are types of prodromal symptoms (i.e. cognitive, affective, and behavioural) associated
with the participants’ perception of their ability to identify and manage manic and
depressive prodromal symptoms?
Prior to the data being reviewed information relating to demographic and clinical
features of the sub-sample of participants who completed the Prodromal Experience
Questionnaire will be presented in section 4.4.1.
4.4.1 Results: Experience of prodromal symptoms
Twenty-nine females (60.42 percent) and 19 males (39.58 percent) completed the
Prodromal Experience Questionnaire. Table 4.13 provides a summary of the clinical and
demographic factors associated with the sub-sample of participants.
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Table 4.13. Descriptive information (clinical and demographic variables) for the sub-
sample who completed the Prodromal Experience Questionnaire
Sub-sample of participants (N = 48)
M (SD) Range
Age
No. of manic episodes
47.17 (9.64)
20.21 (57.06)
24 - 72 yrs
1 - 216
No. of depressive episodes 25.24 (27.57) 1 - 144
Time since diagnosis 12.90 (8.20) 1 - 40 yrs
A comparison of the descriptive information for the total sample in table 4.2 shows that
the sub-sample did not significantly differ with regard to the above clinical and
demographic variables. No significant differences were found when the sub-sample was
compared to the remaining participants from the total sample with reference to the above
variables. Refer to Appendix 21 section 10 for additional information.
Table 4.14 provides a summary of the prodromal symptoms that were most commonly
endorsed by participants with reference to experience of manic and depressive
prodromes, ability to identify prodromes when they first present, and prodromes that are
consistently experienced.
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Table 4.14 The most commonly endorsed prodromes by polarity






































































A review of the information in the above table indicates that a high percentage of the
sub-sample had experienced similar prodromal symptoms. There is a considerable
reduction in the percentage of participants who believe that they are able to manage
prodromal symptoms. Furthermore, with the exception of consistently experienced
prodromes, the three most common manic prodromal symptoms were mentioned in
relation to prodromes that are experienced, identifiable when they first present, and
manageable. When commonly endorsed depressive prodromes are reviewed it is
apparent that different prodromes are identified as being experienced, consistently
experienced, identifiable when they first present, and manageable.
Table 4.15 provides descriptive information on the number of prodromal symptoms that
participants stated they experienced, were able to identify when they first presented,
were consistently experienced, and were able to manage.
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Total Sample (N = 48)
M (SD)
Manic prodromes
Experienced 13.47 (5.38) 14.90 (3.62) 14.33 (4.40)
Consistently
experienced
6.84 (6.31) 8.07 (5.65) 7.58 (5.86)
Identified when first
present
5.79 (6.28) 6.03 (5.53) 5.94 (5.77)
Managed 3.21 (4.99) 4.62 (5.34) 4.06 (5.20)
Depressive prodromes
Experienced 12.26 (6.76) 15.86 (2.95) 14.44 (4.88)
Consistently
experienced
5.74 (6.24) 9.31 (6.35) 7.90 (6.49)
Identified when first
present
5.63 (7.18) 8.55 (6.89) 7.40 (7.08)
Managed 2.00 (4.19) 4.24 (5.60) 3.35 (5.15)
The range was 0-18, with the exception of males’ experience of manic prodromes (range = 2-18).
Independent t-tests were used to test for effect of gender regarding experience of
prodromes. No significant differences were observed.  For information on the non-
significant findings refer to Appendix 21 section 10.
To investigate the experience of the total sample, paired t-tests were used. No significant
differences with observed for the experience of prodromes by polarity.
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4.4.2. Participants’ experience of affective prodromes
Table 4.16 provides a summary of descriptive statistics associated with participants’
experiences of affective prodromes.
Table 4.16 Summary of participants’ experience of affective prodromes
Males (N = 19)
M (SD)
Females (N = 29)
M (SD)
Total Sample (N = 48)
M (SD)
Manic prodromes
Experienced 3.74 (1.73) 4.34 (.94) 4.10 (1.33)
Consistently
experienced
1.68 (1.92) 2.24 (1.69) 2.02 (1.78)
Identified when first
present
1.32 (1.73) 1.79 (1.42) 1.60 (1.55)
Managed 0.79 (1.44) 1.28 (1.56) 1.08 (1.51)
Depressive prodromes
Experienced 2.68 (1.64) 3.55 (.827) 3.21 (1.27)
Consistently
experienced
1.32 (1.49) 2.00 (1.56) 1.73 (1.55)
Identified when first
present
1.21 (1.75) 1.93 (1.65) 1.65 (1.71)
Managed 0.58 (1.17) 1.03 (1.40) 0.85 (1.32)
The range for the manic prodromes was 0-5 and 0-4 for depressive prodromes.
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Independent t-tests were used to investigate if gender had an impact on how prodromes
are experienced. A significant effect of gender was observed for the number of
depressive prodromes that participants stated they experienced t = 2.43, d.f. = 46, p =
0.01. Female participants reported that they experienced more affective depressive
prodromes (Mean = 3.55, SD = .827) compared with the male participants (Mean = 2.68,
SD = 1.64).
Paired t-tests were used to investigate if there was a significant difference in the
samples’ experience of manic and depressive affective prodromes. There was a
significant difference between the numbers of affective prodromes experienced,
t = 6.86, d.f. = 47, p <.001. The descriptive statistics indicate that more manic affective
prodromes were experienced (Mean = 4.10, SD = 3.21) than depressive affective
prodromes (Mean = 3.21, SD = 1.27).
4.4.3 Participants’ experience of cognitive prodromes
Table 4.17 provides a summary of descriptive information associated with male, female,
and the total research sample’s experience of cognitive prodromes.
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Experienced 4.58 (2.06) 4.86 (1.36) 4.75 (1.66)
Consistently
experienced
2.16 (1.19) 2.62 (2.19) 2.44 (2.18)
Identified when first
present
1.95 (2.17) 1.76 (2.05) 1.83 (2.08)
Managed 0.89 (1.79) 1.34 (1.97) 1.17 (1.89)
Depressive prodromes
Experienced 4.32 (2.48) 5.59 (.682) 5.08 (1.71)
Consistently
experienced
2.32 (2.50) 3.17 (2.35) 2.83 (2.42)
Identified when first
present
2.05 (2.55) 2.76 (2.41) 2.48 (2.46)
Managed 0.58 (1.42) 1.52 (2.08) 1.15 (1.89)
The range for the manic prodromes was 0-5 and 0-4 for depressive prodromes.
Independent t-tests were used to assess if the experience of males and females
significantly differed. A significant difference between the number of cognitive
depressive prodromes experienced by male and female participants was observed
t = 2.65, d.f. = 46, p = .01. The female participants experienced more depressive
prodromes in comparison to the male participants (Male participants: Mean = 4.32, SD =
2.48; Female participants: Mean = 5.59, SD = .682).
Paired t-tests were used to examine participants’ experiences with reference to the
polarity of the prodrome. A significant difference was found between the number of
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cognitive prodromes that are identified when they first present t = 2.24, d.f. = 47, p =
.030. The participants’ responses indicated that more depressive prodromal symptoms
were identified (Mean = 2.48, SD = 2.46).
4.4.4 Participants’ experience of behavioural prodromes
Table 4.18 provides a summary of the participants’ experience of behavioural
prodromes. As above, the information is presented for males and female participants and
also for the sample as a whole.








Experienced 5.21 (2.02) 5.66 (1.59) 5.48 (1.76)
Consistently experienced 3.00 (2.56) 3.21 (2.13) 3.13 (2.28)
Identified when first
present
2.53 (2.59) 2.48 (2.46) 2.50 (2.48)
Managed 1.53 (2.14) 1.97 (2.28) 1.79 (2.21)
Depressive prodromes
Experienced 5.26 (2.77) 6.69 (1.23) 6.13 (2.08)
Consistently experienced 2.11 (2.40) 4.14 (2.80) 3.33 (2.81)
Identified when first
present
2.26 (2.56) 3.93 (2.83) 3.27 (2.82)
Managed 0.84 (1.74) 1.66 (2.54) 1.33 (2.27)
The range for the manic prodromes was 0-5 and 0-4 for depressive prodromes.
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Independent t-tests were used to analyse the data concerning experience of cognitive
prodromes. Significant differences were observed for the number of depressive
behavioural prodromes experienced by male and female participants (t = 2.44, d.f. = 46,
p = .018), the number always experienced (t = 2.59, d.f. = 46, p = .013) and the number
that can be identified when they first present (t = 2.07, d.f. = 46, p = .044) The
descriptive statistics  (refer to Table 4.18) show that female participants experienced
more depressive behavioural prodromal symptoms that were more consistent and more
readily identifiable in comparison to the male participants.
To examine the effect of polarity for the sample’s experience of behavioural prodromes
paired t-tests were used. Significant differences were observed between the numbers of
behavioural prodromal symptoms experienced (t = 2.36, d.f. = 47, p = .022), identified
(t = 2.11, d.f. = 47, p = .04), and managed (t= 2.04, d.f. = 47, p = .047). The descriptive
statistics show that more depressive behavioural prodromes were experienced compared
to manic prodromes (Mean = 6.13, S. D. = 2.08; Mean = 5.48, S.D. = 1.76). Likewise,
depressive prodromal symptoms were viewed as being more identifiable than manic
prodromal symptoms (Mean = 3.27, S.D. =2.82; Mean = 2.50, S.D. = 2.48). More manic
prodromal symptoms, however, were viewed as manageable (1.79, S.D. = 2.21)
compared to depressive prodromal symptoms (1.33, S.D. = 2.27).
4.4.5 The relationship between the experience of prodromes and individual,
disorder, and treatment-related variables
Significant results from the bivariate statistical analyses for the three types of prodromal
symptoms and the individual, disorder, and treatment-related variables of interest are
summarised in Table 19. Refer to Appendix 21 section 10.4 for the non-significant
results.
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Table 4.19. Summary of significant results for prodrome type and individual, disorder,
and treatment-related variables
Prodrome type Variables Result
Affective
Manic: Identify & age rho = -.323, p = .029
Manage & self-efficacy rho =.  413, p = .004
Manage & identify rho =  .605, p = .001
Depressive: Identify & age rho =-.290, p = .050
Identify & prodrome consistency rho =  .344, p = .017
Manage & identify rho =  .399, p = .005
Manage & prodrome consistency rho =  .280, p = .054
Cognitive
Manic: Identify & self-efficacy rho = .375, p = .009
Manage & identify rho = .475, p = .001




rho = .414, p = .003
rho = .321, p = .026
Manic: Identify & self-efficacy rho = .301, p = .038
Manage & identified rho = .475, p = .001
Depressive: Identify & self-efficacy rho = .301, p = .038
Manage & identify rho = .529, p = .001
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4.4.5.1 Participants’ experience of affective prodromes in relation to individual,
disorder and treatment-related variables
A moderate negative significant correlation was found for ability to identify manic
prodromes when they first present and age. A moderate positive significant correlation
was also observed for ability to manage and self-efficacy and ability to manage and
number of manic prodromes identified when they first present.
For depressive prodromes, a negative significant association was found for ability to
identify symptoms and age (small correlation). This indicates that ability to identify
depressive affective prodromes may reduce with age. A moderate positive correlation
was found for consistently experienced symptoms and the participants’ view of their
ability to identify prodromes. When ability to manage depressive affective prodromes
was explored a positive moderate correlation was found for number of prodromes
identified and a small positive correlation was found for the consistency of prodromes
experienced.
4.4.5.2 Participants’ experience of cognitive prodromes in relation to individual,
disorder, and treatment-related variables
A significant positive association was found between participants’ ability to identify
manic cognitive prodromes and self-efficacy (moderate correlation).  A moderate
significant correlation was found for ability to manage these prodromes and number of
prodromes that can be identified when they first present.
With regard to depressive cognitive prodromes a significant positive moderate
association was found for ability to identify these prodromes and general self-efficacy. A
moderate positive significant correlation was also found for ability to manage these
prodromes and general self-efficacy. The number of prodromes identified when they
first present was also positively significantly correlated with participants’ view of their
ability to manage depressive cognitive prodromes: the effect size was moderate.
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4.4.5.3 Participants’ experience of behavioural prodromes in relation to
individual, disorder, and treatment-related variables
Participants’ ability to identify manic behavioural prodromes, when they first present
was positively significantly associated with general self-efficacy (moderate effect size).
Significant associations were observed for ability to manage manic behavioural
prodromes and number of prodromes identified when they first present (moderate effect
size). General self-efficacy was positively significantly associated with participants’
ability to identify behavioural depressive prodromes (moderate effect size).
There was a significant positive (large) association between management and number of
prodromes identified when they first present. A moderate positive significant association
was found for ability to manage behavioural prodromes and consistency of prodromes
across episodes.
4.5 Primary Analysis: Strategy of analysis
To identify the impact of the variables that significantly influence participants’ ability to
identify and manage prodromes four ordinal logistic regression analyses were
conducted. This statistical test was chosen as the dependent variable (participants’
perception of their ability to identify and manage manic and depressive prodromes) was
an ordered polytomous variable (e.g. response options: no, sometimes, yes). Ordinal
logistic regression is a common method for modelling relationships between an ordinal
DV and multiple IVs (Cohen et al., 2003). This analysis enables cumulative
probabilities, odds, and odd ratios for values of the DV, lower than or equal to particular
value, to be compared to those for higher values of the DV (Orme & Combs-Orme,
2009).
Separate ordinal logistic regression models were run for each of the four dependent
variables (DVs). Predictor variables (PVs) were included if they were significantly
associated with the DV as demonstrated in the preliminary analyses. With reference to
participants’ ability to identify manic and depressive prodromes the same predictor
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variables were examined in order to enable comparisons to be made between manic and
depressive prodromes.
The individual PVs were entered into the regression separately. For significant
associations the cumulative odds, cumulative probabilities, and probabilities for the
individual values of the DVs are presented. When more than one PV was significantly
related to the DV the analysis was re-run with the inclusion of all relevant predictor
variables. Figure 4.1 provides a summary of the PVs that were entered into the logistic
ordinal regression analyses.
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Figure 4.1 Summary of DVs and PVs used in the ordinal logistic regression analyses
Ordinal Regression Analysis 1:
DV = participants’ perception of their
ability to identify manic prodromes
Ordinal Regression Analysis 2:
DV = participants’ perception of their
ability to identify depressive prodromes
Ordinal Regression Analysis 3:
DV = participants’ perception of their
ability to manage manic prodromes
Ordinal Regression Analysis 4:
DV = participants’ perception of their
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Four statistical assumptions are associated with ordinal logistic regression analyses
(Orme &Combs-Orme, 2009). The assumptions and information detailing how they
were assessed and whether they were violated are discussed below.
Assumption 1: Relevant variables are included in the analysis.
How assessed: The PVs were included based on evidence from the primary analyses.
Assumption 2: Errors for each case are independent from errors of all others.
How assessed: This assumption was met as the participants from whom the DV is
measured were sampled independently.
Assumption 3: The absence of perfect multicollinearity.
How assessed: The Variation Inflation Factor (VIF) was used to assess if the tolerance
in the amount of variance in the IV was accounted for by the remaining IVs. Tolerance
levels of .10 or less were considered problematic and indicated that the IV should not be
included in the regression (Cohen, et al., 2003). This assumption was not violated.
Assumption 4: The parallel lines assumption states that the effect of the IVs is the same
for all values of the DV.
How assessed: The Parallel Lines Assumption test in PASW 17.0 was used to assess
whether this assumption was violated. When this test was applied to the four analyses
the results showed that the null hypothesis could not be rejected in analyses 1, however
the null hypothesis was rejected in tests 3 and 4. A review of the predictor variables
showed that participant’s ability to identify manic and depressive prodromes had a direct
impact upon this assumption. This variable was, therefore, not included in this analysis.
The multinominal logistic regression model can be used when this assumption is
violated; however, this analysis does not take account of the ordered DV (DeMaris,
2004). Therefore, information from the univariate and bivariate analyses will be used to
explore the impact of participants’ perception of their ability to identify prodromal
symptoms on prodromal management.
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4.5.1 Primary analyses and the research hypotheses and research questions
The results from the primary analysis were used to further explore whether the following
research hypotheses were accepted or rejected:
Hypothesis 1: General self-efficacy will be positively associated with participants’
perception of their ability to identify and manage manic and depressive prodromal
symptoms. (one-tailed)
Hypothesis 2: Social support, in relation to help from significant others in managing
bipolar disorder, will be positively associated with the participants’ view of their ability
to identify and manage prodromal symptoms. (one-tailed)
The following a priori research question was also explored:
i) Does the consistency of prodromal symptoms (across episodes) have an impact on
participants’ perception of their ability to identify and manage prodromal symptoms?
Based on the findings from the preliminary analyses a further research question was
explored:
ii) Are the factors gender and age associated with the participants’ perception of their
ability to identify and manage manic and depressive prodromal symptoms?
4.5.1.1 Primary analysis: The results
4.5.1.1.2 Ordinal logistic regression 1: Ability to identify manic prodromes
Table 4.20 provides a summary of the results from ordinal logistic regression analysis 1
which was used to assess the contribution of age, gender, consistency of symptoms, and
self-efficacy in relation to participants’ ability to identify manic prodromes.
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Age -.04 .02 3.67 (1) .06  .96 -.079  .00
Gender  .67 .39 2.95 (1) .09  .51 -.095 1.43
Consistency 1.15 .40 8.47 (1) .00 3.17  1.46 6.90
Self-efficacy  .06 .08 4.24 (1) .04 1.07   .00  .13
Type of help  .28 .59 .420 (1) .52 1.32   .57 3.06
Each PV was entered individually into the model
When the PV gender was entered into the regression a positive slope (.67) was found but
this did not reach significance level as p = .09.  When the PV age was entered the result
showed that the slope was negative (-.04) thus indicating that with increasing age
participants were less able to identify manic prodromes; however, this relationship was
not significant. When the PV type of help was entered into the model a non-significant
association was found.
The ability to identify manic prodromes was positively associated with the PV self-
efficacy. The sign of the slope is positive, therefore indicating that higher self-efficacy
scores are associated with ability to identify manic prodromes. The OR = 1.07, therefore,
for a standard deviation decrease in self-efficacy, the odds of not being able to identify
manic prodromes increases by a factor of 1.07.
When the PV consistency was entered into the ordinal regression a significant positive
slope was found, this indicated that participants who experienced consistent symptoms
were more able to identify manic prodromes. Figure 4.2 provides a summary of the
estimated logits for ‘unable to identify’ prodromes compared with ‘sometimes able’ and
‘able to identify’ prodromes. From the figure it is evident that participants with



















inconsistent (0) (1) consistent 
Figure 4.2 Effect of prodromal consistency on participants’ perception of their ability to identify
manic prodromes
Figure 4.3 provides a summary of the estimated odds. The figure demonstrates that the
odds of being unable to identify manic prodromes are lower for participants with
inconsistent symptoms.
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Figure 4.3 Effect of consistency on manic prodrome identification
The cumulative odds for not being able to identify manic prodromes were 92 percent
lower for participants who stated they experience consistent manic prodromes.
Figure 4.4 provides a summary of the cumulative probabilities; as above, the figure
demonstrates that the probability of not being able identify symptoms is lower for





































inconsistent (0) (1) consistent
Figure 4.4 Effect of consistency on manic prodrome identification (Cumulative probabilities)
Figure 4.5 examines the probability for the individual values of the DV. As above this
figure demonstrates that the probability of being able to identify symptoms is higher for



















inconsistent (0) (1) consistent
Figure 4.5 Probabilities for each value of the DV (participants’ perception of their ability to
identify manic prodromes)
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The PVs self-efficacy and consistency of manic prodromes were significantly related to
the participants’ ability to identify manic prodromes. The two PVs were therefore
entered into the logistic ordinal regression model in order to determine if participants
who experience consistent prodromes are more able to identify manic prodromes,
when self-efficacy score is entered as a covariate.  Table 4.21 provides a summary of the
results from this analysis.











Self-efficacy 1.007 .033 1.68 (1) .196 2.74 1.22 6.14
Consistency  .042 .412 6.08 (1) .014 1.04  .98 1.11
The results show that consistency of symptoms and ability to identify manic prodromes
is positively significantly related when controlling for self-efficacy. When controlling
for consistency of symptoms, self-efficacy is no longer statistically significant. The OR
for consistency of symptoms is 2.74: the OR is higher after self-efficacy was entered
into the model as a covariate. The odds of not being able to identify manic prodromes
were 2.74 times less for participants who stated they experience consistent manic
prodromes.
4.5.1.1.3 Ordinal logistic regression 2: Ability to identify depressive prodromes
The second logistic ordinal regression analysis was carried out to examine the
relationship between age, gender, consistency, and self-efficacy with reference to
participants’ ability to identify depressive prodromes. The results are summarised in
Table 4.22.
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Age   -.01 .01 1.22 (1) .27 .10 .98 1.01
Gender    .69 .39 3.04 (1) .08 .20 .92 4.31
Consistency  1.11 .41 1.90 (1) .001 .65 .48   .87
Self-efficacy  -.02 .01 1.10(1) .22 .99 .96 1.00
Type of help  -.19 .45 .055 (1) .86 .90 .37 2.16
Each PV was entered individually into the model
The PVs type of help and gender were not significant. When the PV ‘consistency’ was
entered into the ordinal regression a significant positive slope was found: this indicated
that participants who experienced consistent symptoms were more able to identify
depressive prodromes. Figure 4.5 provides a summary of the estimated logits for ‘unable
to identify’ prodromes compared with ‘sometimes able’ and ‘able to identify’ prodromes













inconsistent (0) (1) consistent 
Figure 4.6 Effect of prodromal consistency on participants’ ability to identify depressive
prodromes (Logits)
Figure 4.6 demonstrates that the cumulative logits of being able to identify depressive
prodromes are higher for participants with consistent symptoms.
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Figure 4.7 provides a summary of the cumulative odds for ability to identify depressive
















inconsistent (0) (1) consistent 
Figure 4.7 Effect of consistency on manic prodrome identification (Odds)
Figure 4.7 demonstrates that the estimated odds for being unable to identify prodromes
(compared to sometimes, able to identify) and the odds of being unable to or sometimes
able to identify (compared to being able to identify prodromes) are lower for participants
who experienced consistent symptoms.
Figure 4.8 provides a summary of participants’ ability to identify depressive prodromes



























inconsistent (0) (1) consistent
Figure 4.8 Effect of consistency of manic prodrome identification (Cumulative probabilities)
Figure 4.8 figure also shows that the probability of being unable to identify depressive
prodromes is lower for participants who experienced consistent symptoms.
Figure 4.9 provides a summary of the probability for the individual values of the DV. As
above, this figure demonstrates that the probability of being able to identify symptoms is





















inconsistent (0) (1) consistent
Figure 4.9 Probabilities for each level of the DV (participants’ perception of their ability to identify
depressive prodromes)
4.5.1.1.4 Ordinal logistic regression 3: Participants’ view of their ability to
manage manic prodromes
Table 4.23 provides a summary of the logistic ordinal regression for the participants’
view of their ability to manage prodromes in relation to perceived consistency of
prodromes and general self-efficacy scores.













Consistency .502 .391 1.65  (1) .199 1.65   .77 3.56
Self-efficacy .032 .055 10.27(1) .001 1.03 1.01 1.05
Each PV was entered individually into the model
The ability to identify manic prodromes was positively associated with self-efficacy.
The sign of the slope is positive, therefore indicating that higher self-efficacy scores
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were associated with ability to identify manic prodromes. When the OR = 1.03: for a
standard deviation decrease in self-efficacy, the odds of not being able to manage
prodromes increase by a factor of 1.03.
4.5.1.1.5 Logistic ordinal regression analysis 4: Participants’ view of their ability
to manage depressive prodromes
Table 4.24 provides a summary of the results from the fourth logistic regression
analysis.













Consistency .58 .39 2.20(1) .14 1.78 .83 3.81
Self-efficacy .018 .01 2.43 (1) .12 1.02 .99 1.04
Each PV was entered individually into the model
Consistency of prodromes and self-efficacy score were not significantly related with the
DV ability to manage depressive prodromes.
Results from the three stages of the analyses are reviewed in the discussion section in
relation to the research hypotheses and the research questions. The results are also
considered in relation to previous research findings, in particular results regarding the
effect of gender, consistency of prodromal symptoms experienced, participants’ ability
to identify prodromal symptoms when they first present and whether help from
significant others has an impact on participants’ perception of their ability to identify
and manage prodromal symptoms. Information relating to the association between the
participant’s perception of their ability to identify and manage prodromal symptoms is




The present study used an exploratory quantitative approach to investigate if individual,
disorder, and treatment-related variables were associated with the participants’
perception of their ability to identify and manage prodromal symptoms. Prior to
discussing the key findings, the results concerned with the demographic and clinical
profiles of the participants are reviewed.  The main findings are then summarised and
interpreted in relation to previous research, the research hypotheses, and the a priori
research questions. This information is followed by a critique of the current study in
which the suitability of the methodology is considered. The clinical implications of the
findings are then presented. Lastly, potential future research will be considered.
5.2. Demographic and clinical profile of participants by recruitment source
Participants from the three recruitment sources did not significantly differ with regards
to clinical and demographic-related variables. The individuals with a rapid cycling
specifier experienced significantly more manic and depressive episodes compared to the
bipolar I and II disorder participants. This result was expected as individuals are given a
rapid cycling specifier when they experience four or more episodes in a 12-month period
(DSM-IV, 1994). No other significant differences were observed for diagnosis type.
5.3 Summary and interpretation of the research findings
5.3.1. The role of self-efficacy
The findings concerned with general self-efficacy will be discussed in relation to
research hypothesis 1: Self-efficacy will be positively associated with an individual’s
perception of their ability to identify and manage manic and depressive prodromes.
No significant relationships were found between general self-efficacy scores and the
following variables: gender, number of episodes experienced, and current mood state.
General self-efficacy was, however, significantly negatively associated with level of
psychosocial input received from mental health services. The number of relapses
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experienced may be a contributory factor for the observed low self-efficacy scores as
individuals who received higher levels of support may have experienced more relapses.
The results, however, showed that there was no relationship between the number of
episodes experienced and the level of psychosocial input received. An alternative
explanation is that help from services has a detrimental impact upon individual’s
perception of their ability to cope independently. Generalised self-efficacy refers to a
global confidence in one’s ability across a range of demanding settings (Schwarzer,
1993). If an individual is receiving increased input from services this may indicate to
them that they have failed to cope with their condition; this perception of being unable to
cope could result in a lower sense of general self-efficacy.
There was a significant association between participants’ ability to identify and manage
manic prodromes and higher general self-efficacy scores. This effect was found for the
ability to identify and manage depressive cognitive and behavioural prodromal
symptoms. These results indicate that self-efficacy may be associated with prodromal
monitoring of cognitive and behavioural prodromes but not affective prodromes.
The results show the benefits of examining participants’ views of their ability to identify
and manage different types of prodromes. It is possible that for depressive prodromes,
individuals benefit from seeing the type of symptoms that can be experienced; this may
serve as a prompt that helps individuals to recall their experiences of identifying and
managing depressive prodromal symptoms.
Research in this area highlights the influential nature of current mood state for
individuals with bipolar disorder. For example, self-esteem is thought to be associated
with mood state and research demonstrates that increasing levels of negative self-esteem
predict relapse particularly into bipolar depression (Johnson et al., 2000). Furthermore,
as mood states such as depression, are associated with negative dysfunctional attitudes
and negative attributional styles (Reilly-Harrington et al., 2010) one would expect that
participants identified as depressed (from their responses to the ISS) would have lower
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self-reported general self-efficacy scores.  This, however, was not found in the present
study. Furthermore, the research findings collectively demonstrated that mood state was
not associated with participants’ perception of their ability to identify or manage
prodromal symptoms.
One potential explanation for the current findings is that self-report approaches do not
reveal negative feelings about individuals’ ability to cope (as measured by the General
Self-Efficacy Scale, GSES, Schwarzer & Jerusalemm 1995). For example, research
demonstrates that bipolar participants show high levels of social desirability and social
conformism (Pardoen et al., 1993; Scott et al., 2000) and it is therefore questionable if
explicit measures lead to socially desirable responses. A review of the data, for the
GSES, however, revealed that a normal distribution of responses was found: if the
participants were all responding in a socially desirable manner one would expect the
data to be positively skewed as all the participants would be rating their ability to cope
as high.
An alternative explanation is that general self-efficacy may not affected by mood state.
Perceived self-efficacy is characterised as being competence-based, prospective, and
action-related (Bandura, 2002); it is possible that self-efficacy is determined by previous
experiences and examples of times that the individual has coped.  Furthermore, as
general self-efficacy is associated with the individuals’ ability to cope in a number of
domains, examples of coping that are not explicitly related to their experience of bipolar
disorder may also contribute to participants’ judgements of their efficaciousness
(Luszcynska et al., 2005).  Therefore, with reference to prodromal monitoring,
individuals may benefit from concrete examples of times that they have managed their
symptoms and other difficulties in their lives.
As individuals with bipolar disorder experience considerable changes in mood state it is
helpful to highlight a construct that may not be influenced by mood state. Furthermore,
generalised self-efficacy is implicated in self-management healthcare practices as
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individuals with stronger self-efficacy are more likely to engage in healthy behaviours,
to maintain them, and to recover from perceived health-related set backs (Luszczynska
et al., 2005). Further research, however, is required to assess if the current findings can
be replicated with another sample of individuals with bipolar disorder.
Collectively the results show that general self-efficacy is associated with participants’
ability to identify prodromal symptoms and the management of manic prodromes and
behavioural and cognitive depressive prodromal symptoms. The research hypothesis 1
is therefore accepted as self-efficacy was viewed as being associated with participants’
view of their ability to identify and manage prodromal symptoms.
5.3.2. Disorder-related support from significant others
The findings regarding the impact of help from significant others in identifying and
managing prodromal symptoms will be discussed in relation to hypothesis 2: Social
support, in relation to help from a significant other in managing bipolar disorder, will be
positively associated with an individual’s belief that they can identify and manage
prodromal symptoms.
Social support can be defined as helpful actions performed by significant others. Social
support is generally viewed as beneficial for the course of bipolar disorder (e.g.
reduction in number of relapses (Cohen et al., 2004; Johnson et al., 1999; Kulhara et al.,
1999). No significant relationships, however, were found when the participants’
perception of their ability to identify and manage prodromal symptoms was examined in
relation to whether or not they received help from a significant other.
Social support can provide different functions such as emotional concern (e.g. empathy,
sympathy), instrumental aid (e.g. actions that help individuals to fulfil obligations),
information, and appraisal (e.g. personal feedback) (House, 1981, cited in Romans &
McPherson, 1992). As social support can serve different functions the type of support
that participants received from significant others was categorised based on qualitative
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information provided by the participants. Therefore, help from significant others was
categorised as either emotional/practical support or disorder-related support.
Categorising help in this manner enabled the impact of different types of support on
participants’ perception of their ability to identify and manage prodromes to be
examined.
The findings indicated that disorder-related support is associated with participants’ view
of their ability to identify manic and depressive prodromal symptoms. When the
participants’ perception of their ability to manage prodromal symptoms was examined in
relation to type of help received, no significant effect of help was found. This may be
associated with the type of psychoeducational input that significant others receive from
mental health professionals. For example, while relapse prevention plans are discussed
with significant others during psychosocial interventions such as Family-Focused
Therapy (Simoneau, et al., 1999) the intervention may focus on service-related help such
as contacting mental health professionals. Therefore, the significant other may not be
perceived as actively helping them to manage their prodromal symptoms.
A further potential explanation involves how individuals may feel about asking or
receiving help from significant others in managing prodromal symptoms. For example
individuals who feel stigmatised by their disorder may find it difficult to seek support
(Lam et al., 1999). In addition individuals who have perfectionist tendencies (which can
be viewed as a common dysfunctional assumption among individuals with bipolar
disorder) may have concerns about revealing that they need help to manage their illness
as they may worry this will be construed as a sign of weakness.
An alternative explanation may involve how prodromal management is conceptualised
by the individual with bipolar disorder. It is possible that prodromal management is
viewed as an internal process and therefore based on the individual’s ability to manage
on their own and not influenced by external factors (i.e. help from significant others).
This possibility is supported by research that shows that individuals with bipolar
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disorder show higher levels of sociotrophy (interpersonal independence) and
dysfunctional attitudes that are related to the need for social approval and perfectionism
(Scott & Pope, 2003). For example, it is possible that autonomous personal beliefs lead
individuals to disregard input from significant others regarding prodromal management.
While many benefits of social support have been empirically evidenced, the potential
detrimental effect of social support, characterised by help from a significant other, has
not been examined in this population. The need for social approval may result in help
received from significant others being viewed negatively. For example, it is outside
normal relationship dynamics for a loved one to become a ‘carer’. The Significant
Others Scale (SOS, Power et al., 1988) was used to assess the participants’ perception of
the actual emotional and practical support they received from significant others. The
SOS also provided information on the participants’ ideal level of support.
The findings from the questionnaire provide support for the view that some aspects of
support may be viewed negatively. In particular, the results showed that the participants
wanted to have more emotional support from significant others and less practical support
from significant others. This finding provides support for the view that individuals may
view certain components of support in a negative manner. It is possible that the research
sample views emotional support as a normal part of a loving relationship, whereas
practical support may be associated with needing help to manage with day-to-day tasks
as a result of having bipolar disorder.
When considering the results in relation to the hypothesis 2 it can be concluded that a
significant effect of social support was found for participants’ perception of their ability
to identify prodromal symptoms but not their perception of their ability to manage
prodromal symptoms. The research hypothesis was therefore rejected.
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5.3.3. The impact of disorder-related psychosocial input from mental health
services
Research findings associated with the impact of psychosocial input for identifying and
managing prodromal symptoms will be explored in relation to hypothesis 3: Previous
and current psychosocial input will be positively associated with participants’ perception
of their ability to identify and manage prodromal symptoms.
When the impact of psychosocial input (from mental health services) was reviewed in
relation to participants’ perception of their ability to identify and manage prodromal
symptoms, no significant associations were found. As above, the finding may be
associated with prodromal management being viewed as an internal process that is not
influenced by external factors. This postulation receives support from the finding that
psychosocial input was negatively associated with self-efficacy scores: this indicates that
increased input from services is related to lower self-efficacy scores and may be
associated with a reduction in participants’ perception of their ability to cope with
difficult situations.
When the role of psychosocial input was reviewed in relation to prodromal symptom
type (i.e. cognitive, affective, and behavioural), psychosocial input was positively
associated with the ability to identify manic and depressive behavioural prodromes.
Behavioural symptoms tend to present externally and are therefore more apparent than
affective or cognitive prodromes when they first appear; consequently they may be more
open to interventions provided by mental health professionals. As specific information
on the type of support provided by mental health professionals was not obtained in the
current study, it is not possible to explore this explanation in more detail.
Collectively the results indicated that, with the exception of manic and depressive
behavioural prodromal symptoms, input from psychosocial services does not help
participants to identify and manage prodromal symptoms. Research hypothesis 3 is
therefore rejected and the null hypothesis is accepted.
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5.3.4.Additional factors associated with participants’ experience of prodromal
symptoms
As the study was exploratory in nature a number of variables were analysed in relation
to the participants’ experience of prodromal symptoms and their ability to identify and
manage these symptoms. Key research findings that enable the following research
question to be examined are summarised and interpreted below: Are the following
factors associated with participants’ perception of their ability to identify and manage
prodromal symptoms: time since diagnosis, gender, age, number of episodes
experienced, and current mood state?
5.3.4.1 Time since diagnosis
The variables time since diagnosis and age were significantly associated with each other.
Research has identified an average age of onset for bipolar disorders (e.g. Goodwin &
Jamison, 2007); therefore a positive linear relationship would be expected when the
relationship between these two variables is examined.  A significant association was also
found for age and number of manic episodes experienced; this result was not found for
number of depressive episodes experienced. Individuals tend to experience more manic
than depressive episodes during the course of this illness (ten Have et al., 2002)
therefore a linear relationship would be expected with regards to the experience of manic
episodes.
5.3.4.2 Age
A moderate positive association was found for age and level of psychosocial input
received. Research shows that there is a positive linear relationship between number of
previous episodes and relapse rates (Maj, 1999), therefore participants with a longer
history of bipolar disorder may experience more frequent relapses and hence require
more psychosocial input. When the type of prodrome experienced was reviewed in
relation to age a negative significant correlation was found for age and ability to identify
manic and depressive affective prodromes. This finding is difficult to interpret as age
was not associated with the other types of prodromes. It is possible that there is
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something intrinsically difficult about distinguishing positive or negative thought
patterns when these types of symptoms have been experienced for a considerable length
of time. Furthermore, with reference to depressive affective prodromes, with increased
experience of subsyndromal symptoms individuals may find it harder to distinguish
between this type of symptom and prodromal symptoms.
5.3.4.3 Gender-related findings
Data from the Prodromal Experience Questionnaire indicated that males and females
have different experiences of bipolar disorder with reference to their beliefs associated
with their ability to identify depressive prodromal symptoms. Female participants
perceived that they were better at identifying affective, cognitive, and behavioural
depressive prodromal symptoms in comparison to the male participants. While there was
a trend for females to be better at identifying manic prodromal symptoms this result was
not significant. In addition, no effect of gender was observed when participants’
perception of their ability to manage manic and depressive prodromal symptoms was
examined.
The gender-related difference may be understood in relation to gender-related
differences observed in illness management practices. Findings from physical health
care studies indicate that females are more likely to engage in preventative health care
practices in comparison to males (e.g. Janda et al., 2004; Miller et al., 1996).
Furthermore, males are thought to be less convinced of the value of preventative health
care practices (e.g. Evans et al., 2005). Females may therefore be more likely to engage
in practices that help them to identify depressive prodromal symptoms.
Verbrugge (1985) highlighted three concepts associated with illness management that
help to explain the observed gender differences in preventative health care practices:
perception, evaluation, and action. With regards to the concept of ‘perception’, he
postulated that females are more sensitive to body discomfort due to childhood
socialisation. With reference to ‘evaluation’ he proposed that females are more apt than
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males at labelling their experiences of physical illness, as males may actively ignore
symptoms of physical illness because acknowledging symptoms may be viewed as
emasculating. Lastly, with reference to ‘action’ Verbrugge (1985) hypothesised females
determine early on that their symptoms warrant care.
When viewing prodromal identification as an illness management approach, the gender-
related differences observed with male health care practices may account for the
observed differences in the male and female participants’ ability to identify depressive
prodromes. One would assume, however, that if the observed difference was accounted
for by health care practices alone, a similar pattern of results would be found for manic
symptoms and that females would believe that they are more able to identify manic
prodromes. Within this study, however, no significant gender-related differences for
manic prodromes were observed.
An alternative explanation that may account for the fact that differences were only
observed for depressive prodromal identification, involves emotional regulation gender
differences. Emotional regulation is defined as the process of attending to one’s
emotions, being clear about them, and being able to implement strategies to repair
negative emotional mood states (Thayer et al., 2003). Females have been shown to
report more depressive symptoms than males (Nolen-Hoeksema, 2001), to report higher
levels of emotional awareness (Barrett et al., 2000) and to report greater attention to
emotions than males (Thayer, et al., 2003). Research on emotion perception has also
shown that females perform better than males in both detecting and expressing emotions
(Thayer & Johnsen, 2000). The effect of gender on emotion perception has also been
observed in psychiatric samples (Bozikas, et al., 2006; Sundet, et al., 2007).
Several explanations have been posited in order to explain why females report more
depressive symptoms than males such as biological explanations (e.g. ovarian
hormones), social and cultural issues (e.g. women’s lower social status) (Thayer et al.,
2003) and psychological factors (e.g. females’ tendency to ruminate) (Nolen-Hoeksema,
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et al., 1999). With reference to rumination, females are assumed to use rumination as a
coping style; it is hypothesised that it is this very coping style that serves to increase
their ability to identify depressive symptoms (Nolen-Hoeksema et al., 1993). If
increased sensitivity to depressive symptoms is associated with the coping strategy of
rumination, then this may explain why a gender-effect of identification of manic
symptoms was not observed; it is possible that rumination does not serve to highlight
symptoms associated with a switch to a manic mood state.
As stated above, a gender-related effect was not observed for participants’ perception of
their ability to manage prodromal symptoms. Emotional regulation research may also
explain why females do not perceive that they are more able to manage prodromal
symptoms when compared to male participants. As previously noted, emotional
regulation can be viewed as consisting of three components: being able to attend to
one’s emotions, being clear about one’s emotions, and being able to implement
strategies to repair negative emotions. While females may be better than males at
attending to and clarifying emotions, it is possible that there are no gender differences
with regards to coping strategies for repairing or managing negative emotions. For
example, research conducted by Thalyer et al. (2003) concluded that while women were
more able to attend to emotions they were less able than males to utilise effective
strategies to manage these negative emotional states.
Thalyer et al., (2003) proposed that females do not implement effective ‘repair’
strategies due to their tendency to ruminate. While rumination serves to increase
female’s ability to attend to negative emotions, rumination is viewed as an ineffective
repair strategy. Emotional regulation research may therefore help to elucidate the
incongruent result concerning gender-related differences in participants’ view of their
ability to identify prodromal symptoms and no effect of gender concerning participants’
ability to manage prodromal symptoms.
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5.3.4.4 Number of episodes experienced
A negative correlation was found between the number of manic episodes experienced
and participants’ perception of their ability to manage manic prodromal symptoms. This
finding may be accounted for by the individuals’ view of their ability to cope with manic
prodromes in relation to the linear experience of episodes. Research conducted by
Goosens et al., (2008) found that patients who experienced 10 or more acute episodes of
depression or manic during the course of their disorder reported the use of passive
coping styles. This could indicate that with increased experience of episodes self-
management approaches are less likely to be used. This finding was not, however,
observed for depressive prodromal symptoms. The available data do not enable this
possibility to be explored in more detail.
5.3.5. Issues associated with the polarity of prodromal symptoms
The findings associated with the polarity of prodromal symptoms are discussed in
relation to the following research question: Is the polarity of the prodromal symptom
associated with the participants’ perception of their ability to identify and manage manic
and depressive prodromal symptoms?
Previous research (e.g. Jackson et al., 2003; Lam & Wong, 1997; Sierra et al., 2008)
highlights that patients find it easier to identify manic prodromes in comparison to
depressive prodromes.  Manic prodromes are thought to differ qualitatively from
individual’s day-to-day experiences; it is this qualitative difference that is attributed to
manic prodromes being more readily identified by patients. Whereas it is proposed that
early symptoms of depression may be less overt and therefore less easily recognised
(e.g. Jackson et al., 2003). The results from the Prodromal Experience Questionnaire
indicated that the sample viewed depressive prodromal symptoms as being easier to
identify in comparison to the manic symptoms; this finding is in direct contrast to
existing research evidence regarding participant’s experience of prodromes by polarity.
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A possible explanation for the observed finding may involve the methods used to gain
information on participant’s experiences of prodromes. In the current study a checklist
of items was used (the Prodromal Experience Questionnaire). Research conducted by
Lam and Wong (1997) in which participants were asked to spontaneously recall their
experiences of prodromal symptoms resulted in a mean of three manic and two
depressive prodromes being recalled. Whereas research conducted by Smith and Tarrier
(1992) in which a 40-item checklist of prodromes was used resulted in a mean of 15
manic items and 11 depressive items being identified. It is possible that a pre-determined
checklist measure has resulted in participants endorsing items that are similar to those
experienced in full-blown episodes, to subsyndromal symptoms, and or transient mood
states.
While it is possible that the measure used has served to escalate participants’ recall of
depressive prodromes, one would still expect to see a greater rate of manic prodromes
endorsed on the checklist. Furthermore, when participants were asked to state if they
believed they were able to identify manic and depressive prodromal symptoms (this
question was not directly linked to specific prodromal symptoms) a non-significant
difference was found between participants’ view of their ability to identify manic and
depressive prodromes; while this difference was not significant, based on previous
research, one would expect that participants would recall significantly more manic
prodromes.
An alternative possibility is that there were more depressed participants in the sub-
sample of participants who completed the Prodromal Experience Questionnaire. A
depressed mood state may have caused the participants to over-identify with the
depressive prodromes that were listed, as participants may have been cognitively biased
towards the depressive stimuli. A review of the participant’s mood state (as determined
by the ISS) showed that there were more depressed participants in comparison to the
euthymic, manic, or mixed mood state in the sub-sample. The higher prevalence of
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depressed participants in the sub-sample may account for the increased rate of
depressive prodromes that were identified.
5.3.6. Type of prodromal symptoms
The following information will be discussed in relation to the research question: Are
types of prodromal symptoms (i.e. cognitive, affective, and behavioural) associated with
the participants’ perception of their ability to identify and manage manic and depressive
prodromal symptoms?
When the participants’ experience of prodromal symptoms by type (i.e. affective,
cognitive, and behavioural) was reviewed, the results indicated different factors were
associated with the different types of prodromal symptoms. For example, age was
negatively associated with participants’ view of their ability to identify manic and
depressive affective prodromal symptoms but not the cognitive and behavioural
prodromal symptoms.
Collectively the results indicated that different factors may contribute to participants’
perception of their ability to manage and identify cognitive, behavioural, and affective
prodromal symptoms. Therefore, it may be beneficial to view prodromal symptoms by
type in addition to polarity when working with individuals. This issue is explored in
more detail with reference to clinical implications in section 5.6.
5.3.7. Prodromal monitoring and identifiable and consistent symptoms
The following research questions are relevant to the information discussed in this
section:
Research question: Does the ability to identify prodromal symptoms when they first
present have an impact on participants’ perception of their ability to identify and manage
prodromal symptoms?
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Research question: Does the consistency of prodromal symptoms (across episodes)
have an impact on participants’ perception of their ability to identify and manage
prodromal symptoms?
The results indicated that participants who experienced consistent prodromal symptoms
were more confident in their ability to identify prodromal symptoms. In addition, the
findings showed that being able to identify depressive prodromes when they first present
and consistently experienced prodromes increase individuals’ perception of their ability
to manage depressive prodromes.
The chronic nature of bipolar disorder means that it occurs across time. Recurring
prodromal symptoms may serve to familiarise the individual with their relapse signature
and help the individual to understand that there are some elements of this disorder that
they can expect to experience. Furthermore, an individual’s prior experience with
symptoms can positively influence how current symptoms are managed (e.g. Stoller et
al., 1995). Therefore, it is likely that perceived consistency of prodromal symptoms
would serve to increase participants’ view of their ability to identify and manage
prodromal symptoms.
The results, however, indicated that consistent prodromal symptoms do not serve to
increase an individuals’ view of their ability to manage manic prodromal symptoms.
This may be because manic symptoms are viewed as difficult to manage. This mood
state is viewed by some individuals as pleasant and therefore consistent symptoms
would not serve to change this perception of mania and thereby symptoms consistency
would not assist with the management of these types of prodromal symptoms.
The current research has served to highlight individual, disorder, and treatment-related
variables that are associated with prodromal monitoring and management. Prior to
considering the clinical implications of the current findings, the methodology used in the
study is critiqued below.
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5.4 Critique of the research study
In order to highlight strengths and limitations associated with the current research,
information relating to the sample size, recruitment process, the measures used, how
variables were defined, the retrospective research approach, and the statistical analysis
are reviewed in the following sections.
5.4.1 Power analysis
An a priori power analysis was performed to inform optimal sample size for the primary
analyses. Based on information provided by Cohen (1992), a sample of 91 participants
was required to achieve a medium effect size at a significance level of 0.05 (for an
ordinal regression analysis with five predictor variables).  As the sample consisted of
101 participants, adequate power was therefore achieved.
5.4.2 The research sample
Research that examines prodromal monitoring has been criticised for excluding
participants with bipolar II disorder as this can limit the extent to which the results can
be generalised in clinical settings (Mantere et al., 2008). The present research addressed
this limitation by including both bipolar I and II participants.
A further criticism of this research area involves the exclusion of participants with co-
morbid diagnoses. A high percentage of individuals with bipolar disorder have co-
morbid diagnoses (e.g. McElroy, et al., 2001); consequently, excluding individuals with
a co-morbid diagnosis from research has an impact upon the extent to which the research
findings can be extrapolated to clinical settings. While information on co-morbidity was
not directly sought in this research, co-morbidity was not used as an exclusion criterion.
As information on co-morbid diagnoses was not obtained it is not possible to explore the
relationship between co-morbid diagnoses and features associated with prodromal
monitoring.
126
While information on prodromal monitoring, in the context of self-management, was
given to participants in written and oral formats, no formal measure of participants’
experience or understanding of prodromal monitoring was used in the study. It is
therefore possible that some of the participants did not fully understand what prodromal
symptoms were nor had experience in actively trying to identify and manage these
symptoms. Some individuals with bipolar disorder may experience difficulties
distinguishing between subsyndromal and prodromal symptoms (Lam & Wong, 1997);
therefore when providing information on their experience of prodromal symptoms it is
possible that some participants were reflecting on their experiences with subsyndromal
symptoms. Participants had several opportunities to ask questions about the research:
none of the participants sought clarification about the definition of prodromal symptoms.
As participants did not ask for further clarification, this may indicate that the sample had
a good understanding of prodromal symptoms.
5.4.3 The design and research measures
5.4.3.1 The appropriateness of self-report measures for individuals with bipolar
disorder
A key strength of the current study involves the fact that individuals’ perception of their
experience of prodromal symptoms was sought. To date, the majority of research in this
area has examined prodromal management in relation to objective outcome measures
such as relapse rates and hospitalisation. While this information serves to show that this
approach can be effective for reducing rates of relapse, it does not provide information
on the mechanisms involved in identifying and managing prodromal symptoms. While it
is therefore beneficial to gain information from patients it is necessary to consider the
methods used to obtain this information in order to determine if the approach was
appropriate for individuals with bipolar disorder.
Self-report measures were used to obtain relevant information in the current study. Self-
report questionnaires may have limited usefulness in patients with diminished
concentration. Individuals with bipolar disorder may display deficits on a range of
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neuropsychological tasks in both acute and euthymic phases of the illness (Emilien et
al., 2007); consequently, the suitability of self-report measures with this population
needs to be considered.
Observations of participants completing the questionnaires indicated that they did not
find the process cognitively demanding. Furthermore, a high response rate indicates that
the questionnaires were not perceived as too challenging to complete. It is worth noting
that seven participants withdrew from the study following information about the
questionnaires being provided by the researcher. It is possible that these individuals self-
selected themselves out of the study due to issues associated with fatigue and
concentration difficulties.
5.4.3.2 Retrospective data collection
Completion of the questionnaires was reliant on retrospective information; this type of
recall can be open to bias (Nhiwatiwa, 2003). The study, however, was concerned with
participants’ perception of their ability to cope with prodromal symptoms; responses
therefore were reliant on participants’ ability to reflect on their previous disorder-related
experiences. Consequently, a prospective research design would not have been
appropriate for the current study.
Participant’s self-report responses were not corroborated by a significant other or by a
mental health professional. With reference to the research aims, however, corroboration
was not necessary as it was the participants’ perception of their ability to identify and
manage prodromes that was of particular interest. In addition, previous research has
shown strong agreement between patients and relatives regarding recall of depressive
and manic prodromes (Keitner et al., 1996); this finding indicates that participants’
reported experience of prodromal symptoms may be viewed as a reliable reflection of
their experiences of these types of symptoms.
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5.4.3.3 Questionnaire measures
With the exception of the ISS (Bauer, et al., 1991) the questionnaire measures were not
specifically designed for use with people with bipolar disorder. Furthermore, to date, it
does not appear that the GSES has been used in research involving individuals with
bipolar disorder. It has, however, been used as a measure in research with individuals
with a diagnosis of schizophrenia (e.g. Vauth, et al., 2007). The SOS has also been used
with long-term psychiatric patients (e.g. Creswell et al., 1992). The use of these
measures with long-term psychiatric patients indicates that they may be appropriate for
use with people with bipolar disorder. Furthermore, the measures were chosen to
measure aspects that are relevant to all individuals and were not specific to a particular
psychiatric condition.
The Prodromal Experience Questionnaire was designed for the purposes of this research;
therefore, it has not been subjected to tests of reliability or validity. As it has not been
validated for use with this population the results should be viewed with caution. The
contents of the measure, however, were based on three published research studies that
identified manic and depressive prodromal symptoms that are commonly experienced by
individuals with bipolar disorder (Lam & Wong, 1997; Molnar et al., 1988; Smith &
Tarrier, 1992). It is therefore possible to view the contents of the questionnaire as valid
for this population.  In order to initially investigate whether this tool is appropriate for
use with individuals with bipolar disorder the questionnaire should have been piloted
prior to including it as a measure in the current research. Further research is required to
determine whether this tool is a valid measure of individual’s experience of prodromal
symptoms. This issue will be discussed further with reference to future research in
section 5.6.
5.4.3.4 Measures used to assess the participant’s experience of bipolar disorder
It is possible that some of the measures did not adequately capture the participants’
experience of bipolar disorder. For example the variable time since diagnosis is
problematic as many participants stated that it took a considerable length of time to
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receive a diagnosis of bipolar disorder: this is a well documented issue for people with
this disorder (e.g. Ruggero et al., 2010). A more accurate measure may have been to ask
participants when they believed they first experienced an affective episode.
The participants were asked to provide information on the number of manic and
depressive episodes they had experienced. As this question was not prefaced with a
definition it is difficult to gauge if the participants were viewing the term episode in the
same manner. For example, some participants may have viewed transient mood states as
episodes whereas others may have viewed a relapse followed by a hospital admission as
an episode. A case note review would enable accurate information regarding the number
of episodes experienced to be obtained. In addition, participants could be provided with
an explanation of what constitutes an episode when providing this type of disorder-
related information.
The variable level of psychosocial input was used to measure participants’ previous and
current level of input from mental health professionals. While this measure provides
information on the amount of professional input received it does not provide information
on patient’s treatment expectations, length of input, and overall treatment satisfaction.
This measure, therefore, does not capture the participants’ total experience and view of
psychosocial input received and can only be viewed as a crude measure of service input
received.
Issues associated with the variables time since diagnosis, number of episodes
experienced, and level of psychosocial input highlight the complexities involved in
quantifying an individuals’ experience of bipolar disorder. The difficulties involved with
the above measures may relate to the fact that while an individual’s experience of
bipolar disorder is subjective it is open to the influence of systemic factors. A qualitative
research approach may help address such issues as this methodology would enable




As the study used an exploratory approach a large number of variables were statistically
examined using correlations. While correlations serve to identify significant associations
this statistical test does not indicate direction of causality. The validity of inferences
about cause and effect is determined by factors external to the data analysis (Shadish et
al., 2002); therefore, caution should be taken in inferring the causal relationships
observed in this study.
As the research was exploratory, it is likely that some relevant variables were not
measured. The current research aimed to examine the relationship of a range of variables
and can therefore be viewed as a starting point for investigating key mechanisms
involved in prodromal identification and management.
While methodological limitations of the current research have been identified, the
research findings have helped to elucidate mechanisms involved in identifying and
managing manic and depressive prodromes. Potential clinical implications of the current
findings are discussed below.
5.5 Clinical implications
The current results could help ensure that prodromal monitoring is a targeted and
specific psychological intervention that focuses on aspects that are associated with the
process of prodromal monitoring. For example, the results indicated that general self-
efficacy is associated with the ability to identify and manage prodromal symptoms
therefore part of the therapeutic intervention could focus on increasing and monitoring
self-efficacy. However, the results also indicate that increased input from services has a
detrimental effect on general self-efficacy. Therefore, while working with patients the
individual’s existing resources and strategies for coping could be highlighted throughout
therapy (e.g. the use of strategies associated with Solution-Focused Therapy as outlined
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by de Shazer, 1982) in order to help patients to recognise their contribution to the
therapeutic process.
The results indicated that different factors are associated with the participants’ ability to
identify and manage prodromal symptoms. To help to understand this result Lazarus and
Folkman’s (1984) coping model can be used. Within this model, coping choices are
determined by two factors: the appraisal of the threat (primary appraisal) and the
appraisal of one’s resources to address the threat (secondary appraisal).  The model
posits that coping is a dynamic bidirectional process.
When this model is considered in relation to prodromal monitoring the appraisal
components can be defined as: ability to identify prodromal symptoms (primary
appraisal) and the ability to manage prodromal symptoms (secondary appraisal). When
reviewing the explanatory function of this model in relation to coping with prodromal
symptoms (i.e. the ability to identify and manage prodromal symptoms), the dynamic
element becomes questionable. For prodromal monitoring the two appraisal components
are best construed as separate constructs: this is due to the fact that the ability to identify
and manage prodromal symptoms are not mutually exclusive. For example, the ability to
identify prodromal symptoms does not guarantee that an individual will be able to
manage the recognised symptoms. Therefore, the relationship between the primary and
secondary appraisals may be uni-directional as the ability to manage prodromal
symptoms is reliant on the ability to identify prodromal symptoms but not vice versa.
Why the ability to identify and manage prodromal symptoms is not inter-related may be
due to the different factors that are involved in the ability to complete or engage in each
appraisal stage. For example, the current research identified different factors associated
with the ability to identify prodromal symptoms that are categorised as either manic or
depressive. In addition, different factors become relevant when the polarity and the type
of prodrome are considered. The findings show that different contributory factors are
involved with the process of identifying and managing manic and depressive prodromes.
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When this information is considered in relation to clinical implications, it serves to
highlight the potential benefits of considering the different factors associated with the
different stages of prodromal monitoring when working with patients.
In addition to considering clinical implications of the current research it is sensible to
consider whether this approach is beneficial for all individuals with bipolar disorder. The
emphasis on genetic and biological explanations can cause individuals to believe that
they have no control over this disorder. Highlighting the role of psychosocial factors and
introducing prodromal monitoring can give individuals a sense of control and help them
to be an active agent in the management of this disorder.
While prodromal monitoring can be effective for reducing relapse rates (e.g. Perry et al.,
1999) several assumptions are associated with the individual’s ability to engage with this
approach: insight, motivation, the appropriateness of the approach, and the ability to
monitor internal and external experiences. Key assumptions that are associated with
successful prodromal monitoring are discussed below.
5.5.1 Key assumptions associated with prodromal monitoring
5.5.1.1 Key assumptions associated with prodromal monitoring: Insight
Adequate insight enables people to manage their illness better and can influence their
day-to-day functioning (David et al., 1992). A key component of insight is diagnosis
acceptance. Both insight and acceptance of diagnosis are associated with an individual’s
ability to engage with prodromal monitoring approaches as he or she needs to play an
active role in this intervention.
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5.5.1.2 Key assumptions associated with prodromal monitoring: Patient
perceives approach to be beneficial
“I used to be an 11 stone alcoholic having the time of my life…now I am a 13 stone
depressed man. I’m not depressed because I am bipolar, I’m depressed because I’m
managing my illness.” (anonymous participant)
The above quotation serves to highlight potential negative aspects associated with self-
management and prodromal monitoring. Prodromal monitoring requires individuals to
continually monitor their mood and manage mood states through aspects such as life
style changes, cognitive therapy strategies, or contact with mental health services.
Regular monitoring can be problematic for some individuals. For example, in a study
carried out by Colom et al., (2009a) three participants reported increased anxiety, fear,
and ruminations and one participant began to obsessively check his mood changes
following the introduction of prodromal monitoring. A further issue involves patients
becoming hyper-vigilant against transient mood states or minor changes in their moods
(Schwannauer, 2004). Family members can also become hyper-vigilant toward mood
changes and transient mood states: this could have a detrimental effect on family
dynamics and relationships (Van Gent & Zwart, 1991).
In addition, prodromal monitoring approaches do not enable the individual to have a
‘break’ from bipolar disorder. For example, one participant stated:
“When I’m well I don’t want to think about bipolar disorder.” (anonymous)
This quotation serves to demonstrate that participants may wish to have time away for
their chronic condition when they are remitted. For prodromal monitoring to be
effective, however, individuals must continuously monitor their symptoms.
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5.5.1.3 Key assumptions associated with prodromal monitoring: Motivation
While prodromal monitoring approaches can serve to give control to the patient, whether
or not they wish to be an active agent in their illness management needs to be
considered. For example, a participant questioned why he should be expected to take an
active role in his mental health care:
“Self-management – so this is being put back to us again…like it is all my fault that I
have bipolar disorder.” (anonymous)
As stated above prodromal monitoring requires a substantial commitment and may be
seen by some people as unnecessary or a as a relentless process. A factor that may
increase the likelihood of engaging in this process involves individual’s experience of
the consequences of manic and depressive episodes. For example, one participant
reported:
“I need to manage my illness…if I don’t I could end up manic and in prison again”
(anonymous).
For the above individual the potential costs of prodromal monitoring outweighed the
potential negative consequences they associated with becoming mentally unwell. The
relative costs and benefits of prodromal monitoring should be considered in relation to
the patient’s coping resources and for their stage of illness.
5.5.1.4 Key assumptions associated with prodromal monitoring: The ability to
monitor internal and external experiences
In order to be able to monitor prodromal symptoms, individuals need to be able to re-
label unusual mental events as pathological (David, 1990). It is therefore necessary to be
able to monitor internal experiences: this type of monitoring is reliant on aspects such as
emotional intelligence (EI, Martins et al., in press) and ability to recognise cognitive and
affective shifts.
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Fundamental aspects of EI include the ability to recognise emotions and the ability to
find ways to manage emotions. Two recent systematic reviews have demonstrated that
higher EI is associated with better mental health (Martins et al., in press; Schutte et al.,
2007). Individuals also need to learn that some mood states are transitory or reactive to
external experiences and are therefore not indicative of the start of an episode.
Furthermore, individuals’ ability to monitor and process mood states needs to be
considered prior to commencing prodromal monitoring work with the patient.
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5.5.1.5 Prodromal Monitoring: Suitability of the Approach
While prodromal monitoring can be an effective approach for reducing time to relapse
(e.g. Lam et al., 2005) as the above information demonstrates, key assumptions
associated with this approach need to be reviewed when considering the suitability of the
intervention. As with any clinical intervention, how suitable it is for the individual must
be considered in relation to potential benefits. This may involve considering whether the
individual is ready to engage in this type of work (e.g. have they accepted their
diagnosis), is motivated to monitor their mood state and behaviour on a regular basis, is
able to identify shifts in cognition and affect, and is able to do so in a manner that is not
detrimental to their mental health.
In addition to highlighting assumptions associated with prodromal monitoring, the above
information serves to highlight additional individual-related aspects that could be
considered in relation to extending the current research findings. This information is
discussed below.
5.6 Future Research
This study has several limitations that could be addressed by future research. Potential
research is discussed below that may enable the aforementioned limitations to be
addressed.
5.6.1 Participants’ perception of prodromal monitoring
While the current research aimed to elucidate key factors associated with participants’
perception of their ability to identify and manage prodromal symptoms, issues
associated with prodromal monitoring assumptions (as discussed above) were not
investigated. When considering ability to engage in prodromal monitoring, whether the
individual views this approach as valuable and one that will benefit their quality of life
needs to be considered. The participants’ view of prodromal monitoring (e.g. treatment
expectations), their motivation to engage in this form of self-management and the extent
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to which they have accepted their diagnosis were not investigated in the current
research.
These individual-related factors could have a direct impact upon perception of ability to
identify and manage prodromes. Measuring participants’ views of the benefits of this
approach, for example, would enable a further dimension to be explored – influence of
perception of treatment option and view of diagnosis – in relation to participants’ ability
to identify and manage prodromes. In addition to the measures that were used in the
current study, self-report questionnaires that enable participants’ expectations of
prodromal monitoring and the extent to which they accept their diagnosis, such as the
Insight Questionnaire (David, 1992), could be administered to explore the impact of
these factors on the participants’ view of their ability to identify and manage prodromal
symptoms.
5.6.2 An assessment of the validity and reliability of the Prodromal Experience
Questionnaire
The Prodromal Experience Questionnaire was designed for the purposes of this research.
A longitudinal design could be used to assess validity and reliability of this measure.
Static information such as the type of prodromes experienced by participants could be
collected on two occasions and correlational tests could assess for test-retest reliability
between time 1 and time 2. Other factors, such as the individuals’ perception of their
ability to manage prodromal symptoms, could not be examined using a test re-test
reliability statistical approach as ability to manage is not directly linked with the
experience of prodromal symptoms and is open to the influence of individual-related
factors such as general self-efficacy.
5.6.3. Participants’ understanding of prodromal monitoring
A potential limitation of the current research involved the participants’ understanding of
prodromal symptoms and motivation to use this type of management approach. To
address this issue, future research could involve participants who have taken part in
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psychoeducation and or prodromal monitoring training packages (e.g. Wellness and
Recovery Action Plan training, Early Warning Symptom identification and management
programmes).  Recruiting participants who have completed such courses would increase
the likelihood that the participants view prodromal monitoring as a beneficial approach
and wish to utilise this self-management strategy.
This proposed study could use a longitudinal design as this would enable the relationship
between experience of this approach and perception of ability to identify and manage
prodromal symptoms to be empirically assessed. Furthermore, variables such as general
self-efficacy and experience of prodromal symptoms could be assessed at time 1 and
time 2 using this type of design to assess if experience with this type of approach serves
to increase the participant’s view of their ability to identify and manage prodromal
symptoms.
5.6.4 Measuring the benefits of focusing on individual, disorder-related factors
during therapy
The current study identified the role of general self-efficacy, the ability to identify
prodromal symptoms when they first present, and consistency of symptom presentation
in relation to an increased ability to identify and manage prodromal symptoms. A
research study that examines the effects of utilising explicit psychosocial interventions
to promote the above aspects could be assessed in relation to participants’ perception of
their ability to identify and manage prodromes. In addition, objective outcome measures
such as time to relapse, and number of days spent unwell during the study period could
also be assessed. Pre- and post-measures would enable the effectiveness of teaching
these skills, in addition to usual prodromal monitoring work, to be evaluated.
5.7 Consideration of the impact of the research process on the
researcher’s views of self-management approaches
I first became interested in self-management approaches through my clinical work with
a gentleman who had a recent diagnosis of bipolar disorder. This patient believed that he
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had no control over his symptoms and that the only way he could manage his disorder
was through the use of medication. He found the ethos of self-management approaches
enlightening and gained a sense of control over this his disorder through prodromal
monitoring and associated management approaches. This clinical experience was the
basis for the start of my research interest in this area.
During the course of the data collection I had the opportunity to meet with people who
use prodromal monitoring as a self-management approach. Attending self–help group
meetings, in particular, enabled me to recognise that while this approach can be effective
for some individuals, it can also have an impact upon individual’s relationships, sense of
self, and quality of life. One lady I met discussed that daily mood monitoring makes her
feel that she is never “well.”  Some individuals discussed how it feels to have loved ones
monitoring their mood on a daily basis; they discussed feeling observed and judged. One
individual who voiced sadness at the change in her relationship raised a particularly
poignant and thought provoking point – she said that her partner had taken on the role of
a carer; this included monitoring her prodromal symptoms. Several people however
viewed their partner’s help with symptom monitoring as invaluable. Other people
discussed that prodromal monitoring helps them to stay well.
When I first starting working on this research I viewed prodromal monitoring as an
empowering approach that enabled individuals to become active agents in their
treatment. I had not, however, considered the emotional impact of using an approach
that requires people to daily monitor their mood, behaviour, and thoughts. The use of the
term ‘side effects’ – which is generally associated with medication – helps to summarise
my new found view of prodromal monitoring: prodromal monitoring can be effective
but some individuals may also experience negative effects as a result of using it. This
research experience has helped me to realise that self-management interventions for
chronic mental health problems are not short-term approaches but something that an
individual has to use on a daily basis thereby becoming an integral part of the
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individual’s life. It is therefore necessary to consider the potential implications of using
self-management approaches with patients with bipolar disorder.
5.8 Summary and conclusions
The current research could help inform an idiosyncratic clinical approach for helping
individuals to learn how to identify and manage prodromal symptoms. While
methodological limitations were identified, the findings serve to highlight that the
patient’s general self-efficacy, gender, experience of prodromal symptoms (with
reference to polarity, type, and consistency of symptoms), type of help received from
significant others, and the potential negative impact of service input should be
considered when helping patients to learn to monitor prodromal symptoms. Furthermore,
the current findings indicate that the two components of prodromal monitoring –
identifying prodromes and managing prodromes – should be viewed as separate aspects




Akiskal, H.S. & Pinto, O. (1999). The evolving bipolar spectrum. Prototypes I,
II, III, & IV. Psychiatric Clinical North America. 22(3), 17–34.
Akiskal, H.S., Yerevanian, B.I, Davis, G.C., King, D. & Lemmi, H. (1985). The
nosologic status of borderline personality: clinical & polysomnographic study. American
Journal of Psychiatry. 142, 192-198.
Alloy, L.B., Abramsonb, L.Y., Urosevicb, S., Walshawa, P.D., Nusslockb, R. &
Neerena, A.M. (1985). The psychosocial context of bipolar disorder: Environmental,
cognitive, and developmental risk factors. Clinical Psychology Review, 8, 1043-1075.
Altman, E.S., Rea, M. R., Mintz, J., Miklowitz, D.J., Goldstein, M.J. & Hwang,
S. (1992). Prodromal symptoms and signs of bipolar relapse: A report based on
prospectively collected data. Psychiatry Research, 41, 1-8.
Altman E.G., Hedeker, D., Peterson, J.L. & Davis, J.M. (2001). A comparative
evaluation of three self-rating scales for acute mania. Biological Psychiatry, 50,
468–471.
American Psychiatric Association. Diagnostic & Statistical Manual of Mental
Disorder (4th ed, DSM-IV, APA) (2000).
American Psychiatric Association. Diagnostic & Statistical Manual of Mental
Disorder (3rd ed) (1980). (DSM-IV, APA).
Bandura, A. (1986). Social foundations of thought & action: A social cognitive
theory. Engelwood Cliffs, NJ: Prentice Hall.
Bandura, A. (1994). Self-efficacy. In V. S. Ramachaudran (Ed.), Encyclopedia of
human behavior (Vol. 4, pp. 71-81). New York: Academic Press.
Bandura, A. (2002). Social cognitive theory in cultural context. Journal of
Applied Psychology: An International Review, 51, 269-290.
Barrett, L.F., Lane, R.D., Sechrest, L. & Schwartz, G.E. (2000). Sex differences
in emotional awareness. Personality and  Social Psychology Bulletin, 26, 1027-1035.
Bauer, M. & McBride, R. (2003). Structured group psychotherapy for bipolar
disorder: the Life Goals Program (2nd ed). Springer: New York.
142
Bauer, M.S., Crits-Christoph, P., Ball, W.A., Dewees, E., McAllister, T., Alahi,
P., Cacciola, J. & Whybrow, P.C. (1991). Independent assessment of manic and
depressive symptoms by self-rating. Archives of General Psychiatry, 48, 807-812.
Bauer, M., Crits-Christoph, P., Ball, W., Dewees, E., McAllister, T., Alahi, P.,
Cacciola, J. & Whybrow, P. (1991). Independent assessment of manic and depressive
symptoms by self-rating scale characteristics and implications for the study of mania.
Archives of General Psychiatry, 48, 807-812.
Bauer, M., Vojta, C., Kinosian, B., Altshuler, L. & Glick, H. (2000). The internal
state scale: replication of its discriminating abilities in a multi-site, public sector sample.
Bipolar Disorders, 2, 340-346.
Bebbington, P., Wilkins, S., Jones, P., Foerster, A., Murray, R., Toone, B. &
Lewis, S. (1993). Life events and psychosis. Initial results from the Camberwell
Collaborative Psychosis Study. The British Journal of Psychiatry, 162, 72-79.
Beck, A.T. (1979). Cognitive therapy and emotional disorders. New York:
Guilford.
Beyer, J., Kuchibhatla, M., Looney, C., Engstrom, E., Cassidy, F., Ranga, K. &
Krishnan, R. (2003). Social support in elderly patients with bipolar disorder. Bipolar
Disorders, 5 (1), 22-27.
Bozikas, V. P., Kosmidis, M.H., Anezoulaki, D., Giannakou, M., Andreaou, C.
& Karavotos, A. (2006). Impaired perception of affective prosody in schizophrenia.
Journal of Neuropsychiatry Clinical Neuroscience, 18, 81-85.
Brickman, A.L., LoPiccolo C.J. & Johnson S.L. (2002). Screening for bipolar
disorder. Psychiatric Services, 53, 349.
British Psychological Society (1995). Professional practice guidelines: Division
of Clinical Psychology.
Castle, D., Berk, M., Berk, L., Lauder, S., Chamberlain, J. & Gilbert, M. (2007).
Pilot of group intervention for bipolar disorder. International Journal of Psychiatry in
Clinical Practice, 11 (4), 279-284.
143
Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported
psychological interventions: Controversies & evidence. Annual Review of Psychology,
52, 685-716.
Cohen, J., Cohen, P., West, S.G. & Aiken, L.S. (2003). Applied multiple
regression/correlational analysis for the behavioural sciences (3rd ed). Mahwah, NJ:
Lawrence Erlbaum.
Cohen, A.N., Hammen, C., Henry, R.M. & Daley, S.E. (2004). Effects of stress
& social support on recurrence in bipolar disorder. Journal of Affective Disorders, 82,
143-147.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112 (1), 155-159.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.).
Lawrence Erlbaum Associates.
Colom, F., Vieta, E., Marinez-Aran, Torrent, C., Reinares, M., Goikolea, J.M. et
al. (2003a). A randomized trail on the efficacy of group psychoeducation in the
prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of
General Psychiatry, 60, 402-407.
Colom, F. & Vieta, E. (2004). A perspective on the use of psychoeducation,
cognitive-behavioural therapy and interpersonal therapy for bipolar patients. Bipolar
Disorders, 6, 480-486.
Colom, F., Vieta, E., Sanchez-Moreno, J., Goikolea, J.M., Popova, E., Bonnin,
C.M. & Scott, J. (2009a). Psychoeducation for bipolar II disorder: An exploratory, 5-
year outcome subanalysis. Journal of Affective Disorders. 112, 30-35.
Colom, F., Vieta, E., Reinares, M., Marinez-Aran, Torrent, C., Goikolea, J.M. &
Gasto, C. (2003b). Psychoeducation efficacy in bipolar disorders: Beyond compliance
enhancement. Journal of Clinical Psychiatry, 64 (9), 1101- 1105.
Colom, F., Vieta, E., Sanchez-Moreno, J., Palomino-Otiniano, M., Rinares, M.
Goikloea, J.M. et al. (2009b). Group psychoeducation for stabilised bipolar disorders: 5-
year outcome of a randomised clinical trial. The British Journal of Psychiatry, 194, 260-
265.
144
Cooke, R.G., Krüger, S., Shugar G. (1996). Comparative evaluation of two self-
report mania rating scales. Biological Psychiatry, 40, 279–283.
Cresswell, C.M., Kuipers, L. & Power, M.J. (1992). Social networks and support
in long-term psychiatric patients. Psychological Medicine, 22, 1019-1026.
Dancey, C.P. & Reidy, J. (2004). Statistics without maths (3rd ed). Harlow,
Engl&: Prentice Hall.
David, A., Buchanan, A., Reed, A. & Almeida O.. (1992). The assessment of
insight in psychosis. British Journal of Psychiatry, 161, 599 –602.
David, A. (1990). Insight and psychosis. The British Journal of Psychiatry, 156,
798-808.
de Shazer, S. (1982). Patterns of brief family therapy: An ecosystemic approach.
New York: Guilford Press.
DeMaris, A. (2004). Regression with social data: Modelling continuous &
limited response variables. Hoboken, NJ: John Wiley & Sons.
Emilien, G., Septien, L., Brisard, C., Corruble, E. & Bourin, M. (2007). How far
are we from a rigorous definition and effective management. Progress in Neuro-
Psychopharmacology & Biological Psychiatry, 31, 975-996.
Etain, B., Henry, C., Bellivier, F., Mathieu, F. & Leboyer, M.  (2008). Beyond
genetics: childhood affective trauma in bipolar disorder. Bipolar Disorders, 10, 867-876.
Evans, R.E.C., Brotherstone, H., Miles, A. & Wardle, J. (2005). Gender
differences in early detection of cancer. Journal of Human Genetics, 2 (2), 209-217.
Frank, E., Swartz, H.A. & Kupfer, D.J. (1999).  Interpersonal and Social Rhythm
therapy: managing the chaos of bipolar disorder. Biological Psychiatry, 48 (6), 593-604.
Finn, C.T. (2007). A brief overview of the genetics of bipolar disorder. Focus, 5,
14-17.
Frank, E., Kupfer, D.J., Ehlers, C.L., Monk, T.H., Cornes, C., Carter, S. &
Frankel, D. (1994). Interpersonal and Social Rhythm Therapy for bipolar disorder:
integrating interpersonal & behavioural approaches. Behavior Therapist, 17, 143-149.
145
Frank, E., Kupfer, D., Thase, M. E., Mallinger, A., Swartz, H. A., Fagiolini, A.
et al. (2005). Two-year outcomes for Interpersonal and Social Rhythm Therapy in
individuals with bipolar I disorder. Archives of General Psychiatry, 62, 996-1004.
Frank, E., Swartz, H. A. & Kupfer, D. J. (2000). Interpersonal and Social
Rhythm Therapy: managing the chaos of bipolar disorder. Biological Psychiatry, 48,
593-604.
Frank, E. (2007). Interpersonal and Social Rhythm Therapy: A means of
improving depression and preventing relapse in bipolar disorder. Journal of Clinical
Psychology, 63 (5), 463 – 473.
Gitlin, M.J., Swendsen, J., Heller, T.L. & Hammen, C. (1995). Relapse and
impairment in bipolar disorder. American Journal of Psychiatry. 152, 1635-1640.
            Goldberg, J.F., Harrow, M., & Grossman, L. (1995). Course and outcome in
bipolar affective disorder: A longitudinal follow-up study. American Journal of
Psychiatry, 152, 379-384.
Goodwin, F.K. & Jamison, K.R. (2007). Manic-depressive illness: Bipolar
disorders & recurrent depression (2nd ed). Oxford: University Press.
Goodwin, G.M. & Geddes, J.R. (2003). Latest maintenance data on lithium in
bipolar disorder. European Neuropsychopharamacology, 13 (2), 51-55.
Goosens, P. J.J., Knoppert-van der Klien, E.A.M., & van Achterberg, T. (2008).
Coping styles of outpatients with a bipolar disorder. Archives of Psychiatric Nursing, 22
(5), 245-253.
Gray, J.A. (1990). Brain systems that mediate both emotions and cognition.
Cognition & Emotion, 4, 269-288.
Hall, K. S., Dunner, D.L., & Zeller, G. (1977). Bipolar illness: A prospective
study of life events.  Comprehensive Psychiatry, 18 (5), 497-502.
Hamilton, M. (1967).  Development of a rating scale for primary depressive
illness. British Journal of Social and Clinical Psychology, 6, 278-96.
Hammen, C. & Gitlen, M. (1997). Stress reactivity in bipolar patients and its
relation to prior history of disorder. American Journal of Psychiatry, 154, 856-857.
146
Hayward, P., Wong, G., Bright, J.A. & Lam, D. (2002). Stigma & self-esteem in
manic depression: An exploratory study. Journal of Affective Disorders, 69, 61-67.
Hill, R., Hardy, P. & Shepherd, G. (1996). Perspectives on manic depression: A
survey of the manic depression fellowship. London: The Sainsbury Centre for Mental
Health.
Hirschfeld, R.M.A. (2001). Bipolar spectrum disorder: Improving its recognition
and diagnosis. Journal of Clinical Psychiatry, 62 (s14), 5-9.
Hirschfeld, R.M.A. (2004). Bipolar depression: the real challenge. European
Neuropsychopharmacology, 14, 83-88.
Hunt, N., Bruce-Jones, W. & Silverstone, T. (1992). Life events & relapse in
bipolar affective disorder. Journal of Affective Disorders. 25, 13-20.
ICD-10 (1992). The ICD-10 classification of mental & behavioural disorders:
clinical descriptions & diagnostic guidelines. Geneva, World Health Organization.
Jackson, A., Cavanagh, J. & Scott, J. (2003). A systematic review of manic and
depressive prodromes. Journal of Affective Disorders, 74, 209-217.
Jamison, K.R. (2001). Suicide and bipolar disorder. The Journal of Clinical
Psychiatry, 61 (s9), 47- 51.
Janda, M., Youl, P.H., Lowe, J.B., Elwood, M., Ring, I.T. & Aitken, J.F. (2004).
Attitudes and intentions in relation to skin checks for early signs of skin cancer.
Preventative Medicine, 39, 11-18.
Johnson, S.L. & Roberts, J.R. (1995). Life events and bipolar disorder:
Implications from biological theories. Psychological Bulletin, 117, 434-449.
Johnson, S.L., Sandrow, D., Meyer, B., Winters, R., Miller, I., Kietner, G. et al.
(2000). Social support and self-esteem predict changes in bipolar depression but not
mania. Journal of Affective Disorders, 58, 79-86.
Johnson, S.L., Winett, C., Meyer, B., Greenhouse, W. & Miller, I. (1999). Social
support and the course of bipolar disorder. Journal of Abnormal Psychology, 108, 558-
566.
147
Jones, S. (2004). Psychotherapy of bipolar disorder: a review. Journal of
Affective Disorders, 80, 101-114.
Joyce, P.R. (1985). Illness behaviour and rehospitalisation in bipolar affective
disorder. Psychological Medicine, 15, 521-525.
Keck, P.E., McElroy, S.L., Strakowski, S.M., West, S.A., Sax, K.W., Hawkins,
J.M. et al. (1998). 12-month outcome of patients with bipolar disorder following
hospitalization for a manic or mixed episode. American Journal of Psychiatry, 155, 646-
652.
Keitner, G. I., Solomon, D.A., Ryan, C.E., Miller, I.W., Mallinger, A., Kupfer,
D.J., & Frank, E. (1996). Prodromal and residual symptoms in bipolar I disorder.
Comprehensive Psychiatry, 37 (5), 362-367.
Kessler, R.C., Walters, E.E., Forthofer, M.S. (1998). The social consequences of
psychiatric disorders III: Probability of marital stability. American Journal of
Psychiatry, 155, 1092-1096.
Kessler, R.C., Rubinow, D.R., Holmes, C., Abelson, J.M. & Zhao, S. (1997). The
epidemiology of DSM-III-R bipolar I disorder in the general population survey.
Psychological Medicine, 27, 1079-1089.
Klerman, G.L., Weissman, M.M., Rounsaville, B.J., Chevron, E.S. (1984).
Interpersonal Psychotherapy of Depression. Basic Books: New York.
Kulhara, P., Basu, D., Mattoo, S.K., Sharan, P. & Chopra, R. (1999). Lithium
prophylaxis of recurrent bipolar affective disorder: long-term outcome and its
psychosocial correlates. Journal of Affective Disorder, 54, 87-96.
Lam, D. & Wong, G. (1997). Prodromes, coping strategies, insight and social
functioning in bipolar affective disorders. Psychological Medicine, 27 (5), 1091-1100.
Lam, D. & Wong, G. (2005). Prodromes, coping strategies and psychological
interventions in bipolar disorders. Clinical Psychology Review, 25, 1028-1042.
Lam, D.H., Jones, S.H., Hayward, P. & Bright, J.A. (1999). Cognitive therapy
for bipolar disorder: A therapist’s guide to concepts, methods & practice. John Wiley &
Sons, Ltd. Chichester.
148
Lam, D.H., Bright, J., Jones, S., Hayward, P., Schuck, N., Chisholm, D. & Sham,
P. (2000). Cognitive therapy for bipolar illness – A pilot study of relapse prevention.
Cognitive Therapy and Research, 24 (5), 503-520.
Lam, D.H., Watkins, E.R., Hayward, P., Bright, J., Wright, K., Kerr, N. et al.
(2003). A randomized controlled study of cognitive therapy for relapse prevention for
bipolar affective disorder. Archives of General Psychiatry, 60, 145- 152.
Lam, D., Wong, G. & Sham, P. (2001). Prodromes, coping strategies and course
of illness in bipolar affective disorder- a naturalistic study. Psychological Medicine, 31
(8), 1397-1402.
Lam, D.H., Hayward, P., Watkins, E.R., Wright, B.A., & Sham, P. (2005).
Relapse prevention in patients with bipolar disorder: Cognitive therapy outcome after 2
years. American Journal of Psychiatry, 162 (2), 324-329.
Lam, D., Wright, K., & Smith, N. (2004). Dysfunctional assumptions in bipolar
disorder. Journal of Affective Disorders, 79,193-199.
Lam, D., Burbeck, R., Wright, K. & Pilling, S. (2009). Psychological therapies in
bipolar disorder: the effect of illness history on relapse prevention – a systematic review.
Bipolar Disorders, 11, 474-482. 
Lazarus, R.S. & Folkman, S. (1984). Stress, appraisal, and coping. New York:
Springer.
Lish, J.D., Dime-Meenan, S., Whybrow, P.C., Price, R.A., Hirshfield, R.M.
(1994). Bipolar Depression: The real challenge. European Neuropsychopharmacology,
14, S83-S88.
Long, J.S. & Freese, J. (2006). Regression models for categorical dependent
variables using Stata (2nd ed.) College Station, TX: Stata Press.
Lozano, B.E. & Johnson, S. L. (2001). Can personality traits predict increases in
manic and depressive symptoms? Journal of Affective Disorders, 63, 103-111.
Luszcynska, A., Scholz, U. & Schwarzer, R. (2005). The general self-efficacy
scale: Multicultural validation studies. The Journal of Psychology, 139 (5), 439-457.
MacQueen, G.M., & Young, L.T. (2001). Bipolar II disorder: Symptoms,
Course, & Response to Treatment. Psychiatric Services, 52, 358-361.
149
Maj, M. (1999). Rapid Cycling in bipolar disorder. American Journal of
Psychiatry, 156, 1837-1838.
Malkoff-Schwartz, S., Frank, E., Anderson, B.P., Hlastala, S.A., Luther, J.F.,
Sherrill, J.T., Houck, P.R. & Kupfer, D.J. (2000). Social rhythm disruption & stressful
life events in the onset of bipolar and unipolar episodes. Psychological Medicine, 30 (5),
1005-1016.
Mantere, O., Suominen, K., Valtonen, H.M., Arvilommi, P. & Isometsa, E.
(2008). Only half of bipolar I & II patients report prodromal symptoms. Journal of
Affective Disorders, 111 (2), 366-371.
Martins, A., Ramalho, N., Morin, E. (in press). A comprehensive meta-analysis
of the relationship between Emotional Intelligence & health. Personality and Individual
Differences.
McElroy S.L., Altshuler, L.L., Suppes, T., Keck, Jr., P.E., Frye, M.A., Denicoff,
K.D. et al. (2001). Axis l psychiatric comorbidity and its relationship to historical illness
variables in 288 patients with bipolar disorder. American Journal of Psychiatry,
158:420-426.
McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R. & Cardno, A. (2003).
The Heritability of bipolar affective disorder and the genetic relationship to unipolar
depression. Archives of General Psychiatry, 60, 497-502.
Miklowitz, D.J. & Goldstein, M.J. (1990). Behavioral family treatment for
patients with bipolar affective disorder. Behaviour Modification, 14, 457-489.
Miklowitz, D.J. & Scott, J. (2009). Psychosocial treatments for bipolar disorder:
cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disorders, 11
(s2), 110-122.
Micklowitz, D.J., Otto, M.W., Frank, E., Reilly-Harrington, N.A., Wisniewski,
S.R. & Kogan, J.N. (2007). Psychosocial treatments for bipolar depression: A 1-year
randomized trial from the systematic treatment enhancement program. Archives of
General Psychiatry, 64, 419-427.
Miklowitz, D.J., George, E.L., Richards, J.A., Simoneau, T.L. & Suddath, R.L.
(2003). A randomised study of family-focused psychoeducation and pharmacotherapy in
150
the outpatient management of bipolar disorder. Archives of General Psychiatry, 60, 904-
912.
151
Miklowitz, D.J., Goldstein, M.J., Nuechterlein, K.H., Snyder, K.S. & Mintz, J.
(1988).  Family factors and the course of bipolar affective disorder. Archives of General
Psychiatry, 45, 582-592.
Miklowitz, D.J., Simoneau, T.L., George, E.L., Richards, J.A., Kalbag, Sachs-
Ericsson, A. et al. (2000). Family-focused treatment of bipolar disorder: 1-year effects
of a psychoeducation program in conjunction with pharmacotherapy. Biological
Psychiatry, 48, 582-592.
Miklowitz, D.J., George, E.L., Richards, J.A., Simoneau, T.L. & Suddath, R.L.
(2003). A randomised study of family-focused psychoeducation and pharmacotherapy in
the outpatient management of bipolar disorder. Archives of General Psychiatry, 60, 904-
912.
Miller, D.R., Geller, A.C., Wyatt, S.W., Halpern, A., Howell, J.B., Cockerell, C.
et al. (1996). Melanoma awareness and self-examination practices: results of a United
States survey. Journal of American Academic Dermatology, 34, 962-970.
Molnar, G., Feeney, G. & Fava, G. (1988). Duration and symptoms and bipolar
prodromes. American Journal of Psychiatry, 145, 1576- 1577.
Morriss, R., Marshall, M. & Harris, A. (2002). Bipolar affective disorder – left
out in the cold. British Medical Journal, 324, (7329), 61-62.
Muesser, K.T., Corrigan, P.W., Hilton, D.W., Tanzman, B., Schaub, A.,
Gingerich, A. et al. (2004). Illness management and recovery: A review of the research.
The Journal of Lifelong Learning in Psychiatry, 11 (1), 34-47.
Neale, J.M. (1988). Defence function of manic episodes. In T.F. Oltlmanns &
B.A. Maher (eds), Delusional beliefs. (31-47). Wiley: New York.
Nhiwatiwa, F.G. (2003). The effects of single session education in reducing
symptoms of distress following patient assault in nurses working in medium secure
settings. Journal of Psychiatric and Mental Health Nursing, 10 (5), 561-568.
Nolen-Hoeksema, S., Morrow, J., Fredrickson, B.L. (1993). Response styles and
the duration of episodes of depressed mood. Journal of Abnormal Psychology, 102, 20-
28.
152
Nolen-Hoeksema, S. (2001). Gender differences in depression. Current
Directions in Psychological Medicine, 10, 173-176.
Nolen-Hoeksema, S., Larson, J. & Grayson, C. (1999). Examining gender
difference in depressive symptoms. Journal of Personality & Social Psychology, 77,
1061-1072.
Novick, D.M., Swartz, H.A. & Frank, E. (2010). Suicide attempts in bipolar I
and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disorders,
12, 1-9.
O'Connell, R.A., Mayo, J.A., Flatow, L., Cuthbertson, B. & O'Brien, B.E.
(1991). Outcome of bipolar disorder on long-term treatment with lithium. British
Journal of Psychiatry, 159, 123-9.
O’Connell, R.A. (1986). Psychosocial factors in a model of manic depressive
disease. Integrative Psychiatry, 4, 150-161.
Orme, J.G. & Combs-Orme, T. (2009). Multiple regression with discrete
dependent variables. Oxford: University Press.
Ost, L.G. (2008). Efficacy of the third wave of behavioral therapies: systematic
review and meta-analysis. Behaviour Research & Therapy, 6(3), 296-321.
Oswald, P., Souery, D., Kasper, S., Lecrubier, Y., Montgomery, S., Wyckaert, S.
et al. (2007). Current issues in bipolar disorder: A critical review. European
Neuropsychopharmacology, 17, 687-695.
Pardoen, D., Bauwens, F., Dramaix, M., Tracy, A., Genevrois, C., Staner, L. et
al. (1996). Life events and primary affective disorders: A one year prospective study.
British Journal of Psychiatry, 169, 160-166.
Pardoen, D., Bauwens, F., Tracy, A., Martin, F., Mendlewicz, J. (1993). Self-
esteem in recovered bipolar & unipolar outpatients. British Journal of Psychiatry, 163,
755-762.  
Peet, M. & Harvey, N.S. (1991). Lithium maintenance: I: A standard education
program for patients. British Journal of Psychiatry, 158, 197-200.
Perry, A., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999).
Randomised controlled trial of efficacy of teaching patients with bipolar disorder to
153
identify early symptoms of relapse and obtain treatment. British Medical Journal, 318,
149-153.
Power, M.J., Champion, L.A. & Aris, S.J. (1988). The development of a measure
of social support: The significant Others (SOS) scale. British Journal of Clinical
Psychology, 27, 349-358.
Power, M. J. (2005). Psychological approaches to bipolar disorders: A theoretical
critique. Clinical Psychology Review, 25, 1101-1122.
Reilly-Harrington, N.A., Miklowitz, D.J., Otto, M.W., Frank, E., Wisniewski,
S.R., Thase, M.E. & Sachs, G.S. (2010). Dysfunctional attitudes, attributional styles, and
phase of illness in bipolar disorder. Cognitive Therapy & Research, 34, 24-34.
Ritsnerab, M.S., Gibela, A., Ponizovskyc, A.M., Shinkarenkoa, E., Ratnera, Y. &
Kurs, R. (2006). Coping patterns as a valid presentation of the diversity of coping
responses in schizophrenia patients. Psychiatry Research, 144, (2), 139-152.
Romans, S.E. & McPherson, H.M. (1992). The social networks of bipolar
affective disorder patients. Journal of Affective Disorders, 25 (4), 221-228.
Rosenfarb, I.S., Miklowitz, D.J., Goldstein, M.J., Harmon, L, Nuechterlein, K.H.
& Rea, M.M. (2001). Family transactions and relapse in bipolar disorder. Family
Process, 40, 5–14.
Ruggero, C.J., Carolson, G.A., Kotov, R. & Bromet, E.J. (2010). Ten-year
diagnostic consistency of bipolar disorder in a first-admission sample. Bipolar
Disorders, 12, 21-31.
Schwarzer, R. (1993). Measurement of perceived self-efficacy. Psychometric
scales for cross-cultural research. Berlin, Germany: Freie Universität Berlin.
Schutte, N.S., John M. Malouff, J.M. &, Einar, B. (2007). A meta-analytic
investigation of the relationship between Emotional Intelligence and health. Personality
& Individual Differences, 42 (6), 921-933.
Schwannauer, M. (2004). Cognitive behavioural therapy for bipolar affective
disorder. In M. Power (ed) Mood disorder a handbook of science and  practice, 259-
274. Chichester: John Wiley & Sons Ltd.
154
Schwarzer, R., & Jerusalem, M. (1995).   Generalized Self-Efficacy scale. In J.
Weinman, S. Wright, & M. Johnston. Measures in health psychology: A user’s portfolio.
Causal and control beliefs (p. 35-37).   Windsor, UK: NFER-NELSON.
Schwarzer, R., Mueller, J. & Greenglass, E. (1999). Assessment of perceived
general self-efficacy on the internet: Data collection in cyberspace. Anxiety, Stress, and
Coping, 12, 145-161.
Schwarzer, R. (1994). Optimism, vulnerability, and self-belief as health-related
cognitions: A systematic overview. Psychology and  Health, 9, 161-180.
Scott, J., Stanton, B., Garland, A. & Ferrier, I. (2000). Cognitive vulnerability in
bipolar disorders. Psychological Medicine, 30, 467-472.
Scott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T. et al.
(2006). Cognitive-behavioural therapy for severe and recurrent bipolar disorders. British
Journal of Psychiatry, 188, 313-320.
Scott, J., Stanton, B., Garland, A., & Moorhead, S. (2001). A pilot study of
cognitive therapy in bipolar disorder. Psychological Medicine, 31, 459-467.
Scott, J. & Pope, M. (2003). Cognitive styles in individuals with bipolar
disorders. Psychological Medicine. 33, 1081-1088.
Shadish, W.R., Cook, T.D. & Campbell, D.T. (2002). Experimental and quasi-
experimental designs for generalized causal inference. Boston: Houghton Mifflin.
Sierra, P., Livianos, L., Arques, S., Castello, J. & Rojo, L. (2008). Prodormal
symptoms to relapse in bipolar disorder. Australian and New Zealand Journal of
Psychiatry, 41, 385-391.
Simon, G.E., Ludman, E.J., Unutzer, J., Bauer, M.S., Operskalski, B. & Rutter,
C. (2005). Randomized trial of a population-based care program for people with bipolar
disorder. Psychological Medicine, 35, 13-24.
Simoneau, T. L., Miklowitz, D.J. & Saleem, R. (1998). Expressed emotion and
interactional patterns in the families of bipolar patients. Journal of Abnormal
Psychology, 107, 497-507.
155
Simoneau, T.L., Miklowitz, D.J., Richards, J.A., Saleem, R. & George, E.L.
(1999). Bipolar disorder and family communication: Effects of a psychoeducational
treatment program. Journal of Abnormal Psychology, 108 (4), 588-597.
Smith, J.A. & Tarrier, N. (1992). Prodromal symptoms in manic depressive
psychosis. Social Psychiatry & Psychiatric Epidemiology, 27, 245-248.
Strober, M., Morrell, W., Lampert, C. & Burroughs, J. (1990). Relapse following
discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a
naturalistic study. American Journal of Psychiatry, 147, 457-461.
Stoller, E.P. & Kart, C.S. (1995). Symptoms reporting during physician
consultation. Journal of Aging and Health, 7 (2), 200-232.
Sundet, V.A., Simonsen, F.S., Birkenaes, A.B., Engh, J.A., Jonsdottir, H.,
Ringer, P.A. et al. (2007). The effect of gender on emotion perception in schizophrenia
and bipolar disorder. Acta Psychiatria Scandinavia, 116, 263-270.
ten Have, M., Vollebergh, W., Bijl, R. & Nolen, W.A. (2002). Bipolar disorder
in the general population in The Netherlands (prevalence, consequences and care
utilisation): results from The Netherlands Mental Health Survey and Incidence Study
(NEMESIS). Journal of Affective Disorders, Volume 68 (2), 203-213.
Thayer, J.F. & Johnsen, B.H. (2000). Sex differences in judgement of facial
affect: A multivariate analysis of recognition errors. Scandinavian Journal of
Psychology, 41, 243-246.
Thayer, J.F., Rossy, L.A., Ruiz-Padial, E. & Johnsen, B.H. (2003). Gender
differences in the relationship between emotional regulation and depressive symptoms.
Cognitive Therapy & Research, 27 (3), 349-364.
Tohen, M., Waternaux, G.M. & Tsuang, M.T. (1990). Outcome in mania: a 4-
year prospective follow-up of 75 patients utilising survival analysis. Archives of General
Psychiatry, 47 (12), 1106-1011.
Van Gent, E. M. & Zwart, F. M. (1991). Psychoeducation of partners of bipolar-
manic patients. Journal of Affective Disorders, 21, 15-18.
156
Vauth, R., Kleim, B., Wirtz, M. & Corrigan, P.W.  (2007). Self-efficacy and
empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry
Research, 150, 71-80.
Verbrugge, L.M. (1985). Gender and Health: An update on hypotheses and
evidence. Journal of Health and  Social Behavior, 26, 156-182.
WHOQoL Group (1998). Development of the World Health Organization
WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551-558.
Winters, K.C. & Neal, J.M. (1985). Mania and low self-esteem. Journal of
Abnormal Psychology, 94, 282-290.
Wright, K. & Lam, D. (2004). Bipolar affective disorder: Current perspectives on
psychological theory and treatment. In M. Power (ed) Mood disorder a handbook of
science & practice, 235-246. Chichester: John Wiley & Sons Ltd.
Young, R.C., Biggs, J.T., Ziegler, V.E. &  Meyer, D.A. (1978). A rating scale for
mania: reliability, validity and sensitivity. The British Journal of Psychiatry, 133: 429-
435.
Zaretsky, A. E., Segal, Z.V. & Gemar, M. (1999). Cognitive therapy for bipolar
depression: A pilot study. Canadian Journal of Psychiatry, 44, 491-494.
157
Appendix 1: DSM-IV diagnostic criteria for bipolar affective disorder
Diagnostic criteria for a Major Depressive Episode (DSM IV Criteria, APA, 1994)
For an individual to be diagnosed with major depression five (or more) of the following
symptoms have to have been present during the same 2-week period and represent a
change from previous functioning; at least one of the symptoms is either (1) depressed
mood or (2) loss of interest or pleasure. Symptoms that are clearly due to a general
medical condition, or mood-incongruent delusions or hallucinations are not to be
included.)
1)   Depressed mood most of the day, nearly every day, as indicated by either subjective
report (e.g., feels sad or empty) or observation made by others (e.g., appears
tearful). Note: In children and adolescents, can be irritable mood
2) Markedly diminished interest or pleasure in all, or almost all, activities most of the
day, nearly every day (as indicated by either subjective account or observation made
by others)
3) Significant weight loss when not dieting or weight gain (e.g., a change of more than
5 percent of body weight in a month), or decrease or increase in appetite nearly
every day
4) Insomnia or hypersomnia nearly every day
5)  Psychomotor agitation or retardation nearly every day (observable by others, not
merely subjective feelings of restlessness or being slowed down)
6) Fatigue or loss of energy nearly every day
7) Feelings of worthlessness or excessive or inappropriate guilt (which may be
delusional) nearly every day (not merely self-reproach or guilt about being sick)
8) Diminished ability to think or concentrate, or indecisiveness, nearly every day
(either by subjective account or as observed by others)
9)  Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation
without a specific plan, or a suicide attempt or a specific plan for committing
suicide
      B)   The symptoms do not meet criteria for a Mixed Episode
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C) The symptoms cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning
      D) The symptoms are not due to the direct physiological effects of a substance (e.g. a
drug of abuse, a medication) or a general medical condition (e.g., hypothyroidism)
      E) The symptoms are not better accounted for by Bereavement, i.e., after the loss of a
loved one, the symptoms persist for longer than 2 months or are characterized by
marked functional impairment, morbid preoccupation with worthlessness, suicidal
ideation, psychotic symptoms, or psychomotor retardation
Diagnostic Criteria for a Manic Episode (DSM IV Criteria, APA, 1994)
A) A distinct period of abnormally and persistently elevated, expansive or irritable
mood, lasting at least 1 week (or any duration if hospitalization is necessary)
B) During the period of mood disturbance, three (or more) of the following symptoms
have persisted (four if the mood is only irritable) and have been present to a
significant degree:
1) Inflated self-esteem or grandiosity
2) Decreased need for sleep (e.g., feels rested after only 3 hours of sleep)
3) More talkative than usual or pressure to keep talking
4) Flight of ideas or subjective experience that thoughts are racing
5) Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external
stimuli)
6) Increase in goal-directed activity (at work, at school, or sexually) or psychomotor
agitation
7) Excessive involvement in pleasurable activities that have a high potential for painful
consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or
foolish business investments)
C) The symptoms do not meet criteria for a mixed episode.
D) The mood disturbance is sufficiently severe to cause marked impairment in
occupational functioning or in usual social activities or relationships with others,
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necessitate hospitalization to prevent harm to self or others, or there are psychotic
features.
E) The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication or other treatment) or a general medical condition (e.g.,
hyperthyroidism).
Diagnostic Criteria for a Mixed Episode (DSM IV Criteria, APA, 1994)
A. The criteria are met both for a manic episode and for a major depressive episode
(except for duration) nearly every day during at least a 1-week period.
B. The mood disturbance is sufficiently severe to cause marked impairment in
occupational functioning or in usual social activities or relationships with others, or to
necessitate hospitalization to prevent harm to self or others, or there are psychotic
features.
C. The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication, or other treatment), or a general medical condition (e.g.,
hyperthyroidism).
Mixed-like episodes that are clearly caused by somatic antidepressant treatment (e.g.,
medication, electroconvulsive therapy, light therapy) should not count toward a
diagnosis of Bipolar I Disorder.
1.2.5 Diagnostic criteria for a Hypomanic Episode
A) A distinct period of persistently elevated, expansive or irritable mood, lasting
throughout at least 4 days, that is clearly different from the usual non-depressed mood.
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B) During the period of mood disturbance, three (or more) of the following symptoms
have persisted (four if the mood is only irritable) and have been present to a significant
degree:
1) Inflated self-esteem or grandiosity
2) Decreased need for sleep (e.g., feels rested after only 3 hours of sleep)
3) More talkative than usual or pressure to keep talking
4) Flight of ideas or subjective experience that thoughts are racing
5) Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external
stimuli).
6) Increase in goal-directed activity (at work, at school, or sexually) or psychomotor
agitation.
7) Excessive involvement in pleasurable activities that have a high potential for painful
consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or
foolish business investments).
C) The episode is associated with an unequivocal change in functioning that is
uncharacteristic of the person when not symptomatic.
D) The disturbance in mood and the change in functioning are observable by others.
E) The mood disturbance not severe enough to cause marked impairment in social or
occupational functioning, or to necessitate hospitalization, and there are no psychotic
features.
F) The symptoms are not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication or other treatment) or a general medical condition (e.g.
hyperthyroidism).
Hypomanic-like episodes that are clearly caused by somatic antidepressant treatment
(e.g. medication, electroconvulsive therapy, light therapy) should not count toward a
diagnosis of bipolar II disorder.
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Appendix 2. The reason why research was excluded at stage 3 of the study
eligibility review process
Study and reason for exclusion at stage 3.
1. Ball, J.R., Mitchell, Corry, J.C., Skillecorn, A., Smith, M. and Malhi, G.S. (2006). A
randomised controlled trial of cognitive therapy for bipolar disorder: Focus on long-term
change. Journal of Clinical Psychiatry, 67 (2), 277-286.
Reason for exclusion:
Mood monitoring also used as an intervention in the control group.
2. Bauer, M.S., McBride, L., Williford, W.O., Glick, H., Kinosian, B., Altshuler, L., et
al. (2006). Collaborative care for bipolar disorder: Part I. Intervention and
implementation in a randomised effectiveness trial. Psychiatric Services, 57 (7), 927-
936.
Reason for exclusion:
The paper discusses proposed research.
3.Bauer, M.S., McBride, L., Williford, W.O., Glick, H., Kinosian, B., Altshuler, L., et
al. (2006). Collaborative care for bipolar disorder: Part II. Impact on clinical outcome,
function, and costs. Psychiatric Services, 57, 927-936.
Reason for exclusion:
Self-management is viewed as part of a larger intervention package.
4. Fagiolini, A., Frank, E., Axelson, D.A., Birmaher, B., Cheng, Y., Curet, D.E. et al.,
(2009). Enhancing outcomes in patients with bipolar disorder: results from the bipolar
disorder centre for Pennsylvanians study. Bipolar Disorders, 11, 382-390.
Reason for exclusion:
Prodromal monitoring is not a focus of the research study.
5. Jones, S.H. and Burrell-Hodgson (2008). Cognitive-behavioural treatment of first
diagnosis bipolar disorder. Clinical Psychology and Psychotherapy, 15, 367-377.
Reason for exclusion:
The study did not use a RCT design.
6. Lam, D. and Wong, G. (2005). Prodromes, coping strategies and psychological
interventions in bipolar disorders. Clinical Psychology Review, 25, 1028-1042.
Reason for exclusion:
The paper provides a review of prodromal monitoring.
7. Lam, D., Wong, G. and Sham, P. (2001). Prodromes, coping strategies and course of
illness in bipolar affective disorder- a naturalistic study. Psychological Medicine, 31 (8),
1397-1402.
Reason for exclusion:
The study did not use a RCT design.
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8. Micklowitz, D.J., Otto, M.W., Frank, E., Reilly-Harrington, N.A., Wisniewski, S.R.,
Kogan, J.N. (2007). Psychosocial treatments for bipolar depression: A 1-year
randomized trial from the systematic treatment enhancement program. Archives of
General Psychiatry, 64, 419-427.
Reason for exclusion:
An intervention approach (daily mood charting) that is used within a prodromal
monitoring approach was used in both the control and experimental groups.
9. Miklowitz, D.J., George, E.L., Richards, J.A., Simoneau, T.L., and Suddath, R.L.
(2003). A randomised study of family-focused psychoeducation and pharmacotherapy in
the outpatient management of bipolar disorder. Archives of General Psychiatry, 60, 904-
912.
Reason for exclusion:
Relapse prevention was used as an intervention in both the control and experimental
groups.
10. Morriss, R. (2004). The early warning symptom intervention for patients with
bipolar affective disorder. Advances in Psychiatric Treatment, 10, 18-26.
Reason for exclusion:
Paper provides an overview of prodromal monitoring work.
11. Novacek, J. and Raskin, R. (1998). Recognition of early warning signs: A
consideration for cost-effective treatment of severe mental illness. Psychiatric Services,
49, 376-378.
Reason for exclusion:
Sample included individuals with a diagnosis of schizophrenia, bipolar disorder, and
unipolar depression. Separate data was not provided for each type of disorder.
12. Palmer, A.G., Williams, H. and Adams, M. (1995). CBT in a group format for bi-
polar affective disorder. Behavioural and Cognitive Psychotherapy, 23, 153-168.
Reason for exclusion:
The study did not use a RCT design.
13. Pollack, L. (1996). Inpatient self-management of bipolar disorder. Applied Nursing
Research, 9(2), 71-79.
Reason for exclusion:
Qualitative research approach used.
14. Russell, S.J. (2008). Role of a ‘stay well’ approach in the management of bipolar
disorder. Australian and New Zealand Journal of Psychiatry, 42 (7), 551-554.
Reason for exclusion:
Ethos of the staying well approach is described in the paper but no outcome data is
reported.
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15. Russell, S.J. and Browne, J.L. (2005). Staying well with bipolar disorder. Australian
and New Zealand Journal of Psychiatry, 39, 187-193.
Reason for exclusion:
Study used a qualitative approach.
16. Scott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T. et al.
(2006). Cognitive-behavioural therapy for severe and recurrent bipolar disorders. British
Journal of Psychiatry, 188, 313-320.
Reason for exclusion:
The role of prodromal monitoring in the intervention group was unclear.
17. Simoneau, T.L., Miklowitz, D.J., Richards, J.A., Saleem, R., and George, E.L.
(1999). Bipolar disorder and family communication: Effects of a psychoeducational
treatment program. Journal of Abnormal Psychology, 108 (4), 588-597.
Reason for exclusion:
Prodromal monitoring was not viewed as key feature of the intervention.
18. Stevens, S. (2005). Implementing a self-management model of relapse prevention
for psychosis into routine clinical practice. Journal of Psychiatric and Mental Health
Nursing, 12,495-501.
Reason for exclusion:
Sample includes individuals with psychosis, therefore not exclusively looking at
individuals with bipolar disorder.
19. Wright, J. and Austin, Z. (1996). An individualized self-monitoring instrument
(ISMI) to promote self-management in bipolar illness. The Canadian Journal of Hospital
Pharmacy, 49 (3), 164-166.
Reason for exclusion:
Case study approach used.
20. Zaretsky, A.. Segal, E., Z. V., and M. Gemar. (1999). Cognitive therapy for bipolar
depression: A pilot study. Canadian Journal of Psychiatry, 44, 491-494.
Reason for exclusion:
Role of prodromal monitoring in the intervention is unclear.
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Appendix 3: Methodological rating form
Note: If not enough information is given regarding a specific item a rating of 0 is given.
1.     Clarity of sample description
0 Poor. Vague description of sample (e.g. only mentioned whether patients were
diagnosed with the disorder).
1 Fair. Fair description of sample) (e.g. mentioned inclusion/exclusion criteria,
demographics etc).
2 Good. Good description of sample (e.g. mentioned inclusion/exclusion criteria,
demographics, prevalence of co-morbid disorders, information on illness history such as
length, time since diagnosis).
2.     Representativeness of the sample
0 Poor. Sample is very different from the patients seeking treatment for the disorder
(e.g. there is unfair exclusion criteria).
1 Fair. Sample is somewhat representative of patients seeking treatment for the disorder
(e.g. patients were only excluded if they met criteria for other major disorders).
2 Good. Sample is very representative of patients seeking treatment for disorder (e.g.
authors made efforts to ensure representatives of the sample).
3.     Reliability of diagnosis in question
0 Poor. The diagnostic process was not reported, or not assessed with structured
interviews by a trained interviewer.
1 Fair. The diagnosis was assessed with structured interview by a trained interviewer.
2 Good. The diagnosis was assessed with structured interview by a trained interviewer
and adequate inter-rater reliability was demonstrated (e.g. kappa coefficient
4.     Specificity of outcome measures
0 Poor. Very broad outcome measures, not specific to the disorder (e.g. SCL-90R total
score).
1 Fair. Moderately specific outcome measures
2 Good. Specific outcome measures, such as a measure for each symptom cluster.
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5.     Reliability and validity of outcome measure
0 Poor. Measures have unknown psychometric properties, or properties that fail to meet
current standards of acceptability.
1 Fair. Some, but not all measures have known or adequate psychometric properties.
2 Good. Al measures have good psychometric properties. The outcome measures are the
best available for the author’s purpose.
6.     Use of blind evaluators
0 Poor. Blind assessor was not used
1 Fair. Blind assessor was used but no checks were used to assess the blind.
2 Good. Blind assessor was used in the correct fashion. Checks were used to assess
whether the assessor was aware of the treatment condition.
7.     Assessor training
0 Poor. Assessor training or accuracy are not specified, or are unacceptable.
1 Fair. Minimum criterion for assessor training is specified (e.g. Assessor has had
specific training in the use of the outcome measure), but accuracy not monitored or
reported.
2 Good. Minimum training of assessor training is specified. Inter-rater reliability was
checked, and/or assessment procedures were calibrated during the study to prevent
evaluator drift.
8.     Assignment to treatment
0 Poor. Biased assignment, e.g. patients selected their own
1 Fair. Random or stratified assignment. There may be some systematic bias but not
enough to pose a serious threat to internal validity. There may be therapist by treatment
confounds. N may be to small to protect against bias.
2 Good. Random or stratified assignment, and patients are randomly assigned to
therapies within condition. When theoretically different treatments are used, each
treatment is provided by a large enough number of different therapists. N is large enough
to protect against bias.
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9.     Design
0 Poor. Active treatment vs. WLC, or briefly described TAU.
1 Fair. Active treatment vs. TAU with good description or placebo condition.
2 Good. Active treatment vs. another previously empirically documented active
treatment.
10.     Power analysis
0 Poor. No power analysis was made a priori to the initiation of the study.
1 Fair. No power analysis based on an estimated effect size was used.
2 Good. A data-informed power analysis was made and the sample size was decided
accordingly.
11.     Assessment points
0 Poor. Only pre and post-treatment follow-up or pre and follow-up.
1 Fair. Pre, post and follow-up < 1 year.
2 Good. Pre, post and follow-up > 1 year.
12.     Manualised replicable, specific treatment programme
0 Poor. Description of treatment procedure is unclear, and treatment is not based on
publicly available, detailed treatment manual.
1 Fair. Treatment is not designed for the disorder or description of the treatment is clear
and based on a publicly available and detailed manual. However, there are some
ambiguities about the procedure. Patients may have received additional forms of
treatment but this is balanced between-groups or otherwise controlled.
2 Good. Treatment is designed for the disorder. A detailed manual is available, and/or
treatment is explained in sufficient detail for replication. No ambiguities about the
treatment procedure. Patients only receive the treatment under investigation.
13.     Number of therapists
0 Poor. Only one therapist, i.e. complete confounding between therapy and therapist.
1 Fair. At least two therapists, but the effect of therapist on outcome is not analysed.
2 Good. Three or more therapists and the effect of therapist on outcome is analysed.
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14.     Therapist training/experience
0 Poor. Very limited clinical experience of the treatment/disorder (e.g. students).
1 Fair. Some clinical experience of the treatment/disorder.
2 Good. Long clinical experience of the treatment/disorder (e.g. practising therapists).
15.     Checks for treatment adherence
0 Poor. No checks were made to assure that the intervention was consistent with
protocol.
1 Fair. Some checks were made (e.g. assessed a proportion of therapy tapes).
2 Good. Frequent checks were made (e.g. weekly supervision of each session using a
detailed rating form).
16.     Checks for therapist competence
0 Poor. No checks were made to assure that the intervention was delivered
appropriately.
1 Fair. Some checks were made (e.g. assessed a proportion of therapy tapes).
2 Good. Frequent checks were made (e.g. weekly supervision of each session using a
detailed rating form).
17.     Medication adherence measured and controlled for in statistical analysis if
required
0 Poor. No attempt to measure and control for medication adherence.
1 Fair. Medication adherence measured but between-group differences not explored or
information not used as a covariate in subsequent statistical analyses.
2 Good.  Medication adherence measured and information used to investigate between-
group differences and when required used as a covariate in relevant statistical analyses.
18. Control for concomitant psychological treatments
0 Poor. No attempt to control for concomitant psychological treatments.
1 Fair. Asked participants not to take part in other psychological treatments during and
post study period.
2 Good. Ensured that participants did not receive any other psychological interventions.
168
19. Handling of attrition
0 Poor. Proportions of attrition are not described or described but no dropout analysis is
performed.
1 Fair. Proportions of attrition are described and dropout analysis or intent-to-treat
analysis is performed.
2 Good. Attrition or the proportion of attrition is described, dropout analysis is
performed and results are presented as intent-to-treat analysis.
20. Statistical analysis and presentation of results
0 Poor. Inadequate statistical methods are used and/or data is not fully presented.
1 Fair. Adequate statistical methods are used but data are not fully presented.
2 Good. Adequate statistical methods are used and data is fully presented
21. Equality of therapy hours (for non-WLC designs only)
0 Poor. Conditions differ markedly (> 20 percent difference in therapy hours).
1 Fair. Conditions differ somewhat (10-19 percent difference in therapy hours).
2 Good. Conditions do not differ (<10 percent difference in therapy hours).
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Appendix 4. Data extraction form













matched on demographic variables at baseline:
matched on illness-related factors (e.g. no. of episodes) at baseline:
                              Control group        Experimental group
        age:
        female:
        sample size:
        attrition rate:
Intervention description
Control group:







Are the tests appropriate for the data used:
Are confounding variables adequately controlled:
Is the research ethical?






Appendix 5: Key study details
Key methodological, design features, and research outcomes of the reviewed research studies






Australia To assess whether a group intervention reduced the rate of
relapse and improved the quality of life for people with
Bipolar Disorder.
                     Experimental      Control
Sample size:          9                     8
Females:                7                     7
Age:                    44(± 13)          44(± 8)




Spain To compare the efficacy of group psychoeducation with
standard treatment for reducing rate of relapse for people
with Bipolar Disorder.
                     Experimental     Control
Sample size:        60                   60
Females:              38                   38
Age of onset:       22.26 (±6.29)  23.25 (±7.55)




Spain To assess the efficacy of psychoeducation, with reference
to reduction in episodes with a optimal treatment
adherence group of participants.
                     Experimental    Control
Sample size:      25                    25
Females:            15                    16
Age:                   35.36(±10.87) 34.48 (±10.87)




Spain To assess the long-term efficacy of group psychoeducation
designed to reduce recurrences of episodes and time spent
in an episode for people with Bipolar Disorder.
                     Experimental      Control
Sample size:        60                   60
Females:              38                   38
Age:                     34.03(±9.32)  34.26 (±7.80)




Spain To carry out a post-hoc analysis with Bipolar II patients
involving data designed to assess the effectiveness of a
psychoeducation group which was designed to reduce
relapse rates.
                     Experimental     Control
Sample size:          8                   12
Females:                ?                     ?
Age:                      40                  40
Diagnosis:    Bipolar II
√
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Lam et al. (2000) United
Kingdom
To assess the effectiveness of a time-limited relapse
prevention package designed to increase mood stability
and reduce relapse rate for people with Bipolar Disorder.
                     Experimental      Control
Sample size:         13                   12
Females:                 ?                     ?
Age:                           39 (±10.9)
Diagnosis:   Bipolar Disorder I
√
Lam et al. (2003) United
Kingdom
To assess the effectiveness of a Cognitive Therapy for
reducing relapses and promoting social functioning for
patients with Bipolar Disorder.
                     Experimental      Control
Sample size:          52                  51
Females:                30                  28
Age:                       41.5(±10.8)   46.4 (±12.1)
Diagnosis:    Bipolar I
√
Lam et al. (2005) United
Kingdom
To investigate the long-term effect of Cognitive Therapy
(2-year follow-up) for patients with Bipolar Disorder.
                     Experimental      Control
Sample size:          52                   51
Females:                30                   28
Age:                      41.5 (±10.8)    46.4(±12.1)
Diagnosis:    Bipolar I
√
Perry et al. (1999) United
Kingdom
To determine if prodromal monitoring of manic and
depressive symptoms reduces rates of relapse for bipolar
patients.
                     Experimental     Control
Sample size:          34                    35
Females:                23                      4
Age:                         ?                      ?
Diagnosis:    Bipolar I & II
X
Scott et al. (2001) United
Kingdom
To explore the feasibility and potential benefits of
Cognitive Therapy for reducing relapse rates, hospital
admissions and improve quality of life for people with
Bipolar Disorder.
                      Experimental     Control
Sample size:          21                    21
Females:                11                    11
Age:                      40.5(±6.7)       37.8(±8.7)




USA To evaluate a multi-component care management
programme for people with Bipolar Disorder.
                       Experimental      Control
Sample size:          212                229
Females:                144                157
Age at onset:           44.1(±13.4)    44.3 (±12.9)












Ninety min sessions run by two research assistants
included prodromal monitoring, coping skills and
psychoeducation
Control group:









Definition of relapse: if participants met the DSM-
IV criteria for a manic or depressive episode,
and/or required hospital admission.
 i. Social functioning significantly improved in the
intervention group.
 ii. Social relationship subscale of the WHOQoLBREF
showed significant improvement for intervention
group.
 iii. 1 person in intervention group experienced relapse





Manualised psychoeducation delivered in a group
format.
Twenty-one sessions of 90 minutes consisting of: illness
awareness, treatment compliance, early detection of
prodromal symptoms and recurrences, and life style
regularity. Conducted by experienced clinical
psychologists + TAU
 Control group:
21 weeks of treatment as usual (TAU) i.e. standard
psychiatric care and pharmacological treatment, group

















a n d  p l a s m a
concentrations of
mood stabilisers.
Definition of relapse: participant fulfilling DSM-IV
criteria or clinical cut-offs on the YMRS and/or
HDRS)
 i. During intervention and at 2-year follow-up
significantly more participants in the control group
relapsed.
 ii. Time to reoccurrence was significantly shorter in
the control group for manic, depressive and mixed
episodes.
 iii. At follow-up significantly more patients in control
group had relapse for depressive episode when
compared with the experimental group but not
manic/Hypomanic episodes.
 iv. More patients in the control group were
hospitalised during treatment (non-significant
result) this result was significant at follow-up.
 v. No difference was observed between time to
hospitalisation for the two groups but people in
control group spent significantly more time in
hospital.
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As above Definition of relapse: A score of 12+ on the YMRS
or the HAM-D. Once relapse confirmed the DSM-IV
criteria was applied to determine polarity of the
episode.
 i. Significantly more patients in the control group
fulfilled criteria relapsed during the treatment and
follow-up stage compared to the treatment group.
 ii. Participants who relapsed in experimental group
had significantly longer period between episodes.
 iii. The number of total recurrences was significantly
lower in the treatment group.
 iv. Significantly fewer participants in the treatment
group experienced a manic, mixed, or depressive
episode in the follow-up stage when compared with
the control group.
 v. Significantly more patients in the control group
were hospitalised (N = 4) compared to patients in
the treatment group (N=0).
 vi. Significantly more patients in the control group
(N=9) were hospitalised at the follow-up stage
compared with 2 from the treatment group.
Colom et al.
(2009a)
As described in Colom et al. (2003a)
Follow-up period:
 5 year period, during this time all participants continued
to receive standard pharmacological treatment without




As above Definition of relapse/recurrence: Defined as the
emergence of a new acute episode according to
DSM-IV criteria and scores above or equal to 20
on the YMRS and 12 on the HDRS-17 for mixed
recurrence.
 i. The psychoeducation group had significantly fewer
recurrences and longer time between episodes.
When type of episode was reviewed a slightly
lower effect size was observed for depressive
episodes
 ii. People in the psychoeducation group spent
significantly fewer days ill: this was significant for
all types of episodes.
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significantly fewer days ill: this was significant for
all types of episodes.
 iii. Significantly fewer people in the psychoeducation
group were hospitalised. The median number of
days spent in hospital was significantly lower for
the psychoeducation group.
 iv. At five year follow-up there was no significant
between group differences in medication
adherence. There was a reduction in rates of non-




As described in Colom et al. (2003a) 20
weeks/ 5
years
As above Definition of relapse/recurrence: Defined as the
emergence of a new acute episode according to DSM-
IV criteria and scores above or equal to 20 on the
YMRS and 12 on the HDRS-17 for mixed recurrence.
 i. No between group differences in reoccurrence rates
(i.e. as defined by DSM-IV or indicated by YMRS
and/or HDRS) were observed during intervention
stage.
 ii. At five year follow-up there was a significant
difference in rates of relapse with more people in
control group (100%) relapsing.
 iii. Significantly more participants in the control group
experienced a Hypomanic episode.
 iv. Significantly more participants in the control group
experienced a depressive episode and a Hypomanic
episode.
 v. There was no significant difference regarding the
number of patients who required hospitalisation or
the mean number of days spent in hospital when




One to one CBT sessions.
Patients seen for an average of 15 sessions which
included: teaching of CBT skills to cope with
prodromes, identifying early warning signs &
implementing coping strategies, introduction of the
stress diathesis model, psychoeducation (e.g. importance
of sleep and routine, dealing with long term
vulnerabilities associated with illness). Four clinical
psychologists with a minimum of 6 years post





M R C ,  S P S ,
SCBS,  Ea r ly




Definition of relapse: any major bipolar episode
that fulfilled DSM-IV criteria for major
depression, mania, or hypomania.
 i. When data was adjusted for gender, previous
episodes, previous number of hospitalisations,
suicide attempts a significant effect for hypomanic
and total bipolar episodes was found was found
between the 2 groups.
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stress diathesis model, psychoeducation (e.g. importance
of sleep and routine, dealing with long term
vulnerabilities associated with illness). Four clinical
psychologists with a minimum of 6 years post
qualification experience delivered the treatment.
Control group:
TAU (routine outpatient care and appropriate MDT
input as required) The research team had no influence
over MDT input.
SADS. suicide attempts a significant effect for hypomanic
and total bipolar episodes was found was found
between the 2 groups.
 ii. The experimental group were significantly better at
coping with manic prodromes at 6 and 12 months
and significantly better at coping with depressive
prodromes at 12 months.
 iii. The experimental group had significantly lower
MAS score at 12 months. The experimental group
had significantly lower BHS at 6 months but not at
12-month follow-up.
 iv. Significant difference on the SPS score with an
improvement in the experimental group. The
experimental group had significant improvement
on the SCBS at 6 and 12 months.
 v. Experimental group had significantly lower BHS
scores over the 12-month period.





Cognitive Therapy manualised approach (CT) one to one
sessions
CT (information on diathesis-stress model; CBT for
mood monitoring, prodromal monitoring, behaviour
modification to manage prodromes, psychoeducation on
importance of sleep and routine, work on extreme
striving attitudes) lasted for 12-18 sessions within a 6-
month period. Two booster sessions in second 6 months
administered by four Clinical Psychologists (3 male,
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Definition of relapse/recurrence: Any major bipolar
episode that fulfilled DSM-IV criteria for major
depression, mania, or hypomania.
 vii. Significantly fewer relapses in experimental group
compared with control group.
 viii. The experimental group had significantly fewer
experiences of depressive, manic, hypomanic
episodes in 12 month period.
 ix. The experimental group spent significantly fewer
days in hospital.
 x. The experimental group had significantly fewer
days in hospital for depressive not manic episodes.
 xi. A significant reduction in BDI scores, across time,
occurred in the experimental group.






Cognitive Therapy manualised approach one to one
sessions.
CT (same as above regarding therapy content) consisted
of 12-18 individual sessions within 6 months and 2
booster sessions in second 6-months administered by
four Clinical Psychologists (3 male, experience 5 yrs +).

















Definition of relapse/recurrence: Any major bipolar
episode that fulfilled DSM-IV criteria for major
depression, mania, or hypomania.
 i. Significant between group differences for time to
first episode post intervention for depressive but
not manic/Hypomanic episodes. Experimental
group experiencing bigger time delay.
 ii. At follow-up:
 iii. A non-significant difference in proportion of
participants who had at least 1 relapse.
 iv. Significant between group differences for number
of days in a bipolar episode (previous episodes and
medication compliance controlled for) with
experimental group experiencing shorter episodes.
 v. Significant between group difference for DAS goal
attainment at 18 months, social functioning 24
months, coping with mania and depressive
prodromes at 24 months, mania ratings at 30
months in terms of the experimental group having
significantly better ratings compared to the control
group.
 vi. Based on self-report measures the experimental
group were more compliant at 24 and 30 compared




One to one therapy: 2-stage intervention was carried out
by 1 research therapist: 1) patients were trained to
identify manic and depressive prodromes. 2) An action
plan was planned and rehearsed. Prodromal symptom
information obtained via card sorting exercise and
standard checklist. Diaries used to identify symptoms
linked with normal mood variation. The patient
identified three health care professionals to approach for
early treatment (one of whom would be available at all
times). Relapse plan was printed on a laminated card the





SCID II Definition of relapse/recurrence: A minimum of 5
days of symptoms of mania, hypomania, mixed
affective disorder, or major depression according
to standardised symptom criteria.
 i. Time to first manic relapse was significantly longer
in th control group.
 ii. There was no significant difference in length of
manic episode between the two groups.
 iii. 18 months post study there was a significant
difference in overall social functioning and





One to one Cognitive Therapy sessions
Participants received up to 25 sessions. Therapy
included an approach for symptom management (self-
monitoring), relapse prevention techniques which
included prodromal monitoring and coping strategies for
identified early warning symptoms. Two therapists with
experience in working with severe affective disorders










Definition of relapse/recurrence: When participants
meet diagnostic criteria for an affective episode.
 i. Experimental group showed a significant reduction
in the following mood measures: BDI, ISS Dep,
ACT, PC and GAF. A non-significant
improvement was noted in the ISS_WB, CL-90 and
WASA data.
 ii. When WASA subscale analysis was done a
significant improvement in the CT group found for
social activities involving others.
 iii. A greater reduction in symptoms that met
diagnostic criteria for affective episode observed in
the experimental group but effect not significant.
 iv. A significant reduction in symptoms and
improvement in functioning found immediately
following CT compared with pre-CT ratings for
following measures: GAF, WASA, BDI, ISS Dep,
ISS ACT, Scl-90).
 v. A significant improvement also found pre CT and
at follow-up 18 months, however an increase in
symptoms was observed.
 vi. A significant change in mental state over time also
observed with fewer people meeting criteria for
relapse or persistent illness after CT.
 vii. Hospital admission rates were also lower pre and
post treatment: 1 year pre CT: 38%, during CT:




One to one assessment and group intervention
Received initial assessment (which included typical
early signs of mood episodes and coping strategies) and
care planning structured monthly telephone monitoring
of mood symptoms and medication use, feedback to
mental health team, additional support when required
(e.g. crisis intervention) and a structured
psychoeducation group. Care managers (nurse care
managers with minimum 5 years clinical experience)
administered the treatment. Group consisted of 5 weekly
sessions followed by twice monthly sessions for duration
of intervention. Stage 1 included early symptom
monitoring and coping strategies, education about
bipolar disorder, and triggers. Stage 2 focused on life
goals. Information on self-management plans (e.g. early








Definition of relapse/recurrence: Defined as the
clinical cut-offs on the SCID Psychiatric Status
Rating scale
 i. The treatment group had significantly lower scores
over 12 month period for mania symptoms.
 ii. There was a significant between group effect for
time spent in hospital (manic episode) with fewer
individuals in the experimental group having spent
time in hospital.
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psychoeducation group. Care managers (nurse care
managers with minimum 5 years clinical experience)
administered the treatment. Group consisted of 5 weekly
sessions followed by twice monthly sessions for duration
of intervention. Stage 1 included early symptom
monitoring and coping strategies, education about
bipolar disorder, and triggers. Stage 2 focused on life
goals. Information on self-management plans (e.g. early
symptom monitoring) were also updated in stage 2.
time in hospital.
 iii. No significant between group difference was found
for depressive scores throughout the follow-up
period.
 iv. A significant group x time interaction was found –
depressive symptoms in the experimental group
showed larger decline over time.
 v. No significant between group difference for
medication adherence (it is however unclear how or
whether medication adherence was monitored.)
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Appendix 6: In-depth study details for relevant research
(BDI = bipolar I disorder, BDII = bipolar II disorder).
1. Study name: Castle et al. (2007)                                                      county of origin: Australia
Aims
A pilot study designed to assess the effectiveness of a collaborative therapy package for people
with BD. A key aim was to assess whether the package reduced rates of relapse, improved global
functioning, and quality of life for people with BD.
Methods
recruitment: participants were referred by service providers at public and private treatment
facilities, self-referral, and nongovernmental organisations.
allocation: random
blinding: √
research setting: outpatient clinic
duration of study: 12 weeks                                                                 follow-up period: 3 months
inclusion criteria: current DSM-IV diagnosis of BD, 18 years old and over, able to converse in
English, under the care of a medical practitioner, no evidence of organic aetiology or
developmental disability.
exclusion criteria: if symptom severity would interfere with ability to take part in group
programme
Participants
diagnosis: BD I, BD II
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group           Experimental group
        age:                 44 (±8)                          44 (±13)
        female:              7                                   7
        sample size:       9                                  8
        attrition rate:    0                                  0
        information on marital status provided
Intervention description
Control group: TAU (i.e. pharmacological treatment and continued care by GP or psychiatrist) +
weekly phone calls to control for extra contact time with researchers
Experimental group: TAU + group-based intervention
Content of group intervention: group intervention delivered in an out-group setting once a week
for 90 minutes over a period of 12 weeks. Group content: education, peer support, new coping
strategies, managing and monitoring prodromes and cognitive skills. Participants encouraged to
record information in participant work book. Phone calls made between sessions to offer support
for homework tasks. Manualised approach used to ensure treatment fidelity. The groups were run
by 2 research assistants with clinical experience and training of psychosocial group interventions
and group activities.
Measures
Participants assessed at baseline and at 6 months regarding: psychiatric status, relapse rates,
social functioning, quality of life, and level of functioning.




ANCOVA and Ordinal Logistic Regression Analysis used (dependent variable was outcome
measure at 6 months, measure and baseline, independent variable was group type). Chi-square,
Mann-Whitney U Test, and T-Tests used to analyse baseline characteristics (depending on data
type).
Definition of relapse:
If participants met the DSM-IV criteria for a manic or depressive episode, and/or required
hospital admission.
Results:
Four control participants experienced relapse compared with one relapse in experimental group
(non-significant result).
Social functioning was found to significantly improve in the intervention group.
Social relationship subscale on the WHOQoLBREF showed significant results for intervention
group
Additional information
Are the tests appropriate for the data used: X some of the tests are inappropriate for sample size
of 17 participants (i.e. Ordinal Regression Analysis with 10 predictor variables)
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled? X
Sample size: small
Treatment fidelity measured: X
Methodological quality: moderate
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2. Study name: Colom, et al. (2003a)                                                         county of origin: Spain
Aims
To compare the efficacy of group psychoeducation with standard treatment
Methods
recruitment: participants were recruited from individuals enrolled in the naturalistic follow-up of
the Bipolar Disorders Program of the Hospital Clinic (University of Barcelona)
allocation: randomised
blinding: √
research setting: clinical setting
duration of study: 20 weeks                                                        follow-up period: 2 year
inclusion criteria: life time diagnosis of BD I or II, euthymic for at least 6 months,  ability to
provide consent, and sufficient data available for prior course of illness.
exclusion criteria: DSM-IV Axis l co-morbidity (not including caffeine and nicotine
dependence), IQ <70, organic brain damage, deafness, in current receipt of psychotherapy or
participating in a pharmacological trial.
Participants
diagnosis: BDI, BD II
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group               Experimental group
        Age at onset:             23.25 (7.55)           22.26 (6.69)
        female:                      38                           38
        sample size:                60                          60
        attrition rate:             7                            16
        no information on relationship status or employment status.
Intervention description
Control group: 21 weeks of treatment as usual (TAU) i.e. standard psychiatric care and
pharmacological treatment, group meetings 8-12 participants (without specific instruction from
psychologist)
Experimental group: TAU + manualised psychoeducation delivered in a group format (21
sessions of 90 minutes) consisting of: illness awareness, treatment compliance, early detection of
prodromal symptoms and recurrences, and life style regularity. Conducted by experienced clinical
psychologists.
Measures
 Baseline: SCID I and II, YMRS, HDRS-17, Holmes and Rahe inventory for stressful life events.
Medication compliance measured via interviews with participant and significant other and plasma
concentrations of mood stabilisers.
Outcomes
Overview of analysis:
Recurrence-Free Curve analysis using Kaplan-Meir survival analysis used. To explore between-
group baseline characteristics chi-square tests, t-test and fisher exact probability test was used
(depended on data type).
Definition of relapse:
Participant fulfilling DSM-IV criteria or clinical cut-offs on the YMRS and/or HDRS)
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Results:
During intervention and at 2 year follow-up significantly more participants in the control group
relapsed.
Time to reoccurrence was significantly shorter in the control group for manic, depressive and
mixed episodes.
At follow-up significantly more patients in control group had relapse for depressive episode when
compared with the experimental group.
At follow-up more patients in control group had manic and/or Hypomanic relapse (non-
significant result).
More patients in the control group were hospitalised during treatment (non-significant result)
At 12 month follow-up control group had significantly more hospital admissions significant
result.
The mean number of days in hospital was significantly higher for the control group.
No difference was observed between time to hospitalisation for the two groups.
At two year follow-up a significant difference was observed between the two groups regarding
Lithium levels but not valporate levels.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid?  X Participants not recruited from clinical setting
Medication adherence controlled for in analysis? √
Sample size: moderate
Treatment fidelity measured: √
Methodological quality: moderate
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3. Study name: Colom et al. (2003b)                                                         county of origin: Spain
Aims
To assess the efficacy of psychoeducation in euthymic patients with optimal treatment adherence.
Methods
recruitment: Patients recruited from a sample of 400 patients enrolled in the naturalistic
prospective follow-up of the Bipolar Disorders Program at the University of Barcelona.
allocation:
blinding: √
research setting: clinical setting
duration of study: 20 weeks                                                                  follow-up period: 2 years
inclusion criteria: DSM-IV criteria for Bipolar Disorder I, aged 18-65 years old, being euthymic,
score of <6 on the HAM-D, (<8 for minimum of 6 months), sufficient information on prior course
of illness, good treatment compliance demonstrated by three compliance assessments (patient and
significant other compliance interview and plasma concentrations of mood stabliser).
exclusion criteria: DSM-IV co-morbidity (except for caffeine and nicotine dependence), IQ <
70, organic brain damage, involvement in other forms of therapy during trial period.
Participants
diagnosis: BDI
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group            Experimental group
        Age at onset:       23.12 (7.36)               22.96 (7.05)
        Age:                     34.48 (7.80)               35.36 (10.87)
        female:                16                               15
        sample size:         25                              25
        attrition rate:        0                                0
        no information on marital or employment status.
Intervention description
Control group: 20 weeks of TAU (i.e. standard psychiatric care and pharmacological treatment,
group meetings 8-12 participants (without specific instruction from psychologist)
Experimental group: TAU + manualised psychoeducation delivered in a group format (20
sessions of 90 minutes) consisting of: illness awareness, treatment compliance, early detection of
prodromal symptoms and recurrences, and life style regularity. Conducted by two experienced
psychologists.
Measures
Baseline assessment (carried out by psychiatrist) involved: SCID-I and SID-II, YMRS, HAM-D,
Holmes and Rahe inventory for stressful life events. Information noted on medication and reasons
for change in medication. Assessed monthly by psychiatrist and weekly by a research assistant
for: information on number of hospitalisations, reasons for admission, total days spent in hospital,
symptom checking, treatment registration. Medication compliance assessed via compliance




Chi-square (or Fisher Exact Probability when required) used to examine dichotomous
demographic factors, relapse during follow-up. T-test was used to examine data regarding relapse
during treatment and follow-up. Recurrence curve analyses by Kaplan-Meyer’s survival analysis.
ANOVAs used to test the impact of CBT/PE on social scores and relapse rates. Analysis was on
an intention-to-treat analysis.
Definition of relapse:
A score of 12+ on the YMRS or the HAM-D. Once relapse confirmed the DSM-IV criteria was
applied to determine polarity of the episode.
Results:
Recurrences
Significantly more patients in the control group fulfilled criteria for recurrence during the
treatment and follow-up phase compared to the treatment group. When relapse patients reviewed
significant difference time to relapse (which showed longer time for treatment group).
The number of total recurrences were significantly lower in the treatment group.
Significantly fewer participants in the treatment group experienced a manic or mixed episode in
the treatment stage when compared with the control group.
Significantly fewer participants in the treatment group experienced a manic, mixed, or depressive
episode in the follow-up stage when compared with the control group.
Significantly more patients in the control group were hospitalised (N = 4) compared to patients in
the treatment group (N=0).
Significantly more patients in the control group (N=9) were hospitalised at the follow-up stage
compared with 2 from the treatment group.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: X no controlling but no significant differences
at baseline.
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis: X no but no between-group differences at
baseline or follow-up.
Sample size: moderate
Treatment fidelity measured: X
Methodological quality: moderate
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4. Study name: Colom et al. (2009a)                                                        county of origin:  Spain
Aims
To assess the long-term efficacy (5 years) of group psychoeducation designed to prevent
recurrences and to reduce time spent ill for people with Bipolar Disorder.
Methods
recruitment: participants were recruited from individuals enrolled in the naturalistic follow-up of
the Bipolar Disorders Program of the Hospital Clinic (University of Barcelona)
allocation: randomised
blinding: √
research setting: clinical setting
duration of study: 20 weeks                                                                   follow-up period: 5 years
inclusion criteria: life time diagnosis of BD I or II, euthymic for at least 6 months,  ability to
provide consent, and sufficient data available for prior course of illness.
exclusion criteria: DSM-IV Axis l co-morbidity (not including caffeine and nicotine
dependence), IQ <70, organic brain damage, deafness, in current receipt of psychotherapy or
participating in a pharmacological trial.
Participants
diagnosis: BDI, BD II
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                                  Control group              Experimental group
        Age:                           34.26 (7.80)          34.03 (9.32)
        Age at onset:             23.25 (7.55)          22.26 (6.69)
        female:                      38                          38
        sample size:              60                          60
        attrition rate:             7                          16
        attrition rate:            11                         10  at follow-up
        no information on marital or employment status
Intervention description
Control group: 21 weeks of TAU i.e. standard psychiatric care and pharmacological treatment,
group meetings 8-12 participants (without specific instruction from psychologist)
Experimental group: TAU + manualised psychoeducation delivered in a group format (21
sessions of 90 minutes) consisting of: illness awareness, treatment compliance, early detection of
prodromal symptoms and recurrences, and life style regularity. Conducted by experienced clinical
psychologists.
Follow-up periods was 5 years: during this time all participants continued to receive standard
pharmacological treatment without psychological intervention in the study centre.
Measures
Assessment of recurrences, symptom checking, and treatment registration was carried out every
two months. The following measures were used: SCID-I, SCID-II, YMRS, HRSD-17, Holmes
and Rahe inventory for stressful life events (also repeated if a new episode was suspected by the
psychiatrist).  Additional information that was recorded: reasons for medication change, number
of hospitalisations, reasons for admission, total number of days in hospital. Medication adherence
assessed through interview with participant, interview with significant other, analyses of plasma




Kaplan-Meyer’s survival analysis used to examine recurrence. Cox proportional hazards
regression analysis used to examine the association between number of previous episodes and
time to recurrence (independent of other predictors). Covariates that were included in analyses:
age at onset, number of previous episodes and number of hospitalisations. Analysis of baseline
measures carried out by chi-square, fisher z-test, and t-tests dependent on data type. At follow-up
chi-square used to examine number of patients who relapsed, ANCOVA used to examine
comparison of mean number of recurrences during the treatment and the follow-up phase
(covariates included age at onset, number of previous episodes, number of hospitalisations).
Definition of relapse/recurrence:
Defined as the emergence of a new acute episode according to DSM-IV criteria and scores above
or equal to 20 on the YMRS and 12 on the HDRS-17 for mixed recurrence.
Results:
Significant between-group differences found for time to recurrence (shorter time for the control
group).
The psychoeducation group had significantly fewer recurrences. When type of episode was
reviewed a slightly lower effect size was observed for depressive episodes (0.91 vs 0.80).
People in the psychoeducation group spent significantly fewer days ill: this was significant for all
types of episodes.
Significantly fewer people in the psychoeducation group were hospitalised. The number of
individuals hospitalised was lower in the psychoeducation group: this difference was not
significant. The median number of days spent in hospital was significantly lower for the
psychoeducation group.
At five year follow-up there was no significant between-group differences in medication
adherence. There was a reduction in rates of non-adherence for both groups from entry to 5-year
follow-up.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis: X (but no between-group differences)
Sample size: good
Treatment fidelity measured: √
Methodological quality: moderate
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5. Study name: Colom, et al. (2009b)                                                        county of origin: Spain
Aims
To carry out a post-hoc analysis of data for BD II patients from a larger study (Colom et al.
2009a)
Methods
recruitment: participants were recruited from individuals enrolled in the naturalistic follow-up of
the Bipolar Disorders Program of the Hospital Clinic (University of Barcelona)
allocation: randomised
blinding: √
research setting: clinical setting
duration of study: 20 weeks                                                                      follow-up period: 5 year
inclusion criteria: life time diagnosis of BD I or II, euthymic for at least 6 months,  and
sufficient data available for prior course of illness., ability to provide consent
exclusion criteria: DSM-IV Axis l co-morbidity (not including caffeine and nicotine
dependence), IQ <70, organic brain damage, deafness, in current receipt of psychotherapy or
participating in a pharmacological trial.
Participants
diagnosis: BDII
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group                Experimental group
        Mean age:        40                                 40
        female:                ?                                  ?
        sample size:      12                                  8
        attrition rate:     0                                  0 (sub-analysis from previous study)
        limited demographic information. No information on marital or employment status.
Intervention description
Control group: 21 weeks of treatment as usual (TAU) i.e. standard psychiatric care and
pharmacological treatment, group meetings 8-12 participants (without specific instruction from
psychologist)
Experimental group: TAU + manualised psychoeducation delivered in a group format (21
sessions of 90 minutes) consisting of: illness awareness, treatment compliance, early detection of
prodromal symptoms and recurrences, and life style regularity. Conducted by experienced clinical
psychologists.
Measures
 Baseline: SCID I and II, YMRS, HDRS-17, the SOFAS, and Holmes and Rahe inventory for
stressful life events. Information on relapse rates, and hospitalisation recorded.
Outcomes
Overview of analysis:
The comparison of the baseline characteristics was carried out using Chi-Square, Mann Whitney
U-Test and Fisher’s Z dependent on the data type.
Definition of relapse/recurrence:
Defined as the emergence of a new acute episode according to DSM-IV criteria and scores above
or equal to 20 on the YMRS and 12 on the HDRS-17 for mixed recurrence.
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Results:
No between-group differences in reoccurrence rates  were observed during intervention phase. At
five year follow-up there was a significant difference in rates of relapse with more people in
control group (100%) relapsing compared with intervention group (62.5%). Significantly more
participants in the control group experienced a Hypomanic episode. Significantly more
participants in the control group experienced a depressive episode (100%) compared with the
intervention group (63%). The control group spent significantly more days with symptoms of
hypomania and depression. There was no significant difference regarding the number of patients
who required hospitalisation or the mean number of days spent in hospital. There were significant
between-group differences on the SOFAS scores at 2- and 5-year follow-up; the scores indicated
an improvement in the experimental group.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled:  √ BUT medication adherence not reported or
included in analysis
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis: X
Sample size: small
Treatment fidelity measured: X
Methodological quality: moderate
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6. Study name: Lam et al. 2000                                                county of origin: United Kingdom
Aims
To assess the effectiveness of a time-limited relapse prevention package for Bipolar Disorder on
mood stability and experience of frequent relapse.
Methods
recruitment: patients were approached to take part. Specific information not provided.
allocation: random
blinding: √
research setting: clinical setting
duration of study:  6 months                                                             follow-up  period: 12 months
inclusion criteria: DSM-IV diagnosis of Bipolar Disorder, on prophylactic treatment, minimum
of 2 episodes in the last two years or 3 in last 5 years, aged 18-65 years.
exclusion criteria: diagnosed with schizoaffective illness, currently in rapid cycling or mixed
affective episode, currently in acute episode (BDI > 30, MRSS >9), involved in another form of
psychotherapy, actively suicidal, with a primary alcohol or drug addiction.
Participants
diagnosis: BDI
matched on demographic variables at baseline: X
matched on illness-related factors (e.g. no. of episodes) at baseline: X matched on number of
previous episodes but control group had significantly more hospitalisations and suicide attempts.
                              Control group            Experimental group
        sample size:          12                               13
        attrition rate:         1                                 1
         demographic information given for two groups as a whole:
         Mean age: 39 (10.9)
         Female: 13
         Information on marital and employment status provided.
Intervention description
Control group: TAU (routine outpatient care and appropriate MDT input as required) The
research team had no influence over MDT input*.
Experimental group: TAU + CBT sessions (patients seen for an average of 15 sessions) which
included: CBT skills to cope with prodromes, taught to identify early warning signs and
implement coping strategies, psychoeducational model for Bipolar Disorder (i.e. stress diathesis
model), importance of sleep and routine, dealing with long term vulnerabilities associated with
illness. Patients were offered up to 20 sessions and clinical judgement was used to determine how
many sessions to offer patients.
Four clinical psychologists with a minimum of 6 years post qualification experience delivered the
treatment.
Measures
 MAS, ISS, BHS, MRC, SPS, SCBS, Early Warning and Coping Interview, MCQ, MHVT.
SADS used at recruitment, 6 and 12 months. Diagnosis of Bipolar episodes made by information




Chi-square test used to analyse dichotomous data, Poisson regression for counts used to
investigate number of episodes, ANOVA used for continuous variables and ANCOVA used when
appropriate.
Definition of relapse/recurrence:
Definition of relapse: any major bipolar episode that fulfilled DSM-IV criteria for major
depression, mania, or hypomania.
Results:
Episodes:
Significantly more manic, hypomanic, depressed, total episodes and hospitalisation in the control
group.
When data was adjusted for gender, previous episodes, previous number of hospitalisations,
suicide attempts a significant effect for hypomanic and total bipolar episodes was found.
Mood measures (6 months and 12 months):
The experimental group had lower mean scores at 6 and 12 months on the BDI, BHS, HRSD,
MAS. The difference did not reach statistical significance. The experimental group had
significantly lower MAS and scores at 12 months. The experimental group had significantly
lower BHS at 6 months but not at 12 month follow-up. Significant differences on the SPS score
with an improvement in the experimental group. The experimental group had significant
improvement on the SCBS at 6 and 12 months. The experimental group were significantly better
at coping with manic prodromes at 6 and 12 months. Also significantly better at coping with
depressive prodromes at 12 months. Monthly measures of BDI, BHS, ISS, MCQ:
Experimental group had significantly lower BHS scores over the 12-month period. Experimental
group had significantly better medication compliance. However, experimental group had lower
medication adherence and higher BHS scores at follow-up compared to scores at 6 months.
Fluctuation in the experimental group scores on the BDI, BHS, MCQ and ISS found over the 12-
month period.
Medication:
No significant difference in terms of no. of participants, in each group, being prescribed Lithium
and carbamazepine, antidepressants at recruitment, 6 and 12 months.
A significantly higher proportion of participants in the control group were on neuroleptics at 12
months. More participants in the control group were on 2+ types of mood stabilisers over the 12
month period.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? Unclear how participants approached.
Medication adherence controlled for in analysis: X
Sample size: small
Treatment fidelity measured: supervision provided and therapy sessions were audio-taped,
however, no information provided on how taped sessions reviewed.
Methodological quality: moderate
13
7. Study name: Lam et al. (2003)                                                              county of origin: UK
Aims
To assess the effectiveness of Cognitive Therapy compared to TAU as a means of preventing
relapses and promoting social functioning.
Methods
recruitment: via psychiatrist referral or from maintenance clinic list
allocation: random
blinding:   √
research setting: clinical setting
duration of study: 6 months                                                   follow-up period: 12 months
inclusion criteria: prescribed adequate dose of prophylactic medication; aged 18-70; at least 2
episodes in past 2 years or 3 in past 5 years; not fulfilling criteria for a episode.
exclusion criteria: actively suicidal (assessed by BDI suicide item score of 3); fulfilling
criteria for substance use disorder
Participants
diagnosis: BDI according to DSM-IV
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group           Experimental group
        age:                M= 46.4 (±12.1)                41.5 (±10.8)
        age of onset    26.2 (9.5)                           28.2 (11.4)
         female:          28                                      30
        sample size:    51                                      52
        attrition rate:   15.68%                             15.68%
        no information on marital status or employment status.
Intervention description
Control group: TAU
Experimental group: Cognitive Therapy manualised approach (CT) + TAU
CT consisted of 12-18 individual sessions within 6 months and 2 booster sessions in second 6
months administered by 4 Clinical Psychologists (3 male, experience 5 yrs +)
Content of CT: information on diathesis-stress model; CBT for mood monitoring, prodromal
monitoring, behaviour modification to manage prodromes, psychoeducation on importance of
sleep and routine, work on extreme striving attitudes.
Measures
SCID-IV, MRCSPS, MHV (1995 Ed), Coping with Prodromes Interview, BDI, ISS, BHS,
control subscale of DAS, MCQ.




Group differences explored using the Chi-Square test for ordinal data and the Spearman
Correlation Coefficient for skew data, ANOVA was used for continuous variables, and Cox
Regression was used for survival analysis (number of weeks to first episode was the dependent
variable). Logistic Regression was used to explore the proportion of participants who relapsed
in each group.
Definition of relapse/recurrence:
Any major bipolar episode that fulfilled DSM-IV criteria for major depression, mania, or
hypomania.
Results:
Significantly fewer relapses (i.e. any bipolar episode that fulfilled DSM-IV criteria for major
depression, mania or hypomania) in CT compared with control group.
The experimental group had significantly fewer experiences of depressive, manic, hypomanic
episodes in 12 month period.
The experimental group spent significantly fewer days in hospital for BD episodes.
The experimental group had significantly fewer days in hospital for depressive episodes.
Mood measures
A significant reduction in BDI scores, across time, occurred in the experimental group.
There was a significantly greater degree of mood fluctuation in the control group.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled? √
Sample size: moderate
Treatment fidelity measured: X
Methodological quality: high
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8. Study name: Lam et al. (2005)                                             county of origin: United Kingdom
Aims
To investigate long-term effect of CBT at 2 year follow-up to provide an estimate of the enduring
effect of cognitive therapy. This study was a follow-up study to Lam et al. (2003).
Methods
recruitment: via psychiatrist referral or from maintenance clinic list
allocation: random
blinding:   √
research setting: clinical setting
duration of study: 6 months                                                              follow-up period: 12 months
inclusion criteria: prescribed adequate dose of prophylactic medication; aged 18-70; at least 2
episodes in past 2 years or 3 in past 5 years; not fulfilling criteria for a episode.
exclusion criteria: actively suicidal (assessed by BDI suicide item score of 3); fulfilling criteria
for substance use disorder
Participants
diagnosis: Bipolar I according to DSM-IV
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √
                              Control group            Experimental group
        age:                M= 46.4 (±12.1)                41.5 (±10.8)
        female:                  28                               30
        sample size:           51                                52
        attrition rate:       15.68%                       15.68%
        no information on marital or employment status.
Intervention description
Control group: TAU
Experimental group: Cognitive Therapy manualised approach (CT) + TAU
CT consisted of 12-18 individual sessions within 6 months and 2 booster sessions in second 6
months administered by 4 Clinical Psychologists (3 male, experience 5 yrs +)
Content of CT: information on diathesis-stress model; CBT for mood monitoring, prodromal
monitoring, behaviour modification to manage prodromes, psychoeducation on importance of
sleep and routine, work on extreme striving attitudes. Seen for an average of 14 sessions.
Measures
 At 6-month intervals blind assessors administered the SCID, HDRS, BRMRS, Coping with
Prodromes Schedule, SFS, (patients’ description of coping with prodromes was transcribed
verbatim), DAS, MCS completed by key workers.
Outcomes
Overview of analysis:
The Chi-Square test was used to analyse dichotomous variables, ANOVA for continuous
variables, Cox regression for survival analysis (no. of weeks to first episode entered as a
dependent variable), Logistic Regression used to compare proportions of patients who had
relapsed in the two groups. ANCOVA used when appropriate.
Definition of relapse/recurrence:




Survival analysis of number of weeks to first episode:
Significant between-group differences for time to first episode post intervention for depressive
but not manic/Hypomanic episodes. With experimental group experiencing bigger time delay.
18 month follow-up:
Non-significant difference in proportion of participants who had at least 1 relapse.
Significant between-group differences for number of days in a bipolar episode (previous episodes
and medication compliance controlled for) with experimental group experiencing shorter
episodes.
Mood measures (number of previous episodes and medication compliance entered as covariates):
Significant between-group difference for DAS goal attainment at 18 months, social functioning
24 months, coping with mania and depressive prodromes at 24 months, mania ratings at 30
months in terms of the experimental group having significantly better ratings compared to the
control group.
Medication:
No significant between-group differences with the exception of number of mood stabilisers
prescribed at 18 month period.
Based on self-report measures the experimental group were more compliant at 24 and 30
compared with the control group regarding their medication.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis: √
Sample size: good




9. Study name: Perry et al. (1999)                                           county of origin: United Kingdom
Aims
To determine the efficacy of teaching patients with bipolar disorder to identify early warning
symptoms associated with their relapse (both manic and depressive episodes). Also under
investigation was whether patients would seek help from health care professionals once early
warning symptoms were identified.
Methods
recruitment: Patients with a clinical diagnosis of BD were identified from computerised patient
records of hospital admission to 3 NHS trusts. Patients were approached their psychiatrist and key
worker thought they were suitable candidates. Patients were also referred for possible study
inclusion by consultant psychiatrists and mental health workers in the three trust research sites.
allocation: Random allocation based on four stratification factors: age (18-40 years/41 to 75
years), sex, use of Lithium, and presence/absence of carer (defined as 10hrs of contact with
patient – unclear over what time period, e.g. day or week).
blinding: √ single blind randomised controlled trial. (Study raters unaware of conditions but
therapists and patients aware of condition.)
research setting: Mental health setting
duration of study: 12 weeks                                                              follow-up period: 15 months
inclusion criteria: life time diagnosis of BD (assessed by trained research assistants using the
SCID-III), 2+ relapses (1 of which occurred in previous 12 months), aged 18-75 years old.
exclusion criteria: inability to read/write in English, substance misuse/dependence as primary
problem, organic cerebral cause for BD. No information on how exclusion criteria assessed.
Participants
diagnosis: bipolar disorder (type 1 and type 11 or both)
matched on demographic variables at baseline:
matched on illness-related factors (e.g. no. of episodes) at baseline:
                                                Control group             Experimental group
        age at onset:                       ?                                         ?
        median duration of BD:   11 years (2-41)                  12 years (2-34)
        female:                              24                                       23
        sample size:                      35                                       34
        attrition rate:                     0                                          1
        information on relationship and employment status provided
Intervention description
Control group: Patients in this group received routine care delivered by psychiatrists, key
worker, and general practitioner that included drug treatment, mood monitoring, adherence to
treatment, support, education about bipolar disorder, and inpatient care (when required).
Experimental group: One research therapist carried out the intervention. A two-stage
intervention was used: 1) patients were trained to identify manic and depressive prodromes. 2) An
action plan was planned and rehearsed. Prodromal symptom information obtained via card sorting
exercise and standard checklist. Diaries used to identify symptoms linked with normal mood
variation. The patient identified three health care professionals to approach for early treatment




Trained research assistants administered the SCID and a measure of social functioning (Hurry et
al., 1983). Patients’ psychiatrists and key workers were contacted by the research assistant, on a
monthly basis, for patient contact and relapse information. If a relapse was identified a research
assistant interviewed the patient using the SCID-III to date the relapse. Information on drug
treatment and contact with mental health services was collected via the patient files on a six
monthly basis by the research assistant.
Outcomes
Overview of analysis
Manic and depressive treated as independent variables. Time to relapse analysed using log rank
test. The data on relapse was analysed using t-test test, Mann Whitney U tests, and median
differences tests with 95% confidence intervals. Intent to treat analysis carried out.
Definition of relapse: A minimum of 5 days of symptoms of mania, hypomania, mixed affective
disorder, or major depression according to standardised symptom criteria (the two week duration
criterion for major depression was not adhered to for this outcome measure.
Results
Time to first manic relapse was 65weeks in the experimental group and 17 weeks in the control
group (significant between-group difference) and time to first depressive relapse was 21 weeks in
the experimental group and 26 weeks in the control group (non significant result).
There was no significant difference in length of manic episode between the two groups.
18 months post study there was a significant difference in overall social functioning and
employment in the experimental group.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Are the two groups matched on relevant factors: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis: √
Sample size: good
Treatment fidelity measured: X
Methodological quality: moderate
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10. Study name: Scott et al. 2001                                             county of origin: United Kingdom
Aims
To explore the feasibility and potential benefits of CT (i.e. improved general functioning and
reduced relapse and hospitalisation rates) pre, during and post intervention.
Methods
recruitment: A letter was sent to general adult psychiatry working within the Newcastle area
asking individuals to refer patients for consideration for study inclusion.
allocation: randomised allocation
blinding: √
research setting:  unclear from information provided in the paper
duration of study:  6 months                                                              follow-up period: 18 months
inclusion criteria: minimum age 18 years old, Bipolar I and II, a minimum of 1+ episode in the
last 2 years.
exclusion criteria: Bipolar Disorder secondary to organic disorder, severe physical ill health,
cognitive impairment sufficient to impair judgement to consent, unable to willingly give written
consent. I
If a potential participant was in an acute setting at time of referral or met criteria for mania they
were accepted at point of discharge or when mental state was stable to enable capacity to consent.
Participants
diagnosis: BD I and II
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: √ (* 6 more BDI
participants in experimental group)
                              Control group        Experimental group
        age:                     37.8 (8.7)                     40.5 (6.7)
        age at onset:       24.2 (10.5)                   24.7 (12.4)
        female:                14                                11
        sample size:         21                               21
        attrition rate:        6                                 3
        information on employment or marital status
Intervention description
Control group: 6 month WLC who received TAU (i.e. medication, out patient and other services
as previously. Participants in this group were given the opportunity to receive CBT once study
period completed.
Experimental group: Participants in this group received up to 25 sessions of one to one CT after
an initial assessment and TAU. CT included approached for symptom management (self-
monitoring), relapse prevention techniques which included prodromal monitoring and coping
strategies for identified early warning symptoms. Two therapists with experience in working with
severe affective disorders delivered the therapy.
Measures
 A semi-structured interview (carried out by an independent psychiatrist) and hospital records
were used to gain information on: demographic, pre-morbid personality, social functioning,
current and past psychiatric history, current treatments and services received, medication
adherence. Independent psychiatrist completed the SADS-L and the GAF. Participant self-report




Chi-square was used to explore baseline differences for dichotomous data, ANOVA used for
continuous variables, ANCOVA used to assess change in symptoms and functioning by group
and time (covariates: age, age of onset, and gender). To explore pre and post relapse and
hospitalisation rates chi-square tests used. Paired t-tests used to explore CT ratings.
Definition of relapse/recurrence:
When participants meet diagnostic criteria for an affective episode.
Results:
No between-group differences observed or age, gender, illness-related factors, and personal
characteristics. Five participants in the experimental group and 7 in the control group met criteria
for drug/alcohol dependence/problems, 60% of participants met criteria for personality disorder
(BD – 15, antisocial – 11, 14 participants met criteria for 1+ disorders).
No significant difference was found on symptom ratings at baseline.
WLC showed little change between baseline and 6 month assessment whereas the CT group
showed a significant reduction in the following mood measures: BDI, ISS Dep, ACT, PC and
GAF. A non-significant improvement was noted in the ISS_WB, CL-90 and WASA data.
When WASA subscale analysis was done a significant improvement in the CT group found for
social activities involving others.
No between-group was observed fro medication or TAU received.
Relapse rates:
A greater reduction in symptoms that met diagnostic criteria for affective episode observed in the
CT group but effect not significant.
Changes in symptoms and functioning (data from 29 participants including those who took part in
the control group but later took up offer of CT):
A significant reduction in symptoms and improvement in functioning found immediately
following CT compared with pre-CT ratings for following measures: GAF, WASA, BDI, ISS
Dep, ISS ACT, Scl-90).
A significant improvement also found pre CT and at follow-up 18 months, however an increase in
symptoms was observed.
A significant change in mental state over time also observed with fewer people meeting criteria
for relapse or persistent illness after CT.
Hospital admission rates were also lower: 1 year pre CT: 38%, during CT: 0%, and 1 year post
CT: 7%.
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √
Medication adherence controlled for in analysis:  X but no significant between-group differences
Sample size: moderate
Treatment fidelity measured: X
Methodological quality: moderate
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11. Study name: Simon et al. (2005)                                                           county of origin: USA
Aims
To evaluate a multi-component care management programme for people with Bipolar disorder.
Methods
recruitment: Patients were enrolled at a Model Behaviour Health clinics. Potential participants
identified through computerised visits and hospital records. People with a diagnosis of Bipolar I
and II were invited to a baseline assessment.
allocation: random
blinding: √
research setting: clinical setting
duration of study:   unclear                                                                follow-up period: 12 months
inclusion criteria: minimum age of 18 years old, diagnosis of BD I and II confirmed by SCID or
a record review.
exclusion criteria: cognitive impairment severe enough to preclude ability to consent.
Participants
diagnosis: BD I and II
matched on demographic variables at baseline: √
matched on illness-related factors (e.g. no. of episodes) at baseline: ?
                              Control group        Experimental group
        Age at onset:       44.3 (12.9)                44.1 (13.4)
        female:                157                           144
        sample size:        229                           212
        attrition rate:       14                            13
Intervention description
Control group: TAU
Experimental group: Received initial assessment (which included typical early signs of mood
episodes and coping strategies) and care planning structured monthly telephone monitoring of
mood symptoms and medication use, feedback to mental health team, additional support when
required (e.g. crisis intervention) and a structured psychoeducation group. Care managers (nurse
care managers with at least 5 years clinical experience) provided the above treatment.  A
collaborative treatment plan was developed based on assessment information. The group
programme was adapted from Bauer and McBride’s Life Goals Program (Bauer and McBride,
2003). Group consisted of 5 weekly sessions followed by twice monthly sessions for duration of
intervention. Phase 1 included early symptom monitoring and coping strategies, education about
bipolar disorder, and triggers. Phase 2 focused on life goals. Information on self-management
plans (e.g. early symptom monitoring were also updated in phase 2).
Measures
 SCID (at assessment and to confirm a suspected relapse), ISS (monthly), medication use record,
PSR score based on information from SCID. At follow-up SCID and LIFE administered.  Follow-
up measures were administered every 3 months. The follow-up was carried out by mental health




Repeated measures linear model with relevant baseline characteristics used (age, sex, depression
severity, mania severity, psychological symptoms, substance abuse and recent hospitalisations).
Intent to treat analysis carried out.
Definition of relapse/recurrence:
Defined as the clinical cut-offs on the SCID Psychiatric Status Rating scale
Results:
Mania scores
The treatment group had significantly lower scores over 12 month period for mania symptoms.
No significant between-group scores found for time with mania symptoms.
There was a significant between-group effect for time spent in hospital (manic episode) with
fewer individuals in the experimental group having spent time in hospital.
Depression
No significant between-group difference was found for depressive scores throughout the follow-
up period.
A significant group x time interaction was found – depressive symptoms in the experimental
group showed larger decline over time.
Medication
No significant between-group difference for medication (it is however unclear how or whether
medication adherence was monitored.)
Additional information
Are the tests appropriate for the data used: √
Are confounding variables adequately controlled: √
Is the research ethical? √
Is the design ecologically valid? √ But issues with generalisability to other health care centres
Medication adherence controlled for in analysis X
Sample size: √ but below the number given by the power calculation.
Treatment fidelity measured: X
Methodological quality: high
